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Fracture and cell cytotoxicity are major problems associated with implant loosening, 
postoperative infection and ultimate implant failure.  This project aims to characterize the 
tensile properties, fatigue performance and biocompatibility of a novel Titanium Graphite 
composite.  This metal matrix composite, patented by SH Teoh et al, has the potential to 
deliver high wear resistance, superior durability and good biocompatibility. 
 
Titanium-graphite composites with 5-wt% and 10-wt% graphite were fabricated using 
powder metallurgy.  Commercial purity titanium was thoroughly mixed with high purity 
graphite powder, compacted via the blended elemental method and hot isostatically 
pressed to form metal matrix composites. The fabricated had generally low porosities of 
below 2% and exhibited a triphasic microstructure comprising equiaxed titanium grains, 
titanium carbide and unreacted graphite. 
 
The tensile properties of the composites were investigated using a universal testing 
machine. The composites displayed good tensile stiffness, but relatively poor tensile 
strengths. The fatigue performance of the composites was also evaluated by applying a 
sinusoidal uniaxial tensile load of frequency 20 Hz and Stress Ratio 0.1, under laboratory 
conditions. The Endurance Limit of the composites under cyclic tensile loads was found 
to be lower than that of pure titanium. Post-testing measurements of the oxide content of 
the composites revealed that the composites had a relatively high oxide content of 0.5%, 
which resulted in embrittlement, and hence poor fatigue and tensile performance.  
 
 x 
Biocompatibility studies were conducted on the composites, their wear debris, as well as 
the raw powder used to fabricate the composites. The 3T3 fibroblast cell line and primary 
rat osteoblast cells were used in these experiments. The cells were either cultured with 
the wear debris or raw powder particles, or were seeded on the polished surfaces of the 
composites. Cell proliferation was evaluated using the alamarBlueTM assay, while cellular 
viability was determined by observation under a fluorescence microscope, after the cells 
have been stained with a mixture of Calcein AM  and Ethidium homodimer-1. The results 
indicated that the titanium graphite composites, and their wear debris, did not adversely 
affect cellular proliferation nor viability, and hence display good biocompatibility. 
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In designing long-lasting and functional joint prosthetic implants, engineers and 
clinicians face two major obstacles, namely biocompatibility and durability. Wear 
and fatigue fracture account for most implant failures. Wear, apart from 
weakening and roughening the surface of the implant, also generates debris, 
which cause adverse tissue reactions, eventually leading to substantial loss of 
bone around the implant and consequently loosening of the fixation.  
 
Titanium and its alloys have been extensively studied and is the most widely used 
biometal for its relatively low modulus, high strength to weight ratio, excellent 
corrosion resistance and biocompatibility.  Titanium, however, exhibits poor wear 
resistance. In an effort to improve on the wear resistance of titanium, a titanium-
graphite metal matrix composite was developed and patented by NUS [1]. In 2002, 
NUS signed a Memorandum of Understanding with the National Institute for 
Materials Science, Japan, to further improve on the patented material, as well as 
to characterize its properties. The main aim of this project was the study of the 
feasibility of the improved titanium-graphite composite for use as an orthopedic 
biomaterial. The microstructure of the said composite would be extensively 
characterized. The tensile mechanical properties and long term durability, in terms 
Chapter 1: Introduction 
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of resistance to fatigue would be examined. In addition, the biocompatibility of 




In the industrialized world, advances in medical care have increased the average 
life-span of the population. These advances, however, represent a doubled edged 
sword. The human body has not been able to evolve to the extent necessary to 
function optimally in our twilight years. As a result, debilitating diseases such as 
osteoarthritis, bone cancer and avascular necrosis plague the elderly. In America, 
for instance, 165 000 hip replacements and 326 000 knee replacements are 
performed in 2001 [2]. Total joint replacements with metallic alloys and synthetic 
polymers have revolutionized the treatment of end-stage arthritis over the past 
three decades. Total joint arthroplasty provides dramatic pain relief and vast 
improvement in joint function for patients with a variety of end-stage joint 
diseases, and approximately half a million such operations are performed 
worldwide, at a cost exceeding five billion dollars annually. There is therefore an 
enormous economic potential o be reaped in the field of biomaterials. There are 
currently thousands of medical devices available and the global medical devices 
market is estimated to be worth US$169 billion. [3].   
 
Of even greater significance is the impact of biomaterials in improving the quality 
of life of patients. Ever since the first hip prosthesis was fabricated by Charnley in 
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November 1962, [4] a wide variety of hip prosthesis have been developed and 
clinically tested. The more successful prostheses include metal-on-metal 
(comprising 316 stainless steel, cobalt-chromium alloys, titanium), metal-on-
polymer (comprising metal femoral heads and ultra high molecular weight 
polyethylene (UHMWPE) acetabular cups), ceramic-on-ceramic (consisting of 
alumina and zirconia heads and cups), and ceramic-on-polymer (comprising 
ceramic heads and UHMWPE cups). Whilst these prostheses have achieved 
commendable success in relieving pain and improving mobility of the patients, 
problems of poor long-term durability abound. Few of these prostheses survive 
beyond 25 years [5].  
 
The major long term complications of total joint arthroplasty are aseptic loosening 
and periprosthetic osteolysis, resulting in implant failure, bone stock deficiency, 
periprosthetic fractures, and subsequent revision surgery. Revision surgery in 
such cases is particularly difficult and often requires the use of special 
components and massive bone grafts.  In some cases the extent of bone loss is so 
massive as to preclude revision surgery altogether. One of the theories put 
forward to explain the occurrence of aseptic loosening and periprosthetic bone 
loss postulates that these related processes reflect an adverse cellular response to 
degradation products of implant materials [6]. The degradation products are 
produced by corrosion and wear, which generates millions of particles annually in 
the preiprosthetic space [7, 8]. Improving on the wear resistance of the prostheses 
is thus fundamental to their long-term performance. It is with these concerns in 
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mind that a novel titanium-graphite biomaterial was developed by Teoh et al [SH 
Teoh, R Thampuran, WKH Seah and JCH Goh. Sintered titanium - graphic 
composite having improved wear resistance and low frictional characteristics. U.S. 
Patent 5,758,253, May 26, 1998.]. The main desirable mechanical characteristics 
of an ideal hip implant are as follows: 
1) good biocompatibility; 
2) excellent corrosion resistance in body fluids;  
3) an elastic modulus close to that of bone, such that stresses are transferred 
effectively to the surrounding bone, thus encouraging bone ingrowth;  
4) has a surface capable of allowing stable attachment to bone;  
5) has a low coefficient of friction; and  
6) has high wear resistance.    
 
The triphasic sintered and hot isostatically pressed titanium-graphite composite 
(Figure 1.1) developed by powder metallurgy could potentially meet these 
requirements. It has a lubricating phase made up of free graphite, a hard wear 















Figure 1.1: Triphasic Titanium-Graphite 5-wt% composite 
 
1.3 Objectives and Scope 
Previous work involving the titanium-graphite composite have focused on the 
tribological characteristics and performance of the said composite in a hip wear 
simulator. This study aims to fully characterize the metallographic, mechanical 
and cytotoxic properties of the composite and the wear debris generated. 
Specifically, the objectives and scope of this project are: 
1) To characterize in depth the microstructure and porosity of the composites; 
2) To determine the tensile strength and modulus of the composites; 
3) To determine the fatigue performance of the composites; 
4) To generate and characterize the wear debris; 





Chapter 1: Introduction 
6 
3T3 fibroblast cell line and primary rat osteoblast culture; 
6) To determine if the polished surfaces of the sintered compacts promote   
adhesion of 3T3 fibroblast cell line and primary rat osteoblast culture; and 
7) To study the cytotoxicity of the polished surfaces of the sintered  






















2.1 History of Titanium  
Titanium is the ninth most abundant element in the earth’s crust. Titanium was 
discovered in England by Reverend William Gregor in 1791. He recognized the 
presence of a new element in ilmenite, and named it menachite. At around the 
same time, Franz Joseph Muller also produced a similar substance, but could not 
identify it. The element was independently rediscovered several years later by 
German chemist Martin Heinrich Klaproth in rutile ore. Klaproth confirmed it as 
a new element and in 1795 he named it for the Latin word for Earth (also the 
name for the Titans of Greek mythology). 
 
Titanium has always been difficult to extract from its various ores. Pure metallic 
titanium (99.9%) was first prepared in 1910 by Matthew A. Hunter by heating 
TiCl4 with sodium in a steel bomb at 700-800°C in the Hunter process. Titanium 
metal was not used outside the laboratory until 1946 when William Justin Kroll 
proved that titanium could be commercially produced by reducing titanium 
tetrachloride with magnesium in the Kroll process which is the method still used 
today. 
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Titanium has a density of 4.54 g/cm3 and exists in two forms; α-titanium, which 
has a hexagonally closed-packed (HCP) crystalline structure and β-titanium, 
which has a body centred cubic (BCC) crystalline structure.  At room temperature, 
the α-titanium predominates, unless the metal is alloyed with other metals known 
as β-stabilizers. However, when titanium is heated to 880 oC, which is below its 
melting point of 1660 oC, the HCP α-phase transforms into the BCC β-phase. This 
temperature is known as the α-to-β transition temperature. 
 
The large scale use of titanium and its alloys for orthopaedic applications began in 
the early 1970s. This was spurred, in large part, by the poor performance of cast 
and CoCr femoral stems, which displayed poor fatigue performance and high 
degree of proximal bone resorption, due to the excessive stiffness of the material. 
Interest in titanium and its alloys grew rapidly in Europe and North America in 
the second half of the 1970s. Titanium and its alloys offered several advantages 
over other metals for use as orthopaedic implants. Firstly, they are less stiff and 
have higher strength than the CoCr implants. Their relatively low stiffness 
enabled a more physiological transmission of loads to the femur, which, 
according to Wolfe’s Law, would avoid proximal stress shielding and thus 
prevent bone resorption in the proximal femur. Secondly, they are biocompatible 
and are suitable for use as endoprostheses intended to remain permanently inside 
the human body [9]. Thirdly, due to the formation of a protective oxide film on 
the surface, titanium and its alloys display good corrosion resistance in the body 
fluid. This is essential in maintaining the long term stability of the implant. Lastly, 
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titanium and its alloys have high strength-to-weight ratios. Titanium is as strong 
as steel, but 45% lighter; it is 60% heavier than aluminum, but twice as strong.  
This results in less hindrance to patient mobility when used as orthopaedic 
implants. 
 
2.1.1 Fatigue Properties of Titanium 
Fatigue is a process by which a material is weakened by cyclic loading. The 
amplitude of the applied stress may be lower than the ultimate tensile stress, or 
even the yield stress of the material concerned, yet catastrophic failure occurs. 
The process begins at an initiation site within the material such as microscopic 
crack or surface imperfections, such as notches. These are regions of high stress 
concentration. As the cyclic stress is applied to the material, the crack widens and 
propagates throughout the material, causing eventual failure.  
 
Analysis of the fatigue performance of a material involves investigating its S-N 
characteristics, whereby S is the applied cyclical stress amplitude, and N, the 
number of cycles to failure. The S-N curve of a material could be determined by a 
mounting the test specimen on a universal testing machine, and applying a 
sinusoidal stress on the specimen. The number of cycles to failure of the test 
specimen is then determined for each test amplitude. The test usually begins with 
a relatively high amplitude of cyclical stress, for instance, 80% of the ultimate 
tensile stress of the material, until the material fails. The process is repeated for a 
lower applied stress amplitude and proceeds until a stress amplitude low enough 
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not to cause failure after more than 106 cycles. This stress amplitude is known as 
the Endurance Limit of the material. The existence of the Endurance Limit is due 
to the presence of interstitial elements, such as pin dislocations, which prevent 
slip form occurring [10].  
 
Fatigue was first observed in the failure of iron mine-hoist chains arising from 
repeated small loadings by William Albert in 1829 [11]. The first systematic 
study on fatigue was conducted by Sir William Fairbairn and August Wöhler in 
1860. Wöhler studied the performance of railroad axles, and proposed the use of 
S-N curves in mechanical design. The origin of fatigue failure in microscopic 
cracks was demonstrated by Sir James Alfred Ewing in 1903 [11]. 
 
Some variables pertinent in fatigue testing are listed below: 
minmax σσσ −=∆  
2
σσ ∆=u  
2






=maxσ Maximum applied stress 
=minσ  Minimum applied stress 
=∆σ Stress range 
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=uσ Stress amplitude 
=mσ Mean stress 
R = Stress ratio 
 
Some of the factors which influence fatigue life of a material are: 
1) The magnitude of the applied stress, including stress concentrations caused by 
part geometry. 
2) The surface defect geometry and location. 
3) The quality of the surface finish. Surface roughness, scratches and the 
presence of notches act as local stress concentrators and crack nucleation sites. 
4) Size, frequency and location of internal defects. 
5) Grain size. Most metals, whose microstructure consist of fine grains, exhibit 
longer fatigue life than coarse-grained metals. 
6) Uneven cooling of the material may result in uneven distribution of the 
different phases, and lead to heterogeneous materials properties. 
7) Direction of the applied stress may affect fatigue life of non-isotropic 
materials. 
8) Exposure to harsh environmental conditions may cause corrosion, erosion or 
gas-phase embrittlement of the material, thus reducing fatigue life. 
 
Titanium and its alloys generally exhibit good high cycle fatigue strengths as 
compared with their tensile strengths. The S-N curves of most titanium alloys 
tend to flatten out at 107 cycles, and the fatigue limit is generally between 40% 
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and 60% of the tensile strength [12]. The endurance limit of titanium depends on 
a number of factors such as the alloy composition, heat treatment, type of metal 
working done, as well as the testing conditions. For commercial purity titanium, 
the endurance limit ranges from 130 MPa to 300 MPa [13, 14]. 
 
Nakazawa et al [15] have conducted fatigue tests on Ti-6Al-4V. The tests were 
carried under tension-tension mode at a stress ratio of 0.1. A sinusoidal wave 
frequency of 20 Hz was used for the test, and all tests were performed in 
laboratory air of humidity 40% to 70%. From their investigations, the endurance 
limit of the titanium alloy was found to be 250 MPa. The S-N curve of the Ti-










Figure 2.1: S-N curve of the Ti-6Al-4V [15] 
2.1.2 In-vitro Studies on the Biocompatibility of Titanium 
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The biocompatibility of titanium has been extensively studied. Titanium displays 
high corrosion resistance, high specific strength and good osteointegration 
properties. Many studies involving the cytotoxicity of titanium and its alloys have 
used the Balb/C 3T3 cell line [16, 17, 18, 19] . The 3T3 cell line is a continuous, 
immortalized but not transformed cell line which is commonly used in 
cytotoxicity analysis. The cells are sensitive to contact inhibition and are suitable 
for cytotoxicity tests. In addition, the 3T3 fibroblast cell lines were chosen also 
due to the predominance in connective tissue, robust cell growth and the distinct 
morphology change upon adhesion to surfaces.  The in-vitro studies have found 
that titanium and its alloys display good biocompatibility towards the 3T3 cell 
line. There was no significant reduction in cellular proliferation and cell 
morphology, as compared to the respective control cultures [19]. 
 
The biocompatibility of titanium has also been assessed with osteoblast cells [16, 
18, 20, 21, 22] since most biomedical applications of titanium involve contact 
with bone tissue (for example in orthopaedics and dentistry).  Harris et al have 
assessed the cytocompatibility of different coated titanium surfaces with both 3T3 
cells and osteoblast [16]. The study has concluded that the nitrogen ion implanted 
unalloyed titanium surface was one of the best surfaces for osteoblast and 
fibroblast proliferation. Overall, titanium was found to be not cytotoxic to both 
cell types. 
 
2.2 History of Graphite 
Chapter 2: Literature Survey 
 
14 
Graphite is an allotrope of carbon with a density of 2.21 g/cm3.  It has a lamellar 
structure with weak van der Waals interplanar forces that enables it to be a 
remarkable lubricant. Natural deposits of graphite have been called black lead, 
silver lead, and plumbago, which is another name for the lead ore galena. The 
structure of graphite consists of layers of carbon atoms joined in regular hexagons 
by strong bonds. The layers are held together by long-range, relatively weak 
attractive forces called Van der Waals forces. The layers can slide over each other 
easily, which accounts in part for the lubricating property of graphite. 
 
Graphite is generally greyish-black, opaque and has a lustrous black sheen.  It is 
unique in that it has a combination of both metallic and non-metallic properties of 
both a metal and a non-metal.  It is flexible but not elastic, has a high thermal and 
electrical conductivity, and is highly refractory and chemically inert.  
The unusual combination of properties is due its crystal structure, shown in Figure 
2.2 [23]. The carbon atoms are arranged hexagonally in a planar condensed ring 
system.  The layers are stacked parallel to each other.  The atoms within the rings 
are bonded covalently, whilst the layers are loosely bonded together by van der 
Waals forces.  The high degree of anisotropy in graphite results from the two 
types of bonding acting in different crystallographic directions.  World production 
of graphite was estimated to be about 602,000 tons in 2000, with China being the 
biggest producer followed by India, Brazil, Mexico and then the Czech Republic. 









Figure 2.2: Crystal structure of graphite [23]. 
 
2.2.1 Lubrication Properties of Graphite 
Graphite is a lamellar solid and has the ability to reduce friction when applied 
between two contacting surfaces. Graphite’s ability to form a solid film lubricant 
arises from the fact that weak Van der Waals forces govern the bonding between 
individual layers, which permits the layers to slide over one another and making it 
an ideal lubricant. Hence, the presence of a graphite on the articulating surfaces of 
biomaterials could help reduce wear of the prosthesis.  
 
The tribological properties of metal-graphite composites is characterized by two 
stages. When sufficient wear of the metal matrix at the articulating surfaces has 
taken place, the graphite particles are released onto the sliding surfaces. In the 
first stage, known as the transient stage, graphite film starts to form on the surface. 
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There is significant asperity interaction in this stage. In the second stage, known 
as the steady state, a stable graphite film has formed on the surface and prevent 
direct contact between the articulating surfaces. The constant replenishment of 
graphite particles as the articulating surface is removed due to wear is crucial in 
maintaining the steady state, and hence it is necessary to design metal-graphite 
composites with sufficient unreacted graphite particles throughout the entire 
volume of the composite. 
 
2.3 Powder Metallurgy 
Powder Metallurgy was first described by C.G. Goetzel in 1949 [24]. This 
technique enables the production of metal matrix composites, such as the 
titanium-graphite composites used in this study. This processing technique offers 
good microstructural control of the various phases formed, such as the titanium, 
titanium carbide and graphite phases formed in the titanium-graphite composites. 
Secondly, this approach employs lower processing temperatures, and hence, 
theoretically, would offer better control over interface kinetics of particles used. 
Lastly, this technique allows the matrix alloy compositions and microstructure 
refinements that are only available through the use of rapidly solidified powders 
to be employed [25]. 
 
The basic processes involved in powder metallurgy include mixing, compacting 
and sintering of the powder mixture. Proper mixing of the raw powder is essential 
in ensuring uniform distribution of particles, which eventually results in the 
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formation of a uniform microstructure and porosity of the composite. These 
factors, in turn play a critical role in the mechanical and tribological behaviour of 
the material. In general, the larger the size of the powder particle, the higher the 
degree of distribution uniformity within the mixture. 
 
Once the raw powder has been thoroughly mixed, the next stage involves 
compaction of the powder mixture. There are two types of compaction techniques 
that are commonly used, namely the blended elemental method and hydrostatic 
pressing method.  In the first method, consolidation of the powders is achieved by 
applying a uniaxial load to create the required compaction pressure.  In the second 
method, the required pressure is achieved by applying hydrostatic forces to the 
powders. In this study, compaction was first done in a punch-die assembly, which 
applies a uniaxial compressive force on the powder particles. The compaction 
process in the blended elemental approach has been described in detail by R.M. 
German [26]. Briefly, this process comprises three stages. The first stage involves 
particle rearrangement during initial pressurization. During this stage, the number 
of contacts between particles increases as rearrangement and sliding takes place. 
Upon further pressurization, particle deformation takes place and the area of 
contact between particles enlarge. New contacts are also formed in this stage. It is 
crucial that the compaction pressure is not further increased excessively, lest a 
third stage of strain hardening may occur. Strain hardening may result in the 
fracture of the powder particles and should be avoided. 
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The next step in powder metallurgy involves sintering of the green compacts. This 
is a heat treatment process, which takes place below the melting point of the raw 
powder, increases the thermal energy and enhances the diffusion of the particles. 
This process enhances strength and greatly reduces the porosity of the compacts.  
 
Documented literature [27, 28] has postulated that there are three stages in 
sintering, namely the initial, intermediary and final stages. These stages are 
characterized in terms of the changes in the pore morphology where necking 
between particles can eventually lead to pore closure and full densification.  The 
changes in the pore morphology are caused by atomic migration, which has been 
found to be initiated by three mechanisms namely viscous flow, evaporation-
condensation and self-diffusion.  
 
Several parameters play an important role in the densification process, namely 
particle size, sintering time and temperature. It has been concluded that sintering 
temperature is the most important variable [26, 29]. Control of the environmental 
conditions during sintering is also crucial, especially when sintering titanium-
containing composites. The presence of oxygen at an elevated temperature would 
result in surface oxide formation, which would greatly hinder diffusional bonding, 
and weaken the compact. For this reason, sintering of titanium-graphite 
composites in this study was performed in a vacuum.  
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Hot isostatic pressing (HIP) is the application of heat and pressure simultaneously 
to a part, causing it to shrink and densify uniformly. It can be used directly to 
consolidate a powder or supplementary to further densify a cold pressed, sintered, 
or cast part. The pressure medium is typically a gas (argon or nitrogen) but can be 
a liquid (glass) or molten metal. Heating is done in an electric furnace. By heating 
the material and simultaneously applying high isostatic pressure, it is possible to 
achieve yielding of the material particles, thus uniformly eliminating porosity. To 
densify a powder directly requires a can to transmit the pressure to the powder. 
Applications of HIP include the densifying of high performance ceramics, ferrites 
and cemented carbides, net-shape forming of nickel-base superalloy and titanium 
powders, compacting of high-speed tool steel, diffusion bonding of similar and  
dissimilar materials, and eliminating voids in aerospace castings or creep 
damaged blades [30, 31]. Hot isostatic pressing results in a very uniform grain 
structure, greatly reduced porosity and exceptional properties. Dissimilar 
materials could be bonded together through the application of HIP. Fatigue life is 
often better than achieved by any other processing method [32]. It also is used to 
diffusion bond same and dissimilar materials that could not otherwise be bonded.  
 
2.4 Total Hip Replacement (THR) 
Total hip replacement surgery is a treatment option for patients with severely 
damaged hip joints, usually associated with conditions such as osteoarthritis, 
rheumatoid arthritis and conditions of deficient bone quality like Paget’s disease. 
THR creates an artificial joint that will replace the diseased joint. 
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Figure 2.3:  X-ray images of Hip Joint of a 37-year Old Patient [33]. a) Early 
onset of osteoarthritis, treated by medial displacement steotomy. b) 
Total Hip Replacement 
 
Figure 2.3 [33] shows an osteoarthritic joint before and after THR. Some of the 
key features of a well designed hip prosthesis are: 
1) relieve joint pain;  
2) restore mobility;  
3) restore normal leg length;  
4) be able to support the body weight of the patient; 
5) be anchored securely in bone for long term fixation and durability; and 
6) be biocompatible and stable in vivo. 
  
 



















 Figure 2.4: Schematic of a Hip Prosthesis [34]. 
 
THR surgery is the most commonly performed joint-replacement procedure.  
Each year, over 200,000 Americans undergo THR surgery [35]. A typical THR 
consists of a cup type acetabular component and a femoral component whose 
head is designed to fit into the acetabular cup and thus enabling joint articulations.  
The femoral stem is tapered so that it can be fixed into a reamed medullary canal 
of the femur. During THR surgery, the ball and socket arthritic joint is first 
removed. The top part of the femur is removed, and the tapered stem of the 
femoral component of the prosthesis is fitted within the central (medullary) canal 
of the patient’s femur. Any remaining cartilage and some bone is removed from 
Prosthetic
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the patient’s acetabulum, and a prosthetic acetabular cup is fitted in its place. 
There exists several different types of prostheses for THR, and these are discussed 
below. 
 
The metal-on-plastic implant consists of a metal femoral head and acetabular cup, 
and a plastic spacer is placed in between. The metals used include titanium, 
stainless steel, and cobalt chrome. The plastic spacer is fabricated from 
polyethylene. Implant fixation is achieved by either of two methods: it is either 
press-fit or cemented into place. In the press-fit method, the implant is fit snuggly 
into the bone, and new bone forms around the implant to secure it in position. 
When an implant is cemented, a special bone cement, known as polymethyl 
methacrylate (PMMA) is used to secure the prosthesis in position. This type of 
implant is the most commonly used hip replacement prosthesis. Unlike the metal-
on-plastic implant, the metal-on-metal prosthesis, which uses similar materials, 
does not have a plastic spacer in between. Metal-on-metal implants do not wear 
out as quickly as the metal and plastic materials. The metal and plastic implants 
wear at a rate of about 0.1 millimeters each year. Metal-on-metal implants wear at 
a rate of about 0.01 millimeters each year, about 20 to 100 times less than metal-
on- plastic [36, 37]. Despite the low wear rates, it is not known whether metal-on-
metal implants will last longer. The wear debris that is generated from the metal-
on-metal implants contain metal ions, which are released into the blood, and these 
metal ions can be detected throughout the body. The concentration of these metal 
ions increases over time. Ceramic-on-ceramic implants are designed to be the 
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most resistant to wear of all available hip replacement implants. They wear even 
less than the metal-on-metal implants and are corrosion resistant. Ceramics are 
more scratch resistant and smoother than any of these other implant materials. 
However, ceramics are very brittle material, and display poor impact strength. 
Data on the long term durability of the ceramic-on-ceramic implants, as well as 
possible complications, are unavailable. 
 
2.5 Biological Response to Implants 
The cellular response towards implant materials depends largely on the 
dimensions of the implants. Many implants are relatively inert in bulk form, but 
particles of these materials may bring about detrimental cellular reactions in the 
surrounding bone [16]. An understanding of the different mechanisms involved is 
thus imperative in any study involving biocompatibility of implant materials. 
 
2.5.1 Mechanism of Cellular Response to Bulk Implant Material 
Implant surfaces are generally designed to promote soft and hard tissue 
adherence, eventually resulting in integration with bone and the surrounding soft 
tissue [16]. Upon implantation, the surface of the implant is coated immediately 
with host plasma constituents, including protein components of the extracellular 
matrix (ECM). The amount of cell adhesion to a surface plays a pivotal role in the 
response of the cells to the surface. There are two types of cell adhesion, namely 
cell–substrate and cell–cell. In cell–substrate adhesion, the cells attach to the 
ECM proteins adsorbed onto the substrate surface. Fibroblast and osteoblast are 
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anchorage-dependant cells the formation of such adhesion sites is vital to their 
survival.  
 
Cell adhesion is mediated by several types of transmembrane receptor proteins, 
associated with the cell cytoskeleton. One mechanism of cell adhesion involves 
their adhesion to adsorbed ECM proteins using small highly organized 
complexes, known as focal contacts. Initially, the adhesion sites do not associate 
with the actin cytoskeleton of the cells, and is known as ‘dot’ adhesions. Upon 
maturity, the adhesion sites associate with the actin stress fibres to form ‘dash’ 
adhesions [38]. The formation of cell adhesion sites results in the positioning of 
the actin filaments responsible for the contractile mechanism of the cell [39], 
which has an effect on cellular behaviour and morphology [40, 41]. 
 
If cells are not adequately adhered, a fibrous capsule, with a liquid-filled void, 
may form between the soft tissue and implant [42, 43]. This may result in further 
implant destabilization, inhibition of tissue regeneration and repair, and increased 
possibility of infection, due to poor vascularization around the implant and fibrous 
tissue [42, 44, 45]. 
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2.5.2 Wear Particle Induced Osteolysis 
Total Hip Replacement is a major surgery, and several potential complications 
may occur. These include implant failure, deep vein thrombosis, dislocation of the 
prosthetic hip joint, infection and periprosthetic osteolysis. Complications as a 
result of osteolysis are the most common causes for revision surgery [46]. The 
extent of foreign body response depends on size, type, number and surface area of 
the particles. Larger particles, over 50 µm, induce fibrous encapsulation, while 
smaller particles, below 7 µm, are phagocytosed. Phagocytosis of smaller particles 
is detrimental and results in macrophage activation and release of a variety of 
cytokines like interleukins, tumour necrosis factor a (TNF-a), PGE2 and 
metalloproteases [46].  
 
Particles generated in THRs are much finer, due to abrasion and adhesion types of 
wear. Scanning electron microscopy of the wear debris has revealed that the mean 
size of the particulate debris is 0.5 µm, and nearly 90 % of the particles are less 
than 1 µm. In cases of failed hip arthroplasties involving metal prostheses, studies 
have shown that there is a 7- to 21-fold increase in metal levels adjacent to the 
loose implant. It has also been documented that a granulomatous soft tissue 
membrane, known as the interfacial membrane (IFM), forms at the bone-failed-
prosthesis interface [47, 48, 49]. Histological examination of this membrane has 
shown that it is composed predominantly of macrophages, foreign body giant 
cells, which contain or are in close proximity to the implant particles. In the 
periprosthetic space in vivo, the cells interact with the particles, and in the case of 
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smaller particles, phagocytosis also occurs. The presence of non-degradable 
particles results in a constant state of activation of all cell types in the 
periprosthetic space. Other studies involving commercially pure titanium particles 
have concluded that titanium particles of between 1.5 µm to 4.0 µm had the 
greatest impact on cell vitality and proliferation [20]. 
 
Different types of particles induce different responses in vivo. Titanium particles, 
affects osteoblast viability in-vitro [21], but has been shown to enhance fibroblast 
proliferation (at particle concentration of 0.0083 and below, volume/volume) [50]. 
The effect of carbon particles on cell viability depends on the particle size, aspect 
ratio and crystallinity [51, 52, 53]. It has been shown that carbon fibres of 
nanophase diameters increased osteoblast adhesion (by up to 33 %), proliferation 
(by up to 150%), alkaline phosphatase activity (by up to 300%), and calcium 
deposition (by up to 100%) while at the same time decreased competitive cell 
adhesion compared to their larger diameter counterparts [54, 55]. These findings 
suggest that nanophase  diameter carbon fibres may have potential applications in 
improving osteo-integration and minimizing fibrous-tissue encapsulation. 
Particles of larger, amorphous hydrogenated carbon coating (d90 = 37 µm) were 
found to be relatively inert to primary rat bone marrow cell cultures [51]. Other 
researchers have also found that single carbon fibres of lower crystallinity and of 
a more basic chemical composition were more biocompatible and contributed to 
the regeneration of both soft and hard tissues [56].  
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 Figure 2.5: AP radiograph of a cementless hip arthroplasty. arrows indicate  
       extent of femoral osteolysis. [46] 
 
Osteolysis is the most significant complication arising from THR. Most long-term 
follow-up studies have attributed the incidence of osteolysis as the predominant 
cause of prosthesis failure [57]. The direct correlation between osteolysis and 
wear has been well established. It is thus imperative for manufacturers of hip 
prostheses and clinicians to give due consideration to the incidence of osteolysis 
in prosthesis design, method of fixation to bone, and the choice of bearing 
surfaces in hip arthroplasty. 







Pure grade Hydride-DeHydride (HDH) titanium powder from Toho Titanium, 
Japan, was used to fabricate the sintered compacts. HDH Titanium is also known 
as ELCL titanium (Extra Low Chlorine) for improved biocompatibility. The 
purity of the titanium powder is 99.7 % and the  mean particle size of the titanium 
powder is 40 µm. The particles exhibit an angular morphology, as compared to 
gas-atomized titanium powder, which is spherical. The composition of the 
titanium powder used is shown in Table 3.1. 
  

























0.003 0.001 0.05 0.01 0.02 0.03 0.02 0.06 0.35 
 
High purity graphite powder (99.5%), Mesh -325, purchased from Cerac 
Incorporated, USA, was used in the fabrication of titanium graphite composites. 
The elemental constituents of the graphite powder is shown in table 3.2. 
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 Table 3.2: Elemental constituents of pure graphite powder 
Impurity 




0.01 0.01 0.01 
 
 
3.2 Particle Analysis 
The morphology of the titanium and graphite particles were determined by 
Scanning Electron Microscopy (Jeol, Japan). The nomenclature used to describe 
the particle morphology was derived from ASTM F1877-98(2003)e1. 
 
3.3 Compaction Technique 
The  binary powder mixtures, comprising titanium and graphite powders, were 
thoroughly mixed in two steps. Firstly, the powders were mixed for 1 hour in a V-
shaped blender. Thereafter, the powders were thoroughly mixed using a 
mechanofusion system for 20 minutes. Mechanofusion is a technique of stressing 
the powders at a high level of energy. The simultaneous generation of 
compression and shear forces causes mechanical energy to be applied to the  
powder mixtures resulting in stable, homogeneous blends of the powder mixtures. 
The blended powders were poured in a rectangular punch-die set, of cross-
sectional dimensions (10mm X 55mm). The main function of the punch-die set, is 
to transmit loads symmetrically to form a compact of homogeneous density.  The 
set is made of hardened steel so that it is able to withstand the high pressure used.  
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A hydraulic press was used to uni-axially compress the powder at a pressure of 6 
tons/cm2 (0.6 GPa). The thickness of the compacts formed were about 7mm. Zinc 
Stearic Acid was used as a lubricant.  
 
The compaction pressure affects the density and porosity of the compact. A 
higher compaction pressure results in higher compact density and lower 
percentage porosity. A compaction pressure of 0.6 GPa  was selected for this 
work as previous studies on the material have shown that an increase in 
compaction pressure yielded diminishing returns in increasing compact density 
while reducing the percentage porosity. 
 
3.4 Sintering and Hot Isostatic Pressing of Compacts 
Sintering was performed at the Biomat Laboratory in a Carbolite (C1000) heater, 
which is capable of heating up to 1500 oC in a vacuum-sintering atmosphere at 10-
5 mbars.  High vacuum was achieved in a 2-stage process. The initial roughing 
phase, performed by a rotary pump lowers and sustains the furnace pressure to 10-
2 mbars. The second stage involves a diffusion pump where pressures of 10-5 
mbars were reached.  
 
The compacts were then inserted into a high temperature ceramic tube. Both ends 
of the tube were covered with stainless steel foil to ensure even heating and  
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prevent contamination of the oven by the highly reactive titanium.  The ceramic 
tube containing the green compacts was then placed in the oven.   
 
Sintering would only start once the pressure in the vacuum has been lowered to, 
and sustained at, 10-5 mbars. The various stages of the heating cycle is described 
below and shown schematically in Figure 3.1: 
1) The oven was heated at a rate of 10 oC/min to 500 oC. The temperature was 
sustained at 500 oC for 1 hour to vapourize and remove all the zinc stearic 
acid lubricant.  
2) The oven was further heated at a rate of 5 oC/min to a temperature of 1250 oC. 
This temperature was sustained for 2 hours. In this stage, neck growth 
between the powder particles occur, as well formation of titanium carbide in 
the binary powder compacts. The heating duration of 2 hours was selected as 
previous work has shown appreciable titanium carbide formation and good 
sintered compact mechanical properties. An increase in heating period 
produced diminishing returns in terms of improvements in mechanical 
properties. 
3) The final stage involves cooling of the sintered compacts in the oven, at a 
controlled cooling rate of 10 oC/min, to room temperature. 
 
The nomenclature used to describe the various specimens in this thesis consist of 
two numbers, which correspond to the particle size of the graphite used in the raw 
powder and the graphite content. For example, 10-5 is used to describe the 
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specimens, whose raw powder contained graphite particles of 10 µm in size, and 
whose graphite content is 5%. Table 3.3 describes the nomenclature of the 
specimens used in this study. 
 
 Table 3.3: Specimen Nomenclature. 
Specimen 0-0 10-5 10-10 
Graphite Particle Size N.A. 10 µm 10 µm 











Figure 3.1: Four stage heating cycle of the sintering process 
  
Following sintering, the compacts were sent to Japan for Hot Isostatic Pressing 
(HIP) at 1000 °C, for 1 hour, at a pressure of 200 MPa. HIP would further 




        50      1 hr            2.5 hrs                2 hrs                  108 min 
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increase the density of the compacts, and reduce the porosity uniformly 
throughout the compact volume, for enhanced mechanical properties.  
 
3.5 Microstructure of Compacts 
The microstructure of the surface of the sintered and HIPped compacts were 
grinded with SiC sandpaper of varying grades, polished with diamond suspension 
and SiO2. Finally, the surface of the polished specimen was etched for 15 s with 
Kroll’s Etchant, which was prepared by mixing 2 ml of 40 %hydrofluoric acid, 6 
ml of 65 % nitric acid and 92 ml of de-ionized water. The detailed protocol 
employed for the metallographic examination of the compact surface is described 
below: 
1. The surfaces of the specimens were grinded with SiC sandpaper of grade 
320 to obtain a flat surface. A force of 3 lbs/specimen was applied, and the 
rotation speed was 120 rpm. 
2. Next, the surfaces of the specimens were grinded with SiC sandpaper of 
grade 600 for 1 minute to obtain a smooth surface. A force of 3 
lbs/specimen was applied, and the rotation speed was 120 rpm. 
3. The specimens were washed thoroughly to remove any residual SiC. 
4. The surfaces of the specimens were then polished with diamond suspension 
of particle size 6 µm for 4 minutes. A force of 5 lbs/specimen was applied, 
and the rotation speed was 120 rpm. 
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5. Thereafter the surfaces of the specimens were polished with diamond 
suspension of particle size 1 µm for 3 minutes. A force of 5 lbs/specimen 
was applied, and the rotation speed was 120 rpm. 
6. The final polishing step involves polishing the specimens with SiO2 
suspension for 4 minutes. A force of 3 lbs/specimen was applied, and the 
rotation speed was 120 rpm. 
7. Finally the polished specimens were etched with Kroll microetchant (92 ml 
distilled water, 6 ml nitric acid of 65% concentration and 2 ml hydrofluoric 
acid of 40% concentration. 
8. The microstructures of the specimens were observed under an optical 
microscope. 
Photomicrographs of the micro-structures observed would be shown and 
discussed in Chapter 4, section 4.2. 
 
3.6 Tensile Properties of Compacts 
Tensile tests were conducted in the High Temperature Synthesis Laboratory of the 
National Institute for Materials Science, Tsukuba, Japan. A Shimadzu AG-I 
Autograph Precision Universal Tester was used for the tensile tests. The test 
specimens used are shown in Figure 3.2 below. Refer to Appendix 1 for the 
engineering drawing detailing the precise dimensions. Prior to testing, all surfaces 
of the test specimen were grinded with sand paper of successively larger grit size, 
up to grit 600, to remove any visible surface cracks and stress concentrators.  
 




Figure 3.2: Tensile and fatigue tests specimens 
 
There was insufficient surface area of contact, at the tips of the specimen for 
direct mounting between the grips of the universal testing machine, without 
damaging the test specimens. To ensure that the test specimens are fixed firmly in 
place throughout the duration of the tensile and fatigue tests, a secondary grip, 
shown in Figure 3.3, was designed and fabricated. Refer to Appendix 2 for the 
detailed engineering drawings of the secondary grips. 
 
Tensile tests were performed on a total of 5 test pieces apiece for the 0-0 and 10-5 
specimens, while for the 10-10 specimens, the tensile tests were performed on a 
total of 3 test pieces.  
 




 Figure 3.3: Secondary grips for tensile tests 
 
3.7 Fatigue Properties of Compact 
The fatigue tests were performed on an MTS 858 Tabletop System, a 100kN 
capacity closed-loop electrohydraulic fatigue testing machine. The fatigue tests 
were conducted in the High Temperature Synthesis Laboratory of the National 
Institute for Materials Science, Tsukuba, Japan. The specimens used were 
identical to the ones used in the tensile tests. The same secondary grips used in the 
tensile tests were used in the fatigue tests, to securely mount the specimens to the 
tester. The testing conditions employed were as follows: 
a) Test Medium: Air; 
b) Frequency of Cyclic Loading: 20 Hz; 
c) Ratio of minimum to maximum applied stress: 0.1 
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3.8 Cell Culture 
Biocompatibility of the raw powder, wear debris and bulk compacts was 
determined using Balb/C 3T3 cell line and primary rat osteoblast cell cultures. 
The 3T3 cell line was obtained from American Type Culture Collection (ATCC). 
The 3T3 cell line is a continuous, immortalized but not transformed cell line 
which is commonly used in cytotoxicity analysis. The cells are sensitive to 
contact inhibition and are suitable for cytotoxicity tests. In addition, the 3T3 
fibroblast cell lines were chosen also due to the predominance in connective tissue, 
robust cell growth and the distinct morphology change upon adhesion to surfaces.  
 
Cytotoxicity studies were also conducted on rat osteoblast in-vitro as future 
application of these composites as joint replacement prosthesis would necessitate 
their implantation in the respective patients’ bone. The in-vitro studies provide an 
insight on the effect on cell proliferation of fibroblasts and osteoblasts, when in 
contact with the titanium-graphite composites. All cell work was conducted in a 
tissue culture hood in a sterile clean room. Every possible step was taken to 
maintain the sterility of the culture. 
 
Both 3T3 cells and rat osteoblast were cultured in T75 tissue culture flasks and 
sub-cultured to Passage 5 to obtain sufficient cell number for the biocompatibility 
tests. The tissue culture medium used was Dulbecco’s Modified Eagle’s Medium 
(DMEM), fomented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin/ 
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Streptomycin solution. The cell cultures were placed in a cell culture incubator 
(Sanyo), which maintained a temperature of 37 °C and a CO2 content of 5%. 
The 3T3 cells were obtained from American Type Culture Collection (ATCC). 
The cells were thawed, placed in tissue culture solution and centrifudged at 1000 
rpm for 10 minutes. The supernatant solution was removed and the cell pellet sub-
cultured in the tissue culture flasks, and incubated. The cells were sub-cultured 
every three days at confluency. 
 
The rat osteoblast was obtained from a primary culture from a section of the 
femur of a rat. The bone section was placed in tissue culture flask. Tissue culture 
medium was added and the flask incubated for 24 hrs to allow the osteoblast to 
migrate from the bone chip to the flask.  After 24 hrs, the remaining bone chip 
was removed. The tissue culture medium was removed and the flask rinsed with 
Phosphate Buffered Solution (PBS) three times. The PBS was removed and 5 ml 
of 0.05 % of Trypsin/ 0.02 % EDTA solution was added to the cell culture. After 
incubation for 5 minutes, the cell suspension was transferred to a centrifudge tube 
and 10 ml of tissue culture medium was added to the cell suspension. 15 ml of 
tissue culture medium was added to the tissue culture flask, which was then 
incubated. The cell suspension was centrifuded at 1000 rpm for 10 minutes, after 
which the supernatant fluid was removed. The remaining cell pellet was sub-
cultured in two tissue culture flasks, with 15 ml of tissue culture medium added to 
each flask. The cell culture was then incubated. The cells were sub-cultured at 
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confluency once every week, and the tissue culture medium changed twice 
weekly. 
 
3.9 Biocompatibility of Raw Powder 
The cytotoxic effect of titanium particles has been investigated by several 
researchers [20, 21, 58]. The studies have indicated that the presence of titanium 
particles, in particular particles below 10 µm in sufficiently high concentration, 
have an impact on the proliferation of osteoblast [20]. That study also indicated 
that particles below 10 µm were phagocytosed by the osteoblast, which, it was 
postulated, had an effect on reducing the proliferation rate of the cells. 
 The purpose of the current study was threefold: 
a) to determine if the binary powder mixture of titanium and graphite is 
cytotoxic to the cells; 
b) to determine if the presence of the binary powder mixture had an effect on 
cellular morphology; and 
c) to determine if the raw powder particles are phagocytosed by the cells, and 
the effects thereof. 
 
3.9.1 Preparation of Raw Powder for Cell Culture 
The separated powder was first thoroughly cleaned in separate acetone baths and 
placed in a sonicator for five minutes. The acetone was subsequently removed 
carefully. The powder was then sonicated for another five minutes in a bath of de-
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ionized water. Thereafter, the powder was sterilized in an autoclave, prior to cell 
culture, and kept in a sterile tissue culture hood. 
 
Finally, a powder suspension was prepared. The suspension comprised of PBS, 
1% Penicillin/Streptomycin and 5% separated powder. The suspension was placed 
on an orbital shaker to form a uniform suspension. The concentration of the 
powder suspension was 1.0% (weight/weight).  
 
3.9.2 Cell Culture with Raw Powder 
Cell culture with the separated powder was performed on the 3T3 cells and rat 
osteoblasts in Passage 5. The cells were seeded on 48-well plates, at a density of 
1000 cells/well for 3T3 cells and 10000 cells/well for rat osteoblast. 50 µl of 
powder suspension was added to 450 µl of tissue culture medium, to obtain 0.1% 
(weight/weight) separated powder suspension per well. This concentration was 
selected as it was reported to be representative of the particle concentration found 
in the surrounding tissue of loose implant in biopsy study [59]. The tissue culture 
medium was changed every three days. Care was taken to ensure that no powder 
particle was removed during the medium change.  
 
3.10 Biocompatibility of Wear Debris 
The biocompatibility of the wear debris of the titanium and titanium-graphite 
composites was evaluated by determining the cell proliferation rate of the 3T3 
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cells and rat osteoblast, seeded at 10000 cells/well in a 48-well plate, with wear 
debris added to the cell culture in each well at a concentration of 1%. 
  
3.10.1 Generation of Wear Debris 
Wear debris from the sintered, post-HIPed titanium-graphite composites were 
generated for cytotoxicity analysis. The stages involved were as follows: 
1.  the surfaces of the specimens, cutting tools and all grips and fixtures were 
 cleaned with acetone; 
2.  plane-milling of all surfaces of the specimens to remove the oxide layer; 
3.  milling of the specimen to obtain large debris; 
4.  the debris collected were placed in an agate pestle and ground with an 
 agate mortar; 
 5. the wear debris obtained was cleaned in an acetone bath and sonicated. 
 
3.10.2 Wear Debris Preparation for Cell Culture 
The wear debris generated was first thoroughly cleaned in seperate acetone baths 
and placed in a sonicator for five minutes. The acetone was subsequently removed 
carefully. The debris was then sonicated for another five minutes in a bath of de-
ionized water. Thereafter, the debris was sterilized in an autoclave, prior to cell 
culture. 
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Finally, a wear debris suspension was prepared. The suspension comprised of 
PBS, 1% Penicillin/Streptomycin and 5% wear debris. The suspension was placed 
on an orbital shaker to form a uniform suspension. 
 
3.10.3 Cell Culture with Wear Debris 
The protocol for passaging the 3T3 cells and rat osteoblast has been described in 
Section 4.8.1. After Passage 5, the cells were seeded on 48-well plates, at a 
density of 1000 cells/well for 3T3 cells and 10000 cells/well for rat osteoblast. 50 
µl of wear debris suspension was added to 450 µl of tissue culture medium, to 
obtain 0.1% (weight/weight) wear debris suspension per well. This concentration 
was selected as it was reported to be representative of the particle concentration 
found in the surrounding tissue of loose implant in biopsy study [59]. The tissue 
culture medium was changed every three days. Care was taken to ensure that no 
wear debris was removed during the medium change.  
  
3.11 Biocompatibility of Compacts 
The biocompatibility of the sintered post-HIPed was determined by the 
proliferation rate of cells seeded on the polished surface of the compacts. The 
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3.11.1 Water Contact Angle measurements of Surface of Compacts 
The wetting behaviour of the surfaces of the compacts, both polished and 
unpolished, were determined by performing the water contact angle test. The 
wetting behaviour gives an indication of the degree of hydrophillicity of the 
compact surfaces. The equipment used to evaluate the water contact angle was the 
VCA – Optima Surface Analysis System. A detailed account of the method of 
performing the water contact angle test is described below: 
1) The specimen to be evaluated in placed beneath the syringe; 
2) A water droplet, of volume 50 µl was released from the computer 
controlled syringe onto the specimen surface; 
3) An image of the water droplet was taken at the precise moment contact is 
made with the specimen surface (time = 0s); 
4) Images of the water droplet are taken at 10s intervals, to study the shape of 
the water droplet with time, up to 150s (from time = 10s to time = 150s); 
5) The angle between the tangent to the surface of the water droplet, at the 
point of contact, and the surface of the specimen is measured from time = 
0s to time = 150s. This angle is known as the water contact angle; 
6) The procedure was performed on five different specimens for each 
specimen type (0-0, 10-5, 10-10, polished and unpolished). 
 
Figure 3.4 shows a typical image of the water drop on the specimen surface, and 
the water contact angle measured. 
 











 Figure 3.4: Water contact angle measurement of 10-10 specimen. 
 
3.11.2 Compact Preparation for Cell Seeding 
Prior to the cell cytotoxicity studies, the specimens used were prepared as follows. 
Firstly, all the surfaces of the sintered, post-HIPed compacts were grinded with 
sand paper of grit size 400, to remove the oxide layer. Next, the compacts were 
cut to a height of 3 mm using a diamond cutter (Isomet® Low Speed Saw, 
Buehler Ltd.). The specimens were placed in an acetone bath in a sonicator for 5 
minutes. Next, the specimens were dried, mounted on a specimen holder and 
grinded and polished, as described in Section 4.5 above. Thereafter, the 
specimens were once again placed in an acetone bath and sonicated for 5 minutes, 
followed by sonication in a bath of de-ionized water, and sonicated for another 5 
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3.11.2 Cell Seeding on Surfaces of Compacts 
The autoclaved titanium-graphite composite compacts were placed in 48-well 
plates, one, in each well, with the polished surface facing up. 20 µl of cell 
suspension (containing 1000 3T3 cells and 10000 rat osteoblast cells) was added 
on the surface of each specimen. Care was taken to ensure that the cell suspension 
did not spill over to the bottom of the plate. Cells were allowed to adhered to the 
polished surface of the compacts for 3 hours, after which 500 µl of tissue culture 
medium was gently added to each well. Optical microscopy of the surface of each 
well revealed that an insignificant number of cells had spilled over and adhered to 
the surface of the plate. Most of the cells had indeed attached to the surface of the 
compacts. The cell cultures were placed in the incubator, and the tissue culture 
medium changed every three days. 
 
3.12 alamarBlueTM Reduction 
The alamarBlueTM assay incorporates a fluorometric/colorimetric growth 
indicator based on detection of metabolic activity. Specifically, the system 
incorporates an oxidation-reduction (redox) indicator that both fluoresces and 
changes colour in response to chemical reduction of growth medium resulting 
from cell growth. alamarBlueTM is soluble, stable in culture medium and is non-
toxic. The continuous monitoring of cells in culture is therefore permitted [60]. 
Cells grown in the presence of alamarBlueTM and subsequently analyzed by flow 
cytometry for CD44, CD45RB, CD4, and heat stable antigen are found to produce 
similar numbers of viable cells and antigen expressing cells as non-
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alamarBlueTM exposed cells. In addition, alamarBlueTM does not interfere with 
the ability of hybridomas to secrete antibody [61]. Because alamarBlueTM is 
nontoxic, the cells under study can be returned to culture or used for other 
purposes including histological studies. Proliferation measurements with 
alamarBlueTM may be made either spectrophotometrically by monitoring the 
absorption of alamarBlueTM supplemented cell culture media at two wavelengths, 
or alternatively, proliferation measurements with alamarBlueTM may be made 
fluorometrically. Proliferation may therefore be monitored with alamarBlueTM 
using either a standard spectrophotometer, a standard spectrofluorometer, a 
spectrophotometric microtiter well plate reader, or spectrofluorometric. The 
protocol for monitoring of cell proliferation using alamarBlueTM is described 
below: 
1. Work was done in a darkened clean room. 
2. The cell culture medium was removed from the wells of the 48-well plates. 
3. All specimens were rinsed with PBS. 
4. A mixture of 10% alamarBlueTM stock solution and 90% DMEM without 
serum was prepared. The mixture was placed in an opaque container to 
prevent degradation of the alamarBlueTM when exposed to light. 
5. 0.5 ml of the alamarBlueTM –DMEM mixture was added to each well. 
6. The control for this experiment consisted of 3T3 and rat osteoblast cells 
cultured in the well of the 48-well plate. 
7. All the samples were placed in the incubator and incubated for 4 hours. 
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8. Thereafter, the mixture from each well was transferred in triplicates of 100 
µl to each well of a 96-well plate. 
9. The spectrophotometric absorbance for a wavelength of 560 nm of the 
alamarBlueTM –DMEM mixture was measured in a microplate reader, 
against a reference wavelength of 595 nm. Shaking of the samples was 
done in the microplate reader, for a duration of 3.0 s and a settle time of 
1.0 s, prior to absorbance measurement. 
 
The alamarBlueTM reduction was determined as follows. Firstly, the absorbance of 
the medium alone was subtracted from the absorbance of medium plus 
alamarBlueTM at the wavelength of 595 nm. This value is called AO595. The 
absorbance of the medium alone was then subtracted from the absorbance of 
medium plus alamarBlueTM at the wavelength of 560 nm. This value is called 
AO560. 




AOR =  
The percentage of alamarBlueTM reduced was then obtained as follows: 
% Reduction = A560 – (A595 x R0) × 100 
where: 
 A560: Spectrophotometric absorbance of alamarBlueTM –DMEM mixture  
         of experimental specimens at wavelength of 560 nm. 
 A595: Spectrophotometric absorbance of alamarBlueTM –DMEM mixture  
         of experimental specimens at wavelength of 595 nm. 
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3.13 Fluorescence Microscopy 
The morphology and distribution of live/dead cells was analyzed by fluorescence 
microscopy. Two different combinations of dyes were used to stain the cells 
seeded on the compacts as well as cells cultured with wear debris. Initially, a 
combination of fluorescein diacetate (FDA) and propidium iodide (PI) obtained 
from Molecular Probes, USA. FDA is converted to the fluorescent compound 
fluorescein in living cells and stains the cells green. PI, on the other hand, is 
membrane impermeant and is excluded from viable cells. It stains dead cells red. 
The protocol for staining the cells with FDA and PI is described below: 
1. Work was done in a darkened clean room. 
2. A stock solution of 1mg/ml FDA was prepared by dissolving 1g of FDA 
in 1l of acetone. The solution was stored in an opaque container at 4°C. 
3. The FDA solution was diluted 500-fold in PBS to obtain a concentration 
of 2µg/ml and stored in an opaque container. 
4. The stock PI of concentration 1mg/ml was diluted 10-fold in PBS to 
obtain a final concentration of 0.1mg/ml and stored in an opaque container. 
5. The tissue culture medium was removed and the experimental samples 
rinsed thrice with PBS. 
6. 0.5 ml of the 2µg/ml FDA solution was added to each well. The 48-well 
plates were then wrapped completely in aluminum foil and incubated for 
30 minutes. 
7. The FDA solution was then removed and the samples rinsed thrice with 
PBS. 
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8. 0.5 ml of the 0.1mg/ml PI solution was then added to each well. The 48-
well plates were then wrapped completely in aluminum foil and kept at 
room temperature for 2 minutes. 
9. The PI solution was removed and the samples rinsed. 
10. The samples were viewed under a fluorescence microscope. 
 
More accurate results were obtained with the LIVE/DEAD® Viability/ 
Cytotoxicity Assay Kit (L-3224) from Molecular Probes, USA. The kit consists of 
4 mM in anhydrous DMSO of Calcein AM  and 2 mM in DMSO/H2O 1:4 (v/v) 
of Ethidium homodimer-1(EthD-1). The Calcein AM produces an intense green 
fluorescence in live cells while EthD-1 produces a bright red fluorescence in dead 
cells. Observation of the viability of the cells under a fluorescence microscope 
was done in two steps. Firstly, the optimal dye concentration was determined, as 
outlined below: 
1. 3T3 and rat osteoblast were cultured in separate wells of separate 48-well 
plates, at a density of 10000 cells/well. 
2. LIVE/DEAD® Viability/ Cytotoxicity Assay Kit was removed from the 
freezer and allowed to warm to room temperature. 
3. After 3 days, dead cells were obtained by adding 0.1% saponin for 10 
minutes, at room temperature.  
4. Serial dilution of the LIVE/DEAD® Viability/ Cytotoxicity Assay Kit was 
performed. 6 different concentrations of calcein AM and EthD-1 (0.1, 0.2, 
0.4, 0.6, 0.8 and 1.0 µM) were obtained. 
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5. Each EthD-1 concentration was added to a different well containing dead 
cells. The cell culture plates were wrapped with aluminum foil and kept at 
room temperature for 40 minutes.  
6. The dead cells were observed under a fluorescence microscope. 
7. The EthD-1 concentration which stained the dead nuclei bright red without 
staining the cytoplasm significantly was selected. 
8. Each calcein AM concentration was then a different well containing a 
fresh batch of dead cells. The cell culture plates were wrapped with 
aluminum foil and kept at room temperature for 40 minutes.  
9. The dead cells were observed under a fluorescence microscope. 
10. The calcein AM concentrations which did not give significant 
fluorescence in the dead cell cytoplasm were noted. 
11. The concentrations of calcein AM selected from step number 10 were then 
added to the live cells. 
12. The live cells were observed under a fluorescence microscope. 
13. The concentration of calcein AM which generated sufficient green 
fluorescence in the live cells was selected. 
14. It was determined that, for both 3T3 cells and rat osteoblast, the optimal 
concentration of calcein AM and EthD-1 were 2 µM and 4 µM, 
respectively. 
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Once the optimal dye concentrations were determined, viability analysis of cells 
seeded on the polished surfaces of the compacts, as well as the cells cultured with 
wear debris, was performed, as follows: 
1. The LIVE/DEAD® reagent stock solutions were removed from the freezer 
and allowed to warm to room temperature. 
2. 20 µL of the supplied 2 mM EthD-1 stock solution was added to10 mL of 
sterile, tissue culture–grade D-PBS. The mixture was vortexed to ensure 
thorough mixing. The resultant solution contains approximately 4 µM 
EthD-1 solution. 
3. The reagents were then combined by transferring 5 µL of the supplied 4 
mM calcein AM stock solution to the 10 ml EthD-1 solution prepared in 
step 2. The solution was then vortexed to ensure thorough mixing. 
4. The resultant solution contains approximately 2 µM calcein AM and 4 µM 
EthD-1.  
5. Approximately 500 µL of the working solution was added to each well 
containing either cells cultured with wear debris, cells cultured with raw 
powder, or cells seeded on the polished surfaces of the compacts. 
6. The experimental setup was covered in aluminum foil and left to incubate 
for 45 minutes at room temperature in the clean room. 
7. The labeled cells were observed under a fluorescence microscope through 
longpass and dual emission filters. 
, 
 




Characterization of Particles and Sintered Compacts 
 
4.1 Raw Powder Characteristics 
The raw powder used to fabricate the titanium-graphite composite compacts were 
analyzed for their particle size distribution and morphological characteristics. 
 
4.1.1 Particle Size Distribution of Raw Powder  
Particle size distribution of raw powders used to fabricate compacts: a) Pure 
Titanium; b) Pure Graphite; c) 10-5 Specimens; and d) 10-10 specimens as 
measured by laser diffraction, are shown in Figure 4.1 below. It is observed that 
the all raw powder mixtures exhibit a unimodal particle size distribution. The 
particle sizes for each powder mixture are also quite statistically dispersed, with a 
relatively large standard deviation ranging from 9 µm to 15 µm (see Table 4.1). 
Qualitatively, the data set for each powder mixture does not display significant 



















































































Figure 4.1:  Particle size distribution of raw powders used to fabricate  
compacts: a) pure titanium; b) pure graphite; c) 10-5 specimens; 
and d) 10-10 specimens 
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Statistical information pertaining to the size distribution of the particles is listed in 
Table 4.1 below: 
 
Table 4.1: Raw powder size distribution statistics 
Sample Mean (µm) Std Dev (µm) Median (µm) Mode (µm) 
0-0 31.10 14.82 30.25 37.96 
Graphite 10.28 9.02 10.10 9.371 
10-5 26.25 14.82 25.01 37.96 
10-10 24.68 14.89 22.72 34.58 
 
  
4.1.2 Raw Powder Morphology 
The morphological characteristics of the raw powder was studied with a Scanning  
Electron Microscope, SEM (Jeol, Japan). The titanium particles had an irregular, 
angulated and granular morphology while the graphite particles had smooth flaky 
morphology. From the images of the 10-5 and 10-10 powder mixtures, the 
titanium and graphite particles were uniformly distributed. Refer to Figure 4.2 
below for the Scanning Electron Microscopy images of representative samples of 
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Figure 4.2:  Morphology of raw powders used to fabricate compacts: 
   a) pure titanium; b) pure graphite; c) 10-5 specimens; and  
d) 10-10 specimens 
 
4.2 Sintered Titanium and Titanium-Graphite Compact 
Characteristics 
After polishing and etching, as described in Section 3.5, the surfaces of the 
compacts were observed using optical and Scanning Electron Microscopy. 
 
4.2.1 Microstructure  
The polished surface of the compacts were observed under an optical microscope 
(Olympus, Japan), as shown in Figure 5.6 below. From the photomicrographs and 
SEM images, equiaxed primary alpha titanium was formed after the sintering and 
Hot Isostatic Pressing processes of the pure titanium powder. The binary powder 
mixtures, on the other hand, produced a tri-phasic composite of pure equiaxed 
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regions) and unreacted graphite (black regions). The titanium carbide phase was 
observed to form along the grain boundaries of the titanium matrix.  
 








































Figure 4.3:  Photo-micrographs of sintered, HIPped compacts   
   a) pure titanium; b) 10-5 specimens; and c) 10-10 specimens 
 
The formation of the titanium carbide phase along the grain boundaries of the 
composites could be explained through an understanding of the sintering process. 
Studies done by Kingery and Berg (1955) [11] and Ichinose and Kuczynski 
(1962) [12] have reported that there are three stages in sintering.  They are the 
initial, intermediate and final stages.  These stages are characterized in terms of 
the changes in the pore morphology where necking between particles can 
eventually lead to pore closure and full densification.  The changes in the pore 
morphology are caused by atomic migration, which has been found to be initiated 
by three mechanisms namely viscous flow, evaporation-condensation and self-
diffusion.  The first two mechanisms are bulk transport mechanisms responsible 
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surface diffusion process. Hence the formation of TiC, due to the reaction 
between the titanium and graphite powder particles, which follows the mechanism 
described above, has to take place at the interface between the 2 particles, 
resulting in the formation of TiC along the grain boundaries.  
 
The surfaces of the compacts were then observed in a scanning electron 
microscope (JEOL, Japan), as shown in Figue 4.4 below. The SEM images 
reinforced the observations made from optical microscopy. In addition, it was also 
observed that the size of the pores increased with increasing graphite content. The 
pores of the titanium graphite composites were observed to be isolated and 
formed at the boundary between titanium carbide and the titanium matrix. 
Additionally, the pores occur in regions where there is unreacted graphite. The 
fact that there exists unreacted graphite (which improves lubrication and hence 
increases wear resistance) indicates that the 2 hour sintering period did not allow 
complete necking between titanium and graphite particles to take place. Hence, 
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Figure 4.4:  Scanning electron microscopy images of sintered, HIPped 
compacts: a) pure titanium; b) 10-5 specimens; and  
     c) 10-10 specimens 
 
The SEM images allowed for the measurement of the pore sizes of the sintered 
compacts. The average pores sizes of the compacts were measured and shown in 
Table 4.2. 
 
Table 4.2: Average pore size of sintered and HIPped specimens 
Specimen 0-0 10-5 10-10 
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The addition of graphite resulted in decreasing grain size of the titanium matrix. 
The formation of titanium carbide along the grain boundaries interfered with the 
growth of the titanium matrix grains during the sintering process. The higher the 
graphite content, the smaller the size of the titanium grains. In the pure titanium 
specimen, the average grain size was 140 µm, while the average grain sizes of the 
10-5 and 10-10 composites were 32 µm and 21 µm, respectively. 
 
4.2.2 Porosity of Compacts 
The porosity of the compacts, before and after sintering and HIP, were determined 
as follows: 
The rule of mixtures is used to compute the density of the titanium-graphite 
compacts. 
 














⎡= ρρ  
where:  Qg = weight percent of graphite powder,  
QTi = weight percent of titanium powder,  
Wtotal = total weight of powders,  
ρg = density of graphite (2.21 g/cm3),  
ρTi = density of titanium (4.54 g/cm3) 
 
Theoretical density of compacts, ρth, 








where:  Vc = theoretical volume of compacts 
 






 where:  Wact = actual weight of compacts (measured on weighing machine),  
Vact = actual volume of compacts  





ρρ =  
Porosity, P = (1 – ρrel) x 100% 
 
The calculated porosity of the compacts, before and after sintering and HIP, are 
shown in Table 4.3. 
 
Table 4.3: Porosity of compact 
Fractional Porosity (%) 
Specimen 
Green Compacts After Sintering and HIP 
0-0 10.10 0.41 
10-5 12.22 1.24 
10-10 13.53 1.81 
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It is evident that the process of sintering and Hot Isostatic Pressing significantly 
reduced the porosity of the compacts, although pores were not completely 
removed. It was also observed that the porosity of the sintered, HIPed compacts 
increased with increasing graphite content. The higher graphite content resulted in 
increased formation of the titanium carbide phase along the titanium grain 
boundaries, and hence increased pore density due to incomplete densification at 
the interface of the different phases. 
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Chapter Five 
Hardness, Tensile Properties and  
Fatigue Strength of Compacts 
 
5.1 Hardness of Compacts 
The compacts were cut in three different planes as shown in Figure 5.1 below, and 
the respective Vickers Hardness measured The reason the hardness of the 
compacts was measured in the three different orientations was to determine if the 
various phases and porosity was evenly distributed throughout the composite. The 




 L: Longitudinal 
 T: Transverse 
 CS: Cross-section 
 Figure 5.1: Different orientations of compact surfaces 
 
The Micro-Vickers Hardness of the titanium and titanium carbide phases were 
measured and plotted in a bar chart (see Figure 5.3). The Vickers Hardness 
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Vickers Hardness measurements were made with a test load of 100 gf, for a load 












Figure 5.2: Vickers hardness of compacts 
 
The hardness of the compacts did not vary significantly with orientation of 
compact surfaces, indicating that the hot isostatic pressing had further 
































Figure 5.3: Micro-Vickers hardness of titanium and titanium carbide regions     
       of compacts  
 
The sintered and HIPped titanium-graphite composites, namely the 10-5 and 10-
10 specimens, exhibited significantly higher hardness that the pure titanium 
specimens (0-0). In addition, the Vickers hardness of the compacts appeared to 
increase proportionally with an increase in the graphite content. Given that all the 
specimens had the same compacting, sintering, HIP conditions and raw materials, 
it is reasonable to postulate that the 10-10 specimens significantly more TiC 
content compared to the 10-5 specimens. 
 
The hardness of the sintered and HIPed titanium, as well as the titanium regions 
of the compacts, were comparable with commercially available unalloyed 
titanium samples [12]. There was no significant difference in hardness between 
the titanium regions of the composites, and the pure titanium compacts. The 
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Micro-Vickers Hardness readings of the TiC regions of the composites were 
significantly lower than that of pure titanium carbide (3200 HRV).  
 
5.2 Tensile Properties of Compacts 
The tensile strength determines the maximum uniaxial tensile force, which could 
be safely applied to the composites before failure occurs. The modulus of 
elasticity represents the amount of stress needed to elastically deform the material. 
It is a measure of the stiffness of the material and is closely related to the binding 
energy between atoms.  
 
5.2.1 Tensile Strength and Stiffness of compacts 
Following the tensile tests, the stress-strain curves for the various specimens was 
plotted, as shown in Figure 5.4. The sintered, HIPed pure titanium samples 
exhibited higher stiffness and tensile strength than commercially available 
unalloyed titanium. The standard deviation for both these properties was 
statistically low.  
 
The titanium graphite composites, meanwhile, exhibited higher stiffness than the 
pure titanium samples. There was no significant difference in stiffness observed 
between the 10-5 and 10-10 specimens. The tensile strength of the composites, on 
the other hand, was lower than that of the pure titanium samples. 
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Figure 5.4: Stress-Strain Curves of sintered and HIPped Compacts. 
  
The mean tensile properties of the compacts is summarized in Table 5.1 below. 
 
Table 5.1: Mean Tensile Properties of Compacts. 
Specimen Young’s Modulus  Std Dev Tensile Strength Std Dev 
0-0 113.4 GPa 2.8 GPa 638.6 MPa 18.8 MPa 
10-5 152.4 GPa 6.5 GPa 391.4 MPa 80.0 MPa 
10-10 157.0 GPa 6.2 GPa 127.3 MPa 53.0 MPa 
  
 
Chapter 5: Hardness, Tensile Properties and Fatigue Strength of Compacts 
71 
5.2.2 Tensile Fracture Surfaces of Compacts 
Following tensile fracture, the specimens were successively sonicated in acetone 
and water baths, each for a period of 5 minutes. This procedure was undertaken to 
remove any surface dirt and contaminants. Care was taken not to damage the 
fracture surfaces. Thereafter, the fracture surfaces were observed in a scanning 












      
  
Figure 5.5: 0-0 tensile fracture surface, showing presence of dimples with local  
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 Figure 5.6: 0-0 tensile fracture surface, showing micro-void coalescence 
 
  
 Figure 5.7: 10-5 tensile fracture surface, showing the interface the titanium  
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Figure 5.8: 10-5 tensile fracture surface. Shown is a transgranular crack in the  










                 
  
Figure 5.9: 10-10 tensile fracture surface, showing the TiC and Ti Matrix  
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Figure 5.10: 10-10 tensile fracture surface, showing the formation of dimples, as  
         well as local cleavage facets near the TiC region, in the Ti Matrix. 
 
Observations of the fracture surface revealed that the surface is predominantly 
made up of dimples caused by micro-void coalescence resulting from ligament 
fracture. The dimples can be identified by the appearance of depressions on the 
fracture surface of approximately 2 to 10 µm in diameter. Also observed were 
river patterns, indicating crack propagation along many parallel cleavage planes. 
The 0-0 specimens hence exhibit a mixed mode fracture mechanism involving 
predominantly ductile, as well as, brittle fracture. The relative brittleness of the 0-
0 samples, as compared to commercially available pure titanium specimens, could 
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The titanium graphite composites, meanwhile, exhibited a more brittle mode of 
fracture. Cleavage facets and transgranular cracks were observed on the fracture 
surfaces of the composites. The cleavage facets were caused by the relatively fast 
propagation of cracks across the specimen, and are characterized by a relatively 
flat fracture region 
 
The direction of crack propagation could be identified from observations of the 
fracture surface. Since the crack propagates in the path of least resistance, the 
cracks were most likely to have grown across the brittle cleavage facets. The 
surrounding ductile material was weakened as a result, and fractured through 
microvoid coalescence, characterized by the dimples on the fracture surface. 
  
5.2.3 Discussion on Tensile Properties of Compacts 
As shown in Figure 5.11, the tensile strength of the compacts is inversely 
proportional to the graphite content (up to 10% by weight). This correlates well 
with Figure 5.2, where it was observed that the Vickers hardness of the compacts 
were, on the other hand, proportional to the graphite content. Both these plots 
suggests that for the compacting and sintering conditions employed in this study, 
increasing the graphite content, up to a maximum of 10% by weight, would result 
in a proportionate increase in titanium carbide formation, which results in 
increased hardness, and hence brittleness, of the compacts. 
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There could be several reasons, which would account for the reduction of tensile 
strength with increase TiC content. Firstly, from the fractographs obtained, it was 
observed that there was considerable cleavage of the titanium matrix in regions 
surrounding the TiC formation. The TiC-titanium interface appear to provide little 
resistance to the propagation of cracks. Hence the higher the TiC content, the 
higher the number of cleavage facets on the fracture surface. Finally, as observed 
in the images of the polished surfaces of the compacts, the higher the graphite, 
and hence TiC content, the higher the porosity of the specimen. The presence of 
pores provides a path for the cracks to propagate, and the reduced tensile strength. 








Figure 5.11: Effect of graphite content on tensile strength of compacts 
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As is clearly illustrated in Figure 5.12, the addition of 5% by weight of graphite 
greatly increases the stiffness of the compacts. Increasing the graphite content to 
10% yielded no significant increase in stiffness. Thus increasing the graphite 
content beyond 5% yields diminishing returns in stiffness, and is indeed 









 Figure 5.12: Effect of graphite content on Young's Modulus of compacts 
 
5.3 Fatigue Performance 
When a material is subjected to cyclic loading, even at levels below its yield 
strength, it may eventually fail, due to the propagation of cracks. This mode of 
failure is known as fatigue. Fatigue failures typically occur in three stages. Firstly, 
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a  tiny crack initiates at the surface, often at a stress raiser such as a notch or 
scratch. Next, the crack propagates gradually as the cyclic loading continues. 
Finally sudden fracture occurs when the remaining cross-section of the material is 
unable to support the applied load. 
 
5.3.1 Fatigue Strength of Compacts 
Fatigue tests were conducted on 0-0 and 10-5 specimens. The 10-10 specimens, 
which were extremely brittle, were not tested on. Persistent difficulty was faced in 
the machining and polishing of the 10-10 specimens, which were often damaged 
in the process. During the period of mechanical testing in Japan, only three 10-10 
specimens were successfully machined and polished, to standards required of the 
mechanical tests. It was thus decided that all three specimens should be used for 
the tensile tests. Moreover, due to the disappointing tensile strength of those 
composites, the fatigue strength was also expected to be exceptionally low.  
 
The S-N curves of the 0-0 and 10-5 specimens were plotted in Figures 5.13 and 
5.14 respectively. The sintered, HIPed pure titanium samples displayed lower 
fatigue limit (100 MPa) than commercially available pure titanium samples 
(between 130 MPa and 300 MPa [13, 14]). The 10-5 composites exhibited an 
even lower Endurance Limit of 85 MPa. The 10-10 specimens were too brittle for 
High Cycle Fatigue testing to be performed. An examination of the fatigue 
fracture surfaces is required in order to gain an insight into the fatigue fracture 
mechanics of the composites. 
























Figure 5.14: S-N curve of 10-5 specimens obtained during fatigue testing 
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5.3.2 Fatigue Fracture Surfaces of Compacts 
Following fatigue failure, the specimens were successively sonicated in acetone 
and water baths, each for a period of 5 minutes. This procedure was undertaken to 
remove any surface dirt and contaminants. Care was taken not to damage the 
fracture surfaces. Thereafter, the fracture surfaces were observed in a scanning 
electron microscope (SEM). The images obtained are shown below, in figures 












 Figure 5.15: 0-0 fatigue fracture surface, showing presence of fatigue striations. 
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 Figure 5.17: 10-5 fatigue fracture surface, showing transgranular cleavage facets  
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 The fatigue fracture surfaces of the pure titanium compacts comprised of fatigue 
striations as well as cleavage facets, probably caused by brittle fracture. The 
fracture surfaces of the 10-5 composites, meanwhile, were predominantly 
composed of transgranular cleavage facets. No fatigue striations were identified in 
fatigure fracture surfaces of the 10-5 composites, indicating that brittle, rapid 
fracture had taken place.  
 
5.3.3 Discussion on Fatigue Performance of Compacts 
The sintered, HIPed pure titanium samples displayed lower fatigue limit (100 
MPa) than commercially available pure titanium samples (between 130 MPa and 
300 MPa [13, 14]).  The Endurance Ratio, which is the ratio of fatigue life to 
tensile strength, is very low, at 0.16. This indicates that there is low resistance to 
crack propagation in the sintered, HIP specimens. An examination of the fatigue 
fracture surfaces revealed that the surfaces were made up cleavage facets, chevron 
patterns and fatigue striations. The striations show the position of the crack tip 
after each cycle. The chevron pattern is produced by separate crack fronts 
propagating at different levels in the material. A radiating pattern of surface 
markings fan away from the origin of the crack. The chevron patterns and 
cleavage facets indicate rapid crack propagation and the brittle nature of the 
material failure under cyclic loading. 
 
The 10-5 composites exhibited even lower fatigue limit of 85 MPa than the 0-0 
specimens. The Endurance Ratio, which is the ratio of fatigue life to tensile 
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strength, is very low, at 0.22. In similar fashion to the 0-0 specimens, the 
composites offered little resistance to crack propagation under a cyclic load. An 
examination of the fatigue fracture surface revealed the predominance of cleavage 
fracture surfaces. Fatigue striations were not distinct on the fracture surfaces, 
which indicates that the cracks propagated rapidly during the period of cyclic 
loading. This suggests that the bonding strength at the interface between the 
titanium carbide and titanium matrix was relatively low. The situation was 
worsened by the fact that the titanium carbide phase agglomerated, instead of 
small, discreet reinforcement regions. The agglomeration of the titanium carbide 
phase, in addition to the weak bonding strength with the titanium matrix and 
relatively small grain size of the titanium matrix of the composites, provide little 
resistance to crack propagation during cyclic loading. 
 
The sintered, HIPped specimens hence display poor fatigue properties, and may 
not be suitable for applications involving uniaxial, tensile cyclic loading. 
Following fatigue testing, the fractured specimens were thoroughly cleaned and 
sent for oxygen content analysis. It was found that the oxygen content of each test 
specimen was approximately 0.5%, which was significantly higher than was 
allowed for commercial purity titanium (of about 0.35%) [13]. One possible cause 
of the high oxygen content was the high temperature employed in the HIP process, 
which could have accelerated the diffusion of oxygen into the titanium specimens. 
The higher oxygen content could have embrittled the compacts, leading to poor 
tensile and fatigue performance.  
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Chapter Six 
Characterization of Wear Debris  
 
6.1 Morphology of Wear Debris 
The wear debris was generated by firstly plane milling the surfaces of the sintered 
compacts to produce large debris. Much finer wear debris was obtained by 
grinding the debris obtained with an agate pestle and mortar apparatus. This 
process was described in detail in section 3.10.1. The wear debris was examined 
by scanning electron microscopy, and the morphology analyzed. Shown below in 
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The composition of the various particles (Ti, TiC and graphite) in the wear debris 
was determined by EDX. From the SEM images, it was observed that the size of 
the wear debris in general were finer than the raw powders used. The morphology 
of the titanium and graphite particles, however, was similar. The composite wear 
debris had a larger percentage of particles smaller than 1.6 µm. These sub-micron 
particles were probably made up of graphite as well as titanium particles, which 
were grinded to a greater extent due to the presence of TiC in the wear debris. The 
TiC particles, were larger in size than the titanium particles. The wear generation 
process was not very effective in reducing the size of the extremely hard TiC. 
 
6.2 Particle Size Distribution of Wear Debris 
Due to the poor miscibility of the wear debris, a relatively large amount of debris 
is required in order to perform laser diffraction accurately. Because of the limited 
supply of wear debris, an alternative method was needed to determine the particle 
size distribution of the wear debris.  
 
6.2.1  Particle Size Distribution Based on Total Particle Number 
The particle size distribution of the wear debris at various particle size ranges, as 
a percentage of total particle number, was determined by analyzing the SEM 
images of the wear debris with a software known as CTAn (Skyscan, Belgium). 
By applying the appropriate level of image thresholding, the particles of the wear 
debris were isolated and the particle size distribution, based on particle number, 
determined, for different particle size ranges, as shown in Figures 6.4 to 6.6. 
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Please refer to Appendix 3 for a detailed explanation of the procedure employed 
in determining the particle size distribution of the wear debris. 
 





































Figure 6.4: Particle size distribution of 0-0 wear debris based on particle           
        frequency. 
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Figure 6.5: Particle size distribution of 10-5 wear debris based on particle              
        frequency. 
 
 





































Figure 6.6: Particle Size Distribution of 10-10 Wear Debris Based on Particle    
       Frequency. 
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The mean particle sizes for the 0-0, 10-5 and 10-10 wear debris are 2.34 ± 1.54 
µm, 1.12 ± 0.22 µm and 1.63 ± 0.34 µm respectively. The statistical details of the 
particle size distribution of the wear debris are summarized in Table 6.1. Most 
(70 %) of the titanium wear debris were smaller than 3.2 µm, while most of the 
10-5 (70 %) and 10-10 (70 %) were below 1.2 µm. It was also observed that there 
was a more even spread in the size of the 0-0 wear debris particle, hence the high 
standard deviation value. The sizes of the 10-5 and 10-10 wear debris particles 
varied to a lesser degree from their respective means, as compared to the pure 
titanium wear debris. 
 
Table 6.1: Statistical Information on Particle Size Distribution of Wear Debris  
     (Based on Particle Frequency) 
Sample Mean (µm) Std Dev (µm) Median (µm) Modal Range (µm)
0-0 2.34 1.54 1.2 0.81 – 1.60 
10-5 1.12 0.22 0.6 0.01 – 0.04 
10-10 1.63 0.34 1.2 0.81 – 1.60 
 
The size of the wear debris generated was slightly larger than the size of 
predominantly polyethylene particulate debris retrieved from patients with hip 
prostheses, which had a mean particle size of 0.5 µm [46]. Other studies, however, 
have concluded that ceramic and metallic wear debris are up to 3 µm in size [63, 
64], which compare well with the size of debris generated. In addition, the size of 
the wear debris obtained in the present study did not deviate much from other 
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studies involving biocompatibility of wear debris and titanium particles [20, 21, 
50], whose results provided a basis for comparison.  
 
6.2.2 Particle Size Distribution Based on Total Particle Volume 
The CTAn was an invaluable tool in determining the particle size distribution of 
the wear debris, based on the total particle count. Earlier work involving raw 
powder particle size distribution, determined by laser diffraction (see Chapter 4), 
presented the data based on percentage of total particle volume. Hence, for 
consistency, it is imperative that a means of reasonably approximating the particle 
size distribution of the wear debris, based on percentage of total particle volume, 
be established. 
 
Several studies involving biocompatibility of titanium particles have described 
[65, 66] means of determining particle number by approximating the mean 
particle shape to be a sphere. Based on the SEM images of the wear debris 
generated in the present study, it was observed that: 
a) the morphology of the wear debris is consistent, regardless of particle size; 
b) it is reasonable to approximate the mean particle shape of the wear debris 
to be spherical. 
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Hence, the linear dimensions of the particles is taken to be the diameter of the 
approximated sphere. The volume of each wear debris particle could then be 





⎛= dVdebris π  
 
where: 
Vdebris  = volume of wear debris particle. 
d = linear dimension of the particle. 
 
The linear dimensions of the wear debris particles and corresponding particle 
count has been determined by the CTAn software, as described in Section 6.2.1. 
Thus, the particle size distribution of the wear debris particles, with respect to 
total particle volume, could be determined, and the results are plotted in Figures 
6.7, 6.8 and 6.9. 
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 Figure 6.7: Particle size distribution of 0-0 wear debris (volume percentage). 



















 Figure 6.8: Particle size distribution of 10-5 wear debris (Volume Percentage). 
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 Figure 6.9: Particle size distribution of 10-10 wear debris (Volume Percentage). 
 
The mean particle sizes for the 0-0, 10-5 and 10-10 wear debris are 10.64 ± 2.08 
µm, 8.90 ± 0.26 µm and 9.42 ± 0.27 µm respectively. The statistical details of the 
particle size distribution of the wear debris are summarized in Table 6.2. Most 
(70 %) of the titanium wear debris were smaller than 15.0 µm, while most of the 
10-5 (70 %) and 10-10 (70 %) were below 9.6 µm. It was also observed that there 
was a more even spread in the size of the 0-0 wear debris particle, hence the high 
standard deviation value. The sizes of the 10-5 and 10-10 wear debris particles 
varied to a lesser degree from their respective means, as compared to the pure 
titanium wear debris. 
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Table 6.2: Statistical information on particle size distribution of wear debris  
     (based on particle volume percentage) 
Sample Mean (µm) Std Dev (µm) Median (µm) Modal Range (µm)
0-0 10.64 2.08 16.6 6.41 – 12.8 
10-5 8.90 0.26 12.6 6.41 – 12.8 
10-10 9.42 0.27 12.5 6.41 – 12.8 
 
It is evident that when the particle size distribution is represented in terms of 
percentage total wear debris volume, the mean particle size increases significantly. 
This is due to the fact that the larger sized particles, although small in number, 
would make a far larger contribution to the total debris volume, than would the 
ubiquitous finer particles.  
 
It is also evident that the wear debris particles generated were finer than the raw 
powder particles used to manufacture the specimens. The persistent grinding of 
the particles with the agate mortar significantly reduced the size of the wear 
debris. This observation was all the more evident in the composite wear debris, 
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6.3 Pros and Cons of Using CTAn for Particle Size Analysis 
CTAn is a useful software in determining the particle size distribution in cases 
whereby there is insufficient particle quantity to accurately perform laser 
diffraction. By applying an appropriate level of thresholding, the software is able 
to isolate discrete particles from the image of the particles, and determine the 
pixel count for each individual particle. Calibration simply involves comparing 
the linear dimensions of the particle, measured with the scale bar in the SEM 
image, with the corresponding pixel count generated by the software.  
 
The software is user friendly, and results could be obtained quickly. Only a small 
amount of particles is needed to obtain results. The trial version of the software, 
which is adequate for this purpose, is readily available from the Skyscan website 
[67]. This method provides a relatively clean and fuss-free alternative to laser 
diffraction, whereby the equipment would need to be purged and thoroughly 
cleaned after use. Finally, in laser diffraction the particles need to be miscible in 
water. Difficulties were encountered in the present work, when determining the 
particle size distribution of the raw powders, which were not very miscible in 
water, through laser diffraction (described in Chapter 4). 
 
The disadvantages of this method are that firstly, good, clear images of the 
particles would first have to be obtained, preferably through Scanning Electron 
Microscopy. Care must be taken to ensure that there is minimal clumping of the 
particles. Since CTAn is only able to analyze the particle size based on the pixel 
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count of the image of the particle, inaccuracies could arise if the image of the 
particle is not properly in focus. Secondly, this method allows the measurement of 
particle sizes only in 2 dimensions, and hence, the accuracy of the particle size 
measurement of samples comprising particles which are elongated would be 
largely dependent on the orientation of the particles in the images. Laser 
diffraction eschews this problem as the actual size of the particle is being 
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Chapter Seven  
Biocompatibility Studies 
 
7.1 Biocompatibility of Raw Powder 
The effect of the raw powders on the proliferation of 3T3 and rat osteoblast was 
performed as described in Section 4.8.2. The study was consisted of two parts, 
carried out concurrently:  
a) the alamarBlueTM Reduction at various time points, normalized to the 
control to determine cell proliferation; and 
b) fluorescence microscopy, to determine the distribution of live/dead cells, 
as well as to analyze the morphology of the cells and the range of particle 
sizes, which were phagocytosed by the cells. 
 
7.1.1 alamarBlueTM Reduction of Cells Cultured with Raw Powder  
The proliferation rates of 3T3 cells and rat osteoblast were measured 
quantitatively by determining the extent of alamarBlueTM Reduction at various 
time points. alamarBlueTM is a redox indicator which undergoes reduction in 
response to metabolic activity. The alamarBlueTM reduction yields a colorimetric 
change, whose spectrophotometric absorbance could be measured with a micro-
plate reader. Cells seeded on tissue culture plates without interaction with the raw 
powder, at the same seeding density, were used as controls. The alamarBlueTM 
reduction of the cells seeded on the compacts were measured and plotted at 
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various time points, normalized as a fraction of the reduction measured in the 





















Figure 7.2: alamarBlueTM reduction of rat osteoblast cultured with raw powder 
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7.1.2 Statistical Significance of Cell Proliferation Assay Involving Raw 
Powder 
The Student’s T-Test was carried out to determine the statistical significance of the 
cell proliferation assay involving raw powder. Five sets of results (n = 5) were 
obtained for each time point and the detailed calculations are attached in Appendix 4. 
 
In the initial stages of the 3T3 and rat osteoblast cell culture (up to 24 hours), the 
presence of the different types of raw powder did not result in significant 
difference in cellular proliferation (p > 0.1).  
 
After 48 hours, however, the samples containing the 10-5 powder mixture (p < 
0.05) and the pure graphite powder (p < 0.05) caused a significant reduction in 
3T3 cell proliferation, as compared to the samples containing pure titanium 
powder. Samples containing 10-10 powder mixture (p > 0.1) did not cause a 
significant reduction in 3T3 cell proliferation at this time point. The rat osteoblast 
cell culture showed a similar trend, with samples containing 10-5 powder mixture 
(p < 0.05) and the pure graphite powder (p < 0.05) causing a significant reduction 
in rat osteoblast proliferation, as compared to the samples containing pure 
titanium powder. Likewise, the samples containing 10-10 powder mixture (p > 
0.1) did not cause a significant reduction in rat osteoblast proliferation 
 
After 96 hours of cell culture, samples containing the 10-5 powder mixture continued 
to proliferate at a high rate and there was no significant difference in 3T3 cell and rat 
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osteoblast proliferation, as compared to the samples containing pure titanium powder 
(p > 0.1). Samples containing 10-10 powder mixture and the pure graphite powder 
proliferated at a slower rate and there was significant difference in 3T3 cell and rat 
osteoblast proliferation, as compared to the samples containing pure titanium powder 
(p < 0.01 and p < 0.001, respectively). 
 
 
After seven days (168 hours) of cell culture, there was no significant difference in 3T3 
cell and rat osteoblast proliferation in samples containing the 10-5 powder mixture, as 
compared to the samples containing pure titanium powder (p > 0.1). There was, 
however, significant reduction in 3T3 cell and rat osteoblast proliferation in samples 
containing the 10-10 powder mixture   (p < 0.05), as well as the pure graphite powder 
(p < 0.001). 
 
Hence the results indicate that the presence of 10-10 powder mixture and especially 
graphite powder used in this experiment had a significant effect on the long-term 3T3 
cell and rat osteoblast cellular proliferation. The 10-5 powder mixture, meanwhile, did 
not significantly impact the long term cellular proliferation. 
 
7.1.3  Fluorescence Microscopy of Cells Cultured with Raw Powder 
It was also important to determine if the raw powder were phagocytosed by the 
cells, and if the interaction with the powder brought about a change in 
morphology of the cells. Typical fluorescence microscopy images indicating 
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phagocytosis of powder, as well as morphology of the affected cells after 96 hours 
are shown in Figures 7.3 and 7.4. 
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Figure 7.3: Fluorescence microscopy of interaction of 3T3 cells with raw  
        powder: a) 3T3 cells cultured with pure titanium raw powder; 
        b) 3T3 cells cultured with pure graphite; c) 3T3 cells cultured with  
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Figure 7.4: Fluorescence microscopy of interaction of rat osteoblast with raw  
        powder: a) rat osteoblast cultured with pure titanium raw powder; 
        b) rat osteoblast cultured with pure graphite; c) rat osteoblast  
       cultured with 10-5 binary powder; and d) rat osteoblast cultured with  
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7.1.4 Discussion on Biocompatibility of Raw Powder 
From the micrographs obtained through fluorescence microscopy, it was observed 
that after 96 hours, the viable 3T3 cells and rat osteoblasts phagocytosed smaller 
titanium and graphite particles. Measurements of the size of the phagocytosed 
particles were visually made, with help from the scale bar attached to each image. 
It was observed that particles below 6 µm were phagocytosed by the cells. This 
compared well with the results of other studies [46, 20]. The larger particles 
(above 10 µm), on the other hand, were observed to be attached to the plasma 
membrane of the viable cells. The cells were observed to adhere to the clusters of 
the larger particles. 
 
The fact that the viable cells had internalized a large number of the smaller 
particles suggest that phagocytosis of smaller titanium and graphite particles, up 
to a certain threshold number per cell, would not affect viability. Observations of 
the viable cells which had phagocytosed the particles indicated that the cells 
growing in regions devoid of large particles (above 10 µm) experienced a change 
in morphology, as a result of the phagocytosis. Following ingestion of the 
particles, the cells became less elongated, as compared to the control group. The 
presence of larger particles also had an effect on the cellular morphology of both 
cell types. The cells growing in the proximity of larger particles experienced an 
alteration in morphology, in an attempt to attach themselves to those particles and 
grow around them as the cells proliferated. 
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Pioletti et al [21] have established that osteoblasts phagocytosed most of the 
particles in the first 24 hours. The results of the present study did not contradict 
their findings. From the normalized plots of the alamarBlueTM Reduction with 
time for both cell types, a steep dip in viability was observed within the first 24 
hours. Subsequent to that, the proliferation of the cells resulted in a lower particle 
number to cell ratio, lowering the exposure level significantly. Hence there is a 
stabilization in the proliferation of the cells, as compared to the control group, 
with time.  
 
Comparing the results of the alamarBlueTM reduction of the 3T3 celline and rat 
osteoblasts revealed that, in the presence of the raw powder in vitro, the 
fibroblasts proved more resilient. The presence of pure titanium particles did not 
affect fibroblast proliferation significantly. The 3T3 cells cultured with pure 
graphite particle experienced a significant reduction in proliferation over time, by 
about 10 % after 1 week. The binary powder mixtures (10-5 and 10-10), on the 
other hand, caused a reduction in fibroblast proliferation by between 2.5 % to 
7.5 %.  This reduction in proliferation could be attributed to the presence of 
graphite particles.  
 
The raw powder particles, meanwhile, evoked a more cytotoxic response from the 
rat osteoblast. The graphite particles caused the greatest reduction in cell 
proliferation of up to 20 %. The pure titanium particles, meanwhile, brought about 
a relatively benign reduction in cell proliferation of up to 6 %. The cytotoxic 
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effect of the pure titanium particles was less significant than that observed in 
other studies involving rat osteoblasts [20, 21]. It should be noted, however, that 
while the concentration of titanium particles (1 mg/ml) used in the present study 
was similar to the study conducted by O’Connor et al, the size of the titanium 
particles used in that study were significantly smaller.  
 
There have been no reported findings on the effect of fibroblast proliferation in 
the presence of graphite powder, but several researchers have studied the 
biocompatibility of carbon particles towards osteoblast proliferation. It has been 
reported that, while nano-scale graphite particles were relatively benign, and may 
indeed enhance osteoblast viability [54, 55]. In this study, it has been found that 
the graphite particles, of mean particle size of 10 µm, evoked a cytotoxic response 
from both the 3T3 cells (by up to 10 % reduction in cell proliferation) and, to a 
more significant extent, the rat osteoblasts (by up to 20 % reduction in cell 
proliferation). The difference in biocompatibility between the nanophase carbon 
particles and the micron-sized graphite particles used in the present study could be 
attributed to the difference in particle sizes. It has been postulated that micron-
sized wear debris vary significantly in size and morphology from naturally 
occurring components of bone, such as hydroxyapatite crystals (less than 10 nm) 
collagen fibres (from 100 nm to a few microns in diameter [53].  
 
The different viability responses of the 3T3 cells and rat osteoblasts towards the 
presence of the raw powder particles could be due the fact that fibroblasts are 
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better adapted at attaching themselves to particles. The primary function of 
osteoblast is to develop into bone tissue, while one of the primary functions of 
fibroblast in vivo is to encapsulate and isolate particulate debris. 
  
Finally, in every case investigated in the present study, the alamarBlueTM 
reduction after 3 hours was lower than that of the control. Pioletti et al [68] have 
postulated that loading of particles in the cell culture may cause mechanical 
damage to the cells, and may account for the lower initial cell proliferation. 
 
7.2 Biocompatibility of Wear Debris 
Wear debris was obtained from the sintered, hot isostatically pressed compacts as 
described in Section 4.8.3.1. The morphology and particle size distribution of the 
wear debris has been discussed in Chapter 6. In this section, the cell proliferation 
of 3T3 cells and rat osteoblast, as determined by alamarBlueTM Reduction, and the 
distribution of viable cells, determined from fluorescence microscopy, were 
examined.  
 
7.2.1 alamarBlueTM Reduction of Cells Cultured with Wear Debris  
The alamarBlueTM Reduction of 3T3 cells and rat osteoblast, cultured with wear 
debris, are shown in Figures 7.5a and 7.5b respectively. 
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Figure 7.5b: alamarBlueTM reduction of rat osteoblast cultured with wear debris 
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7.22 Statistical Significance of Cell Proliferation Assay Involving Wear 
 Debris  
 The Student’s T-Test was carried out to determine the statistical significance of 
 the cell proliferation assay involving wear debris. Five sets of results (n = 5) were 
 obtained for each time point and the detailed calculations are attached in 
 Appendix 5. 
 
In the initial stages of the 3T3 cell culture (up to 48 hours), the presence of the 
different types of wear debris did not result in significant difference in cellular 
proliferation (p > 0.1). The presence of the different types of wear debris did not 
result in significant difference in cellular proliferation (p > 0.1) in the rat 
osteoblast cell cultures after 3 hours. However, after 24 hours, the 10-5 (p < 0.05) 
and 10-10 (p < 0.01) wear debris resulted in a significant reduction in rat 
osteoblast proliferation, as compared to the samples containing pure titanium wear 
debris. After 48 hours, there was significant reduction in rat osteoblast 
proliferation, as compared to the samples containing pure titanium wear debris in 
the samples containing 10-5 (p < 0.01) and 10-10 (p < 0.01) wear debris. 
 
After 96 the samples containing the 10-10 wear debris (p < 0.05) caused a 
significant reduction in 3T3 cell proliferation, as compared to the samples 
containing pure titanium wear debris. Samples containing 10-5 wear debris            
(0.05 < p < 0.1) caused a moderate reduction in 3T3 cell proliferation at this time 
point. The presence of wear debris continued to have a significant impact on rat 
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osteoblast proliferation. There was significant reduction in rat osteoblast 
proliferation, as compared to the samples containing pure titanium wear debris, in 
samples containing the 10-5 wear debris (p < 0.05) and the 10-10 wear debris (p < 
0.01).  
 
After seven days (168 hours) of cell culture, there was significant reduction in 3T3 cell 
proliferation in samples containing the 10-5 wear debris (p < 0.05) and the 10-10 wear 
debris (p < 0.01), as compared to the samples containing pure titanium wear debris. 
Likewise, the presence of the 10-5 wear debris (p < 0.01) and the 10-10 wear debris  
(p < 0.001) resulted in significant reduction in rat osteoblast proliferation, as compared 
to the samples containing pure titanium wear debris. 
 
Hence the results indicate that the presence of 10-5 and 10-10 wear debris had a 
significant effect on the long-term 3T3 cell and rat osteoblast cellular proliferation. 
The presence of pure titanium wear debris did not significantly impact the long term 
cellular proliferation. 
 
7.2.3 Fluorescence Microscopy of Cells Cultured with Wear Debris 
The morphology of the cells exposed to wear debris after 96 hours was studied 
under a fluorescence microscope, following staining with Calcein AM  and 
Ethidium homodimer-1. The images obtained are shown in Figures 7.6 and 7.7. 
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Figure 7.6: Fluorescence microscopy of interaction of 3T3 cells with wear  
                   debris: a) 3T3 cells cultured with pure titanium wear debris; 
       b) 3T3 cells cultured with 10-5 wear debris; and c) 3T3 cells  
       cultured with 10-10 wear debris. 
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Figure 7.7: Fluorescence microscopy of interaction of rat osteoblast with wear  
                   debris: a) rat osteoblast cultured with pure titanium wear debris; 
       b) rat osteoblast cultured with 10-5 wear debris; and c) rat osteoblast 
       cultured with 10-10 wear debris. 
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7.2.4 Discussion on Biocompatibility of Wear Debris 
From the micrographs obtained through fluorescence microscopy, it was observed 
that after 96 hours, the viable 3T3 cells and rat osteoblasts phagocytosed smaller 
titanium and graphite particles. From visual inspection of the images, there 
appeared to be more wear debris phagocytosed in each cell as compared to the 
number of raw powder particles internalized by the cells. This could be due to the 
smaller size of the wear debris, and hence, the cells were exposed to more 
particles below 6 µm, as compared to the study involving raw powder. 
 
The presence of pure titanium wear debris reduced cellular proliferation of rat 
osteoblast by up to 10 % after 1 week, but did not significantly affect the 
proliferation of the 3T3 cells. The reduction on rat osteblast proliferation was 
more significant than the raw powder particles. This suggests that the smaller size 
of the titanium particles in the wear debris may be responsible for the reduced 
osteoblast proliferation. O’Connor et al [20] have determined that titanium 
particles of between 1.5 µm to 4.0 µm in size were most detrimental to rat 
osteoblast proliferation, and particles between 5 – 9 µm and below were 
phagocytosed, and brought about a decrease in proliferation of the osteoblast, 
when loaded at a concentration of 1mg/ml, the same concentration used in this 
study. 
 
Wear debris from the titanium-graphite composite brought about a reduction in 
cell proliferation of the rat osteoblasts, by up to 16 %, as well as 3T3 cells, by up 
Chapter 7: Biocompatibility Studies 
 
116 
to 5 %, after 1 week of cell culture. Comparing the alamarBlueTM reduction plots 
with the study involving raw powder, it is apparent that the wear debris of the 
titanium-graphite composite was more cytotoxic than the raw powder particles. 
 
The difference in graphite content between the 10-10 wear debris and 10-5 wear 
debris did not have an appreciable impact on the cell proliferation. There could be 
several reasons for this observation. Firstly, an increase in graphite content of the 
raw powder brought about an increase in the TiC formation, as observed in the 
photomicrographs of the polished specimen surfaces. The Vickers Hardness 
measurements of the specimens substantiates this point, as discussed in Section 
5.1, suggesting that twice as much TiC is formed in the 10-10 specimens, as 
compared to the 10-5 specimens, given the sintering conditions used in this study. 
Hence, the amount of unreacted graphite did not increase substantially in the 10-
10 specimen, as compared to the 10-5 specimen. The reduction in cell 
proliferation in the wear debris cell cultures, as compared to the cultures 
involving raw powder, was brought about predominantly by the increase in small 
titanium particles content, below 5 – 9 µm,, in the wear debris.  
 
A similar trend was observed to the study involving raw powder, whereby there is 
a steep decline in cell proliferation between 3 hours to 24 hours after loading with 
particles. The cell proliferation stabilized thereafter. This could be due to the fact 
that most of the particles were phagocytosed within the first 24 hours, and 
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subsequent to that, as a result of cell proliferation, there was a reduction in the 
exposure level of the particles to the cell.  
 
7.3 Biocompatibility of Sintered Compacts 
The sintered and Hot Isostatically Pressed compacts were polished and seeded 
with 3T3 cells and rat osteoblast, as described in section 4.9.1. The results of the 
cellular propagation of both cell types are described below: 
 
7.3.1 Water Contact Angle Measurements 
The wettability of a surface determines how hydrophilic the surface is. The 
hydrophilicity of a surface is important when seeding cells onto a surface, as it 
would, in theory, be easier for cells to attach themselves on more hydrophilic 
surfaces. The mechanism of cell attachment on bulk surfaces has been described 
in Section 2.5.1. The water contact angle of both the polished and unpolished 
compact surfaces were measured dynamically for a period of 150 s, at intervals of 
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 Figure 7.8: Water contact angle measurements of compact surfaces. 
         a) 0-0 specimens; b) 10-5 specimens; and c) 10-10 specimens. 
 
From the plots, it is evident that the water drop spreads out on the surface of the 
specimen being measured over a period of 150s. The initial water contact angle 
(at time = 0s) is relatively high for all polished specimens, at between 60 to 80 
degrees. This indicates that the polished surfaces of the specimens were relatively 
hydrophobic. An increase in graphite content had a marginal effect in increasing 
the hydrophilicity of the specimen surfaces, probably by increasing the surface 
irregularities from increased carbide formation. Research involving titanium 
oxide films [69] has shown that the water contact angle on the titanium oxide 
films at time = 30s was approximately 33 degrees. However, the water drop on 
the titanium oxide surface did not spread out by much, and after 150s, the water 
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contact angle was approximately 32 degrees, which was not significantly lower 
than the angles measured on the titanium-graphite composites. 
 
There was only marginal differences in water contact angles of the polished and 
unpolished specimen surfaces, for the 0-0 and 10-5 specimens. The unpolished 
surfaces of the 10-10 specimens were, on average, significantly more hydrophilic 
than the polished surfaces. It was observed, however, that the water contact angles, 
measured on the unpolished surfaces, varied more significantly for each sampling 
of the data, as compared to those measured on the polished surfaces. The large 
variance could be due to the unpredictability of the nature of the unpolished 
surfaces.  
 
7.3.2 Statistical Significance of Water Contact Angle Tests on Sintered 
Compacts  
The Student’s T-Test was carried out to determine the statistical significance of 
the results of the water contact angle tests on the sintered compact surfaces. Three 
sets of results (n = 3) were obtained for each time point and the detailed 
calculations are attached in Appendix 6. 
 
There was no significant difference in water contact angle measurements between 
the polished and unpolished surfaces of the pure titanium specimens (p > 0.1), as 
well as the 10-5 specimens (p > 0.1), at all time points. Polishing the surfaces of 
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the 10-10 specimens, however, significantly increased the water contact angle of 
the surfaces (p < 0.05).  
 
There was no significant difference in the water contact angle of the polished 
surfaces of the pure titanium specimen and the 10-5 specimen (p > 0.1) and the 
10-10 specimens (p > 0.05). Additionally, there was no significant difference in 
water contact angle of the unpolished surfaces of the pure titanium specimens and 
the 10-5 specimens (p > 0.1). There was, however, a significant difference 
between the water contact angle measurements on the unpolished surfaces of the 
pure titanium specimen and the 10-10 specimen (p < 0.05). 
 
7.3.3 alamarBlueTM Reduction of Sintered Compacts 
The proliferation rates of 3T3 cells and rat osteoblast were measured 
quantitatively by determining the extent of alamarBlueTM Reduction at various 
time points. alamarBlueTM is a redox indicator which undergoes reduction in 
response to metabolic activity. The alamarBlueTM reduction yields a colorimetric 
change, whose spectrophotometric absorbance could be measured with a micro-
plate reader. Cells seeded on a tissue culture plate, at the same density as those 
seeded on the compacts, were used as controls. The alamarBlueTM reduction of 
the cells seeded on the compacts were measured and plotted at various time points, 
as a fraction of the reduction measured in the control group, as shown in Figure 
7.9 and 7.10 below. 
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 Figure 7.10: alamarBlueTM reduction of rat osteoblast seeded on compact  
                     surfaces  
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7.3.4 Statistical Significance of Cell Proliferation Assay Involving 
Sintered Compacts 
The Student’s T-Test was carried out to determine the statistical significance of 
 the cell proliferation assay involving wear debris. Five sets of results (n = 5) were 
 obtained for each time point and the detailed calculations are attached in 
 Appendix 7. 
 
There was significant difference in alamarBlueTM reduction of the 3T3 cells when 
the cells were first seeded (3 hours) on the 10-5 (p < 0.05) and 10-10 (p < 0.001) 
specimen surfaces, as compared to the alamarBlueTM reduction of 3T3 cells 
seeded on pure titanium surfaces. The presence of graphite on the surfaces of the 
10-5 and 10-10 specimens may have had an affect on the cellular adhesion on the 
specimen surfaces. Similarly, there was significant difference in alamarBlueTM 
reduction of the rat osteoblast when the cells were first seeded (3 hours) on the 
10-5 (p < 0.001) and 10-10 (p < 0.001) specimen surfaces, as compared to the 
alamarBlueTM reduction by rat osteoblast seeded on pure titanium surfaces. 
 
Between 24 hours to one week, there was significant difference in alamarBlueTM 
reduction of the 3T3 cells seeded on the 10-5 and 10-10 surfaces (p < 0.05) as 
compared to the alamarBlueTM reduction of 3T3 cells seeded on pure titanium surfaces. 
The rat osteoblast seeded on the 10-5 specimen surface had a significant difference in 
alamarBlueTM reduction at between 24 hours to 48 hours after cell seeding (p < 0.05), 
as compared to the alamarBlueTM reduction by rat osteoblast seeded on pure titanium 
Chapter 7: Biocompatibility Studies 
 
124 
surfaces. Thereafter, however, at 96 hours and 1 week after cell seeding, there was no 
significant difference in alamarBlueTM reduction by rat osteoblast seeded on the 10-5 
surfaces, as compared to those seeded on the pure titanium surfaces (p > 0.1). 
 
There was no significant differences in the alamarBlueTM reduction by rat osteoblast 
seeded on the 10-10 specimen surfaces, as compared to those seeded on the pure 
titanium surfaces, between 24 hours and 1 week after cell seeding was performed (p > 
0.1). 
 
Hence the results indicate that the presence of graphite on the specimen surfaces may 
have an impact on cellular adhesion, but not significantly on cellular proliferation..  
 
7.3.5 Fluorescence Microscopy of Sintered Compacts 
The distribution of viable and dead cells on the surface of the compacts was 
determined using the LIVE/DEAD® Viability/ Cytotoxicity Assay Kit (Molecular 
Probes, USA), which consists of two dyes: Calcein AM  and of Ethidium 
homodimer-1(EthD-1) as described in Section 4.9.4. The Calcein AM produces 
an intense green fluorescence in live cells while EthD-1 produces a bright red 
fluorescence in dead cells. The results of the fluorescence microscopy of 3T3 
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Figure 7.11: Fluorescence microcopy of 3T3 cells 1 week after seeding on  
compact surface: a) 0-0 surface; b) 10-5 surface; and c) 10-10 
surface        
 
The distribution of viable cells of the rat osteoblasts were similarly studied, and 
the images shown in Figure 7.12 below: 
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Figure 7.12: Fluorescence microcopy of rat osteoblast 1 week after seeding on  
         compact surfaces: a) 0-0 surface; b) 10-5 surface; and  
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7.3.6 Discussion on Biocompatibility of Sintered Compacts 
From the micrographs obtained through fluorescence microscopy, it was observed 
that both the 3T3 cells and rat osteoblasts adhered well onto the polished surfaces 
of all compacts after 1 week. The surfaces of the polished compacts were not 
cytotoxic to the cells and there was no distinct region on each compact whereby 
an increased density of non-viable cells (stained red) was observed.  
 
The cells seeded on the surfaces of the titanium-graphite composites have slightly 
lower proliferation, as compared to those cells seeded on the pure titanium 
surfaces, after one week. One possible explanation could be the presence of 
graphite particles on the composite specimen surfaces slightly hindered cellular 
adhesion. 
There was a slight dip in cell proliferation, compared with the respective control, 
in both the 3T3 and rat osteoblast cultures 3 hours after cell seeding. This 
reduction in proliferation could be due to the hydrophobic nature of the compact 
surfaces, which could have hindered cellular adhesion. The cell proliferation 
stabilized for both phenotypes, with respect to the daily control, 48 hours after 
cell seeding. The 3T3 cells and rat osteoblast seeded on the compact surfaces did 
not exhibit an appreciable reduction in proliferation compared to the daily control 
one week after cells seeding. The 3T3 cells indeed exhibited increased 
proliferation on the 0-0 and 10-5 surfaces. These results indicate that the polished 
compact surfaces osteoblast and fibroblast adhesion and are biocompatible. 
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There was no observable alteration in morphology of both the 3T3 cells and rat 
osteoblast, with respect to the control group of each phenotype (cultured on tissue 
culture plates).  
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Chapter Eight  
Conclusions and Recommendations 
8.1 Conclusions 
The objectives set forth in this study have been achieved. The microstructure, 
mechanical properties and biocompatibility of the titanium-graphite composites 
has been investigated and characterized in this study. 
 
Metal matrix composites comprising commercially pure titanium powder, of 
mean particle size 40 µm, and graphite powder of mean particle size 10 µm, were 
thoroughly mixed through mechanofusion system, consolidated by the blended 
elemental method, sintered and finally hot isostatically pressed to form compacts 
of porosities between 0.41% to 1.81%. The average pore size of the compacts 
increased with increasing graphite content and ranged from 4 µm to 11 µm. The 
pores were observed predominantly at the grain boundaries and the boundaries 
between titanium carbide and the titanium matrix. The microstructure of the pure 
titanium specimens consisted of equiaxed grains of average size 140 µm. The 
microstructure of the titanium-graphite composites (10-5 and 10-10 specimens), 
on the other hand, consisted of three phases: equiaxed titanium matrix, titanium 
carbide and unreacted graphite. The average grain size of the titanium matrix in 
the 10-5 and 10-10 specimens were 32 µm and 21 µm respectively. The unreacted 
graphite content increased with increasing initial graphite composition and were 
observed to be present within the pores. 
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The Vickers hardness of the compacts was evaluated in three different 
orientations, namely the cross-section, longitudinal and transverse sections. The 
average Vickers Hardness of the 0-0, 10-5 and 10-10 specimens were 275 HRV, 
395 HRV and 500 HRV respectively. The hardness of the compacts did not vary 
significantly with the orientation, indicating that the hot isostatic pressing had 
consolidated the compacts uniformly, and the distribution of the titanium, 
titanium carbide and graphite phases, as well as the porosity, was uniform 
throughout the compact.  
 
The uniaxial tensile properties of the compacts were investigated in this study. 
The Modulus of Elasticity of the 0-0, 10-5 and 10-10 compacts were113.4 GPa, 
152.4 GPa and 157.0 GPa, respectively. The formation of the titanium carbide 
phase increased the stiffness of the composites, with respect to the pure titanium 
specimens. Increasing the graphite content of the raw powder mixture from 5% to 
10% yielded diminishing returns in increased stiffness of the composite. The 
increase in graphite content, however, brought about a decrease in tensile strength 
of the composites. The fatigue performance of the compacts was also evaluated in 
the present study. The fatigue limits of the 0-0 and 10-5 specimens were 100 MPa 
and 85 MPa. These figures represent low tensile fatigue strengths. The Endurance 
Ratio of both specimens, is also very low, at 0.16 and 0.22 respectively. This 
indicates that there is low resistance to crack propagation. An examination of the 
fatigue fracture surfaces of the 10-5 specimens provided ample evidence of rapid 
crack propagation. It was anticipated that the fatigue performance of the 10-10 
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specimens would be very poor and hence all available 10-10 specimens were used 
in the tensile tests. The sintered, HIPped specimens hence display poor fatigue 
resistance, and may not be suitable for applications involving uniaxial, tensile and 
cyclic loading. 
 
The biocompatibility of the raw powder, wear debris and bulk compacts were 
investigated. Two different phenotypes of cells were used in this study: NIH 3T3 
ECACC cell line and primary rat osteoblast cell cultures. The cell proliferation 
rate was determined from the alamarBlueTM reduction at various time points, 
normalized to the daily control. The distribution of viable cells, on the other hand, 
was determined through fluorescence microscopy. 
 
The in vitro biocompatibility study of raw powder has revealed that the presence 
of pure titanium particles did not affect fibroblast proliferation significantly. The 
pure graphite particles, on the other hand, brought about a 10% reduction in 
proliferation fibroblast after 1 week. The binary powder mixtures (10-5 and 10-
10) caused a reduction in fibroblast proliferation by between 2.5 % to 7.5 %.  This 
reduction in proliferation could be attributed to the presence of graphite particles. 
The impact of the raw powder on the proliferation of rat osteoblasts was more 
significant. The graphite particles caused the greatest reduction in cell 
proliferation of up to 20 %. The pure titanium particles, meanwhile, brought about 
a reduction in cell proliferation of up to 6 % after 1 week. The 10-5 and 10-10 
powder particle evoked an intermediate cytotoxic response, reducing rat 
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osteoblast proliferation by about 10%. There was evidence of phagocytocys of 
particles below 6 µm by viable cells of both phenotypes. Internalization of 
particles, up to a certain threshold level, would not cause apoptosis of the cells, 
but did cause the cells to elongate. Larger particles, above 10 µm, meanwhile, 
were not phagocytosed, but were observed to be attached to the plasma membrane 
of the viable cells.  
 
The wear debris proved to be more cytotoxic than the raw powder particles, 
especially to the rat osteoblasts. The pure titanium wear reduced cellular 
proliferation of rat osteoblast by up to 10 % after 1 week, but did not significantly 
affect the proliferation of the 3T3 cells. Wear debris from the titanium-graphite 
composite brought about a reduction in cell proliferation of the rat osteoblasts and 
3T3 cells, by up to 16 % and 5 %, respectively after 1 week. The increased 
cytotoxicity of the wear debris could be attributed to the smaller particle size of 
the wear debris. 
 
The 3T3 cells and rat osteoblasts were observed to adhere to the polished surfaces 
of the compacts. The cells seeded on the surfaces of the titanium-graphite 
composites slightly lower proliferation, as compared to those cells seeded on the 
pure titanium surfaces, after one week. This observation could be attributed to the 
presence of graphite particles on the composite specimen surfaces slightly 
hindered cellular adhesion. There was no observable change in morphology of the 
cells seeded on the compact surfaces, as compared to the control group, which 
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were seeded on tissue culture plates. These results indicate that the polished 
compact surfaces promoted osteoblast and fibroblast adhesion and are biocompatible. 
 
8.2 Recommendations 
While the present study has been successful in characterizing the microstructure, 
mechanical properties and biocompatibility of the titanium-graphite composites, 
there are yet several ways in which the research could be improved upon. 
 
Firstly, the mixing of the powder mixture could be further improved to yield 
discreet regions of titanium carbide, distributed evenly throughout the titanium 
matrix, with a concurrent increase in grain size of the titanium matrix, upon 
sintering. This would produce compacts of higher tensile and fatigue strength. 
 
Secondly, while the composites performed poorly in uniaxial tensile and fatigue 
test due to their inherent brittleness, this would not preclude their use in 
applications involving compressive forces. Hence, experiments should be 
conducted to determine their compressive strengths and fatigue properties under 
cyclic compressive loads. 
 
Thirdly, the fretting fatigue performance of the composites could be evaluated. 
The presence of lubricating graphite film on the surface of the composites may 
yield superior fretting fatigue performance, as compared to pure titanium 
specimens. 




Lastly, while the in vitro studies provided an insight on the biocompatibility of the 
titanium-graphite raw powder, wear debris and bulk compacts, it is necessary to 
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Engineering Drawing of Tensile and Fatigue Tests Specimens 
Appendix 2 
A2-1 




Tutorial on Using CTAn Software to Determine Particle Size Distribution 
 
1) Start the CTAn software. 










3) Select region of interest (ROI) on the image file. The region of interest would be 
highlighted red. To calibrate the pixel count data to linear dimensions of the 














4) Convert the region of interest to a binary image for analysis. Select the upper and 
lower global threshold levels by sliders above and under the histogram. Care must 
be taken to ensure that only the relevant particles are completely selected. The 



















5) Click on the “Process Image” button . This function will compute the pixel 
count for each discrete particle, and display the information on a bar chart. In this 




6) Measure the actual particle size from the original image, using the image scale 
bar. In this example, the size of the particle is 9.8 µm. Hence each micron is 
represented by 3.6 pixels. 
7) Repeat Steps 2 to 6 for five other discrete particles on the image, one at a time. 




8) Now repeat Steps 2 to 6 for all the particles. A particle size distribution bar chart, 
based on pixel count would be produced. Convert the pixel count to microns, and 










 A4-1  
Calculations for the Students T-Test on the Cell Proliferation Assay  
 Involving Raw Powder 
 
 
3T3 Cells Specimen 
 
Time: 3 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 0.97 0.94 0.96 0.92 
Replicate, x2 0.99 0.97 0.99 0.98 
Replicate, x3 0.95 0.90 0.95 0.90 
Replicate, x4 0.97 0.93 0.94 0.88 
Replicate, x5 0.98 0.96 0.96 0.92 
Average ( x ) 0.97  0.96  
Σx2 4.71  4.61  
(Σx)2 23.52  23.04  
((Σx)2)/n 4.70  4.61  












σ σσ = +  1.08E-04    




−=  0.96 
 
 

















 A4-2  
 
3T3 Cells Specimen 
 
Time: 24 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 0.95 0.90 0.94 0.88 
Replicate, x2 0.99 0.97 0.96 0.92 
Replicate, x3 0.94 0.88 0.91 0.83 
Replicate, x4 0.94 0.87 0.93 0.86 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.94 0.88 
Σx2 4.51  4.38  
(Σx)2 22.56  21.90  
((Σx)2)/n 4.51  4.38  













σ σσ = +  
1.49E-04    




−=  1.15 
 












 A4-3  
3T3 Cells Specimen 
 







Replicate, x1 0.98 0.96 0.95 0.90 
Replicate, x2 1.00 1.00 0.97 0.93 
Replicate, x3 0.95 0.90 0.93 0.86 
Replicate, x4 0.97 0.94 0.96 0.92 
Replicate, x5 0.99 0.98 0.95 0.90 
Average ( x ) 0.98 0.96 0.95 0.90 
Σx2 4.79  4.52  
(Σx)2 23.93  22.61  
((Σx)2)/n 4.79  4.52  













σ σσ = +  
1.15E-04    




−=  2.56 
 












 A4-4  
3T3 Cells Specimen 
 







Replicate, x1 1.00 1.00 0.99 0.98 
Replicate, x2 1.03 1.05 0.98 0.96 
Replicate, x3 0.98 0.96 1.02 1.04 
Replicate, x4 1.01 1.02 1.00 1.00 
Replicate, x5 0.99 0.98 0.99 0.98 
Average ( x ) 1.00 1.00 1.00 0.99 
Σx2 5.01  4.96  
(Σx)2 25.05  24.80  
((Σx)2)/n 5.01  4.96  













σ σσ = +  
1.07E-04    




−=  0.48 
 












 A4-5  
3T3 Cells Specimen 
 







Replicate, x1 1.01 1.02 0.98 0.96 
Replicate, x2 1.04 1.09 1.02 1.04 
Replicate, x3 0.97 0.94 0.96 0.92 
Replicate, x4 0.99 0.98 1.00 1.00 
Replicate, x5 1.02 1.04 0.96 0.92 
Average ( x ) 1.01 1.01 0.98 0.97 
Σx2 5.07  4.84  
(Σx)2 25.32  24.21  
((Σx)2)/n 5.06  4.84  













σ σσ = +  
2.96E-04    




−=  1.30 
 












 A4-6  
3T3 Cells Specimen 
 







Replicate, x1 0.97 0.94 0.98 0.96 
Replicate, x2 0.99 0.97 0.95 0.90 
Replicate, x3 0.95 0.90 1.00 1.00 
Replicate, x4 0.97 0.93 0.99 0.98 
Replicate, x5 0.98 0.96 0.98 0.96 
Average ( x ) 0.97 0.94 0.98 0.96 
Σx2 4.71  4.80  
(Σx)2 23.52  24.01  
((Σx)2)/n 4.70  4.80  













σ σσ = +  
1.07E-04    




−=  0.96 
 












 A4-7  
3T3 Cells Specimen 
 







Replicate, x1 0.95 0.90 0.94 0.88 
Replicate, x2 0.99 0.97 0.94 0.88 
Replicate, x3 0.94 0.88 0.90 0.81 
Replicate, x4 0.94 0.87 0.93 0.86 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.93 0.87 
Σx2 4.51  4.33  
(Σx)2 22.56  21.62  
((Σx)2)/n 4.51  4.32  













σ σσ = +  
1.42E-04    




−=  1.68 
 












 A4-8  
3T3 Cells Specimen 
 







Replicate, x1 0.98 0.96 0.96 0.92 
Replicate, x2 1.00 1.00 0.94 0.88 
Replicate, x3 0.95 0.90 0.98 0.95 
Replicate, x4 0.97 0.94 0.97 0.94 
Replicate, x5 0.99 0.98 0.96 0.92 
Average ( x ) 0.98 0.96 0.96 0.92 
Σx2 4.79  4.62  
(Σx)2 23.93  23.09  
((Σx)2)/n 4.79  4.62  













σ σσ = +  
1.15E-04    




−=  1.63 
 












 A4-9  
3T3 Cells Specimen 
 







Replicate, x1 1.00 1.00 0.94 0.88 
Replicate, x2 1.03 1.05 0.96 0.92 
Replicate, x3 0.98 0.96 0.91 0.83 
Replicate, x4 1.01 1.02 0.96 0.92 
Replicate, x5 0.99 0.98 0.97 0.94 
Average ( x ) 1.00 1.00 0.95 0.90 
Σx2 5.01  4.50  
(Σx)2 25.05  22.47  
((Σx)2)/n 5.01  4.49  













σ σσ = +  
1.75E-04    




−=  4.01 
 












 A4-10  
 
3T3 Cells Specimen 
 







Replicate, x1 1.01 1.02 0.96 0.92 
Replicate, x2 1.04 1.09 0.99 0.98 
Replicate, x3 0.97 0.94 0.94 0.88 
Replicate, x4 0.99 0.98 0.98 0.96 
Replicate, x5 1.02 1.04 0.95 0.90 
Average ( x ) 1.01 1.01 0.96 0.93 
Σx2 5.07  4.65  
(Σx)2 25.32  23.23  
((Σx)2)/n 5.06  4.65  













σ σσ = +  
2.46E-04    




−=  2.70 
 











 A4-11  
 
3T3 Cells Specimen 
 







Replicate, x1 0.97 0.94 0.98 0.96 
Replicate, x2 0.99 0.97 0.99 0.98 
Replicate, x3 0.95 0.90 0.95 0.90 
Replicate, x4 0.97 0.93 0.99 0.98 
Replicate, x5 0.98 0.96 0.99 0.98 
Average ( x ) 0.97 0.94 0.98 0.96 
Σx2 4.71  4.80  
(Σx)2 23.52  24.01  
((Σx)2)/n 4.70  4.80  













σ σσ = +  
9.75E-05    




−=  1.01 
 











 A4-12  
3T3 Cells Specimen 
 







Replicate, x1 0.95 0.90 0.94 0.88 
Replicate, x2 0.99 0.97 0.96 0.92 
Replicate, x3 0.94 0.88 0.91 0.83 
Replicate, x4 0.94 0.87 0.95 0.90 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.94 0.88 
Σx2 4.51  4.42  
(Σx)2 22.56  22.09  
((Σx)2)/n 4.51  4.42  













σ σσ = +  
1.53E-04    




−=  0.81 
 












 A4-13  
3T3 Cells Specimen 
 







Replicate, x1 0.98 0.96 0.93 0.86 
Replicate, x2 1.00 1.00 0.96 0.92 
Replicate, x3 0.95 0.90 0.92 0.85 
Replicate, x4 0.97 0.94 0.92 0.85 
Replicate, x5 0.99 0.98 0.96 0.92 
Average ( x ) 0.98 0.96 0.94 0.88 
Σx2 4.79  4.40  
(Σx)2 23.93  22.00  
((Σx)2)/n 4.79  4.40  













σ σσ = +  
1.63E-04    




−=  3.17 
 












 A4-14  
3T3 Cells Specimen 
 







Replicate, x1 1.00 1.00 0.93 0.86 
Replicate, x2 1.03 1.05 0.89 0.79 
Replicate, x3 0.98 0.96 0.90 0.81 
Replicate, x4 1.01 1.02 0.89 0.79 
Replicate, x5 0.99 0.98 0.92 0.85 
Average ( x ) 1.00 1.00 0.91 0.82 
Σx2 5.01  4.11  
(Σx)2 25.05  20.52  
((Σx)2)/n 5.01  4.10  













σ σσ = +  
1.27E-04    




−=  8.43 
 












 A4-15  
 
3T3 Cells Specimen 
 







Replicate, x1 1.01 1.02 0.89 0.79 
Replicate, x2 1.04 1.09 0.94 0.88 
Replicate, x3 0.97 0.94 0.88 0.77 
Replicate, x4 0.99 0.98 0.89 0.79 
Replicate, x5 1.02 1.04 0.90 0.81 
Average ( x ) 1.01 1.01 0.90 0.81 
Σx2 5.07  4.05  
(Σx)2 25.32  20.25  
((Σx)2)/n 5.06  4.05  












σ σσ = +  2.70E-04    




−=  6.47 
 











 A4-16  
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.97 0.94 
Replicate, x2 1.02 1.04 1.00 1.00 
Replicate, x3 0.96 0.92 0.93 0.86 
Replicate, x4 0.97 0.93 0.98 0.96 
Replicate, x5 0.98 0.96 0.96 0.92 
Average ( x ) 0.98 0.96 0.97 0.94 
Σx2 4.81  4.69  
(Σx)2 24.04  23.43  
((Σx)2)/n 4.81  4.69  







∑  5.22E-04 





σ σσ = +  2.38E-04 
   




−=  0.82 
 












 A4-17  
Rat Osteoblast Specimen 
 







Replicate, x1 0.95 0.90 0.94 0.88 
Replicate, x2 0.99 0.97 0.96 0.92 
Replicate, x3 0.94 0.88 0.91 0.83 
Replicate, x4 0.94 0.87 0.93 0.86 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.94 0.88 
Σx2 4.51  4.38  
(Σx)2 22.56  21.90  
((Σx)2)/n 4.51  4.38  












σ σσ = +  1.49E-04    




−=  1.15 
 












 A4-18  
 
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.95 0.90 
Replicate, x2 1.00 1.00 0.97 0.93 
Replicate, x3 0.95 0.90 0.93 0.86 
Replicate, x4 0.97 0.94 0.96 0.92 
Replicate, x5 0.99 0.98 0.95 0.90 
Average ( x ) 0.98 0.96 0.95 0.90 
Σx2 4.79  4.52  
(Σx)2 23.93  22.61  
((Σx)2)/n 4.79  4.52  












σ σσ = +  1.15E-04    




−=  2.56 
 











 A4-19  
Rat Osteoblast Specimen 
 







Replicate, x1 1.00 1.00 0.99 0.98 
Replicate, x2 1.03 1.05 0.98 0.96 
Replicate, x3 0.98 0.96 1.02 1.04 
Replicate, x4 1.01 1.02 1.00 1.00 
Replicate, x5 0.99 0.98 0.99 0.98 
Average ( x ) 1.00 1.00 1.00 0.99 
Σx2 5.01  4.96  
(Σx)2 25.05  24.80  
((Σx)2)/n 5.01  4.96  












σ σσ = +  1.07E-04    




−=  0.48 
 












 A4-20  
 
Rat Osteoblast Specimen 
 







Replicate, x1 1.01 1.02 0.98 0.96 
Replicate, x2 1.04 1.09 1.02 1.04 
Replicate, x3 0.97 0.94 0.96 0.92 
Replicate, x4 0.99 0.98 1.00 1.00 
Replicate, x5 1.02 1.04 0.96 0.92 
Average ( x ) 1.01 1.01 0.98 0.97 
Σx2 5.07  4.84  
(Σx)2 25.32  24.21  
((Σx)2)/n 5.06  4.84  












σ σσ = +  2.96E-04    




−=  1.30 
 











 A4-21  
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.98 0.96 
Replicate, x2 1.02 1.04 0.95 0.90 
Replicate, x3 0.96 0.92 1.00 1.00 
Replicate, x4 0.97 0.93 0.99 0.98 
Replicate, x5 0.98 0.96 0.98 0.96 
Average ( x ) 0.97 0.94 0.98 0.96 
Σx2 4.81  4.80  
(Σx)2 24.04  24.01  
((Σx)2)/n 4.81  4.80  












σ σσ = +  1.74E-04    




−=  0.76 
 












 A4-22  
Rat Osteoblast Specimen 
 







Replicate, x1 0.95 0.90 0.93 0.86 
Replicate, x2 0.99 0.97 0.94 0.88 
Replicate, x3 0.94 0.88 0.90 0.81 
Replicate, x4 0.94 0.87 0.93 0.86 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.93 0.86 
Σx2 4.51  4.31  
(Σx)2 22.56  21.53  
((Σx)2)/n 4.51  4.31  












σ σσ = +  1.36E-04    




−=  1.88 
 












 A4-23  
 
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.96 0.92 
Replicate, x2 1.00 1.00 0.94 0.88 
Replicate, x3 0.95 0.90 0.98 0.95 
Replicate, x4 0.97 0.94 0.97 0.94 
Replicate, x5 0.99 0.98 0.96 0.92 
Average ( x ) 0.98 0.96 0.96 0.92 
Σx2 4.79  4.62  
(Σx)2 23.93  23.09  
((Σx)2)/n 4.79  4.62  












σ σσ = +  1.15E-04    




−=  1.63 
 











 A4-24  
Rat Osteoblast Specimen 
 







Replicate, x1 1.00 1.00 0.94 0.88 
Replicate, x2 1.03 1.05 0.96 0.92 
Replicate, x3 0.98 0.96 0.91 0.83 
Replicate, x4 1.01 1.02 0.96 0.92 
Replicate, x5 0.99 0.98 0.97 0.94 
Average ( x ) 1.00 1.00 0.95 0.90 
Σx2 5.01  4.50  
(Σx)2 25.05  22.47  
((Σx)2)/n 5.01  4.49  












σ σσ = +  1.75E-04    




−=  4.01 
 












 A4-25  
 
Rat Osteoblast Specimen 
 







Replicate, x1 1.01 1.02 0.96 0.92 
Replicate, x2 1.04 1.09 0.99 0.98 
Replicate, x3 0.97 0.94 0.94 0.88 
Replicate, x4 0.99 0.98 0.98 0.96 
Replicate, x5 1.02 1.04 0.95 0.90 
Average ( x ) 1.01 1.01 0.96 0.93 
Σx2 5.07  4.65  
(Σx)2 25.32  23.23  
((Σx)2)/n 5.06  4.65  












σ σσ = +  2.46E-04    




−=  2.70 
 











 A4-26  
 
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.98 0.96 
Replicate, x2 1.02 1.04 0.99 0.98 
Replicate, x3 0.96 0.92 0.95 0.90 
Replicate, x4 0.97 0.93 0.99 0.98 
Replicate, x5 0.98 0.96 0.99 0.98 
Average ( x ) 0.97 0.94 0.98 0.96 
Σx2 4.81  4.80  
(Σx)2 24.04  24.01  
((Σx)2)/n 4.81  4.80  












σ σσ = +  1.64E-04    




−=  0.78 
 











 A4-27  
 
Rat Osteoblast Specimen 
 







Replicate, x1 0.95 0.90 0.94 0.88 
Replicate, x2 0.99 0.97 0.96 0.92 
Replicate, x3 0.94 0.88 0.91 0.83 
Replicate, x4 0.94 0.87 0.95 0.90 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.95 0.90 0.94 0.88 
Σx2 4.51  4.42  
(Σx)2 22.56  22.09  
((Σx)2)/n 4.51  4.42  












σ σσ = +  1.53E-04    




−=  0.81 
 











 A4-28  
Rat Osteoblast Specimen 
 







Replicate, x1 0.98 0.96 0.93 0.86 
Replicate, x2 1.00 1.00 0.96 0.92 
Replicate, x3 0.95 0.90 0.92 0.85 
Replicate, x4 0.97 0.94 0.92 0.85 
Replicate, x5 0.99 0.98 0.96 0.92 
Average ( x ) 0.98 0.96 0.91 0.83 
Σx2 4.79  4.40  
(Σx)2 23.93  22.00  
((Σx)2)/n 4.79  4.40  












σ σσ = +  1.63E-04    




−=  5.36 
 












 A4-29  
Rat Osteoblast Specimen 
 







Replicate, x1 1.00 1.00 0.93 0.86 
Replicate, x2 1.03 1.05 0.89 0.79 
Replicate, x3 0.98 0.96 0.90 0.81 
Replicate, x4 1.01 1.02 0.89 0.79 
Replicate, x5 0.99 0.98 0.92 0.85 
Average ( x ) 1.00 1.00 0.91 0.82 
Σx2 5.01  4.11  
(Σx)2 25.05  20.52  
((Σx)2)/n 5.01  4.10  












σ σσ = +  1.27E-04    




−=  8.43 
 












 A4-30  
 
Rat Osteoblast Specimen 
 







Replicate, x1 1.01 1.02 0.89 0.79 
Replicate, x2 1.04 1.09 0.94 0.88 
Replicate, x3 0.97 0.94 0.88 0.77 
Replicate, x4 0.99 0.98 0.89 0.79 
Replicate, x5 1.02 1.04 0.90 0.81 
Average ( x ) 1.01 1.01 0.90 0.81 
Σx2 5.07  4.05  
(Σx)2 25.32  20.25  
((Σx)2)/n 5.06  4.05  












σ σσ = +  2.70E-04    




−=  6.47 
 






Calculations for the Students T-Test on the Cell Proliferation Assay 
Involving Wear Debris 
 
 
3T3 Cells Specimen 
 
Time: 3 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 0.98 0.96 0.98 0.96 
Replicate, x2 0.98 0.97 1.01 1.02 
Replicate, x3 0.99 0.98 0.98 0.96 
Replicate, x4 0.97 0.93 0.98 0.95 
Replicate, x5 0.96 0.92 0.98 0.95 
Average ( x ) 0.98 0.95 0.98 0.97 
Σx2 4.76  4.84  
(Σx)2 23.80  24.21  
((Σx)2)/n 4.76  4.84  












σ σσ = +  7.33E-05    




−=  0.98 
 
 



















3T3 Cells Specimen 
 
Time: 24 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 0.98 0.96 0.98 0.96 
Replicate, x2 1.02 1.04 0.99 0.99 
Replicate, x3 0.95 0.90 0.96 0.92 
Replicate, x4 0.99 0.98 0.97 0.94 
Replicate, x5 0.97 0.94 0.98 0.96 
Average ( x ) 0.98 0.96 0.98 0.95 
Σx2 4.82  4.77  
(Σx)2 24.10  23.86  
((Σx)2)/n 4.82  4.77  












σ σσ = +  1.61E-04    




−=  0.39 
 














3T3 Cells Specimen 
 







Replicate, x1 0.97 0.94 0.96 0.92 
Replicate, x2 1.01 1.01 0.98 0.96 
Replicate, x3 0.94 0.89 0.94 0.88 
Replicate, x4 1.00 1.00 0.95 0.90 
Replicate, x5 0.95 0.90 0.97 0.94 
Average ( x ) 0.97 0.95 0.96 0.92 
Σx2 4.74  4.60  
(Σx)2 23.70  22.98  
((Σx)2)/n 4.74  4.60  












σ σσ = +  2.20E-04    




−=  1.01 
 














3T3 Cells Specimen 
 







Replicate, x1 0.99 0.98 0.97 0.94 
Replicate, x2 1.03 1.06 0.99 0.98 
Replicate, x3 0.97 0.93 0.95 0.89 
Replicate, x4 0.98 0.96 0.98 0.96 
Replicate, x5 1.00 1.00 0.95 0.90 
Average ( x ) 0.99 0.99 0.97 0.93 
Σx2 4.93  4.67  
(Σx)2 24.66  23.36  
((Σx)2)/n 4.93  4.67  












σ σσ = +  1.83E-04    




−=  1.96 
 











3T3 Cells Specimen 
 







Replicate, x1 1.01 1.02 0.98 0.96 
Replicate, x2 0.99 0.99 1.00 1.00 
Replicate, x3 1.03 1.07 0.97 0.94 
Replicate, x4 1.00 1.00 0.99 0.98 
Replicate, x5 0.99 0.98 0.97 0.94 
Average ( x ) 1.01 1.01 0.98 0.96 
Σx2 5.05  4.82  
(Σx)2 25.26  24.08  
((Σx)2)/n 5.05  4.82  












σ σσ = +  9.65E-05    




−=  2.42 
 














3T3 Cells Specimen 
 







Replicate, x1 0.98 0.96 0.98 0.96 
Replicate, x2 0.98 0.97 0.98 0.97 
Replicate, x3 0.99 0.98 0.98 0.95 
Replicate, x4 0.97 0.93 0.99 0.98 
Replicate, x5 0.96 0.92 0.98 0.96 
Average ( x ) 0.98 0.95 0.98 0.96 
Σx2 4.76  4.82  
(Σx)2 23.80  24.10  
((Σx)2)/n 4.76  4.82  












σ σσ = +  3.78E-05    




−=  0.99 
 












3T3 Cells Specimen 
 







Replicate, x1 0.98 0.96 0.96 0.92 
Replicate, x2 1.02 1.04 0.97 0.94 
Replicate, x3 0.95 0.90 0.95 0.90 
Replicate, x4 0.99 0.98 0.96 0.92 
Replicate, x5 0.97 0.94 0.97 0.94 
Average ( x ) 0.98 0.96 0.96 0.92 
Σx2 4.82  4.62  
(Σx)2 24.10  23.08  
((Σx)2)/n 4.82  4.62  












σ σσ = +  1.47E-04    




−=  1.73 
 














3T3 Cells Specimen 
 







Replicate, x1 0.97 0.94 0.97 0.94 
Replicate, x2 1.01 1.01 0.99 0.98 
Replicate, x3 0.94 0.89 0.93 0.87 
Replicate, x4 1.00 1.00 0.98 0.96 
Replicate, x5 0.95 0.90 0.96 0.92 
Average ( x ) 0.97 0.95 0.97 0.93 
Σx2 4.74  4.67  
(Σx)2 23.70  23.35  
((Σx)2)/n 4.74  4.67  












σ σσ = +  2.60E-04    




−=  0.44 
 














3T3 Cells Specimen 
 







Replicate, x1 0.99 0.98 0.96 0.92 
Replicate, x2 1.03 1.06 0.98 0.97 
Replicate, x3 0.97 0.93 0.93 0.86 
Replicate, x4 0.98 0.96 0.97 0.94 
Replicate, x5 1.00 1.00 0.94 0.88 
Average ( x ) 0.99 0.99 0.96 0.91 
Σx2 4.93  4.57  
(Σx)2 24.66  22.85  
((Σx)2)/n 4.93  4.57  












σ σσ = +  2.19E-04    




−=  2.51 
 











3T3 Cells Specimen 
 







Replicate, x1 1.01 1.02 0.96 0.92 
Replicate, x2 0.99 0.99 0.98 0.97 
Replicate, x3 1.03 1.07 0.93 0.86 
Replicate, x4 1.00 1.00 0.97 0.94 
Replicate, x5 0.99 0.98 0.95 0.90 
Average ( x ) 1.01 1.01 0.96 0.92 
Σx2 5.05  4.59  
(Σx)2 25.26  22.94  
((Σx)2)/n 5.05  4.59  












σ σσ = +  1.53E-04    




−=  3.81 
 















Rat Osteoblast Specimen 
 







Replicate, x1 0.97 0.94 0.96 0.92 
Replicate, x2 0.98 0.95 0.98 0.97 
Replicate, x3 0.97 0.93 0.95 0.91 
Replicate, x4 0.97 0.93 0.96 0.92 
Replicate, x5 0.98 0.96 0.95 0.90 
Average ( x ) 0.97 0.94 0.96 0.93 
Σx2 4.72  4.63  
(Σx)2 23.58  23.12  
((Σx)2)/n 4.72  4.62  












σ σσ = +  4.28E-05    




−=  1.44 
 











Rat Osteoblast Specimen 
 







Replicate, x1 0.94 0.88 0.93 0.86 
Replicate, x2 0.96 0.92 0.88 0.77 
Replicate, x3 0.93 0.86 0.93 0.86 
Replicate, x4 0.95 0.90 0.92 0.85 
Replicate, x5 0.94 0.88 0.92 0.85 
Average ( x ) 0.94 0.89 0.92 0.84 
Σx2 4.46  4.20  
(Σx)2 22.28  20.98  
((Σx)2)/n 4.46  4.20  












σ σσ = +  1.12E-04    




−=  2.65 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.93 0.86 0.90 0.81 
Replicate, x2 0.94 0.88 0.91 0.83 
Replicate, x3 0.91 0.83 0.89 0.79 
Replicate, x4 0.92 0.85 0.90 0.81 
Replicate, x5 0.93 0.86 0.91 0.83 
Average ( x ) 0.93 0.86 0.90 0.81 
Σx2 4.29  4.07  
(Σx)2 21.44  20.34  
((Σx)2)/n 4.29  4.07  












σ σσ = +  4.00E-05    




−=  3.79 
 












Rat Osteoblast Specimen 
 







Replicate, x1 0.95 0.90 0.87 0.76 
Replicate, x2 0.91 0.83 0.89 0.79 
Replicate, x3 0.88 0.77 0.84 0.71 
Replicate, x4 0.92 0.85 0.88 0.77 
Replicate, x5 0.90 0.81 0.85 0.72 
Average ( x ) 0.91 0.83 0.87 0.75 
Σx2 4.16  3.75  
(Σx)2 20.79  18.75  
((Σx)2)/n 4.16  3.75  












σ σσ = +  2.20E-04    




−=  3.10 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.90 0.81 0.86 0.74 
Replicate, x2 0.91 0.83 0.88 0.77 
Replicate, x3 0.88 0.77 0.85 0.72 
Replicate, x4 0.89 0.79 0.87 0.76 
Replicate, x5 0.90 0.81 0.86 0.74 
Average ( x ) 0.90 0.80 0.86 0.75 
Σx2 4.01  3.73  
(Σx)2 20.07  18.66  
((Σx)2)/n 4.01  3.73  












σ σσ = +  5.20E-05    




−=  4.44 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.97 0.94 0.97 0.94 
Replicate, x2 0.98 0.95 0.98 0.96 
Replicate, x3 0.97 0.93 0.96 0.92 
Replicate, x4 0.97 0.93 0.96 0.92 
Replicate, x5 0.98 0.96 0.97 0.94 
Average ( x ) 0.97 0.94 0.97 0.94 
Σx2 4.72  4.69  
(Σx)2 23.58  23.43  
((Σx)2)/n 4.72  4.69  












σ σσ = +  2.23E-05    




−=  0.66 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.94 0.88 0.92 0.85 
Replicate, x2 0.96 0.92 0.93 0.86 
Replicate, x3 0.93 0.86 0.91 0.83 
Replicate, x4 0.95 0.90 0.92 0.85 
Replicate, x5 0.94 0.88 0.93 0.86 
Average ( x ) 0.94 0.89 0.92 0.85 
Σx2 4.46  4.25  
(Σx)2 22.28  21.25  
((Σx)2)/n 4.46  4.25  












σ σσ = +  4.00E-05    




−=  3.48 
 










Rat Osteoblast Specimen 
 







Replicate, x1 0.93 0.86 0.90 0.81 
Replicate, x2 0.94 0.88 0.88 0.77 
Replicate, x3 0.91 0.83 0.91 0.83 
Replicate, x4 0.92 0.85 0.90 0.81 
Replicate, x5 0.93 0.86 0.89 0.79 
Average ( x ) 0.93 0.86 0.90 0.80 
Σx2 4.29  4.01  
(Σx)2 21.44  20.07  
((Σx)2)/n 4.29  4.01  












σ σσ = +  5.20E-05    




−=  4.16 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.95 0.90 0.86 0.74 
Replicate, x2 0.91 0.83 0.87 0.76 
Replicate, x3 0.88 0.77 0.82 0.67 
Replicate, x4 0.92 0.85 0.86 0.74 
Replicate, x5 0.90 0.81 0.87 0.76 
Average ( x ) 0.91 0.83 0.86 0.73 
Σx2 4.16  3.67  
(Σx)2 20.79  18.32  
((Σx)2)/n 4.16  3.66  












σ σσ = +  2.20E-04    




−=  3.78 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.90 0.81 0.84 0.71 
Replicate, x2 0.91 0.83 0.85 0.72 
Replicate, x3 0.88 0.77 0.82 0.67 
Replicate, x4 0.89 0.79 0.83 0.69 
Replicate, x5 0.90 0.81 0.85 0.72 
Average ( x ) 0.90 0.80 0.84 0.70 
Σx2 4.01  3.51  
(Σx)2 20.07  17.56  
((Σx)2)/n 4.01  3.51  












σ σσ = +  6.00E-05    




−=  7.49 
 








Calculations for the Students T-Test on the Water Contact Angle Test 





Time: 0 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 64.10 4108.81 62.10 3856.41 
Replicate, x2 80.30 6448.09 71.90 5169.61 
Replicate, x3 74.20 5505.64 77.00 5929.00 
Average ( x ) 72.87 5354.18 70.33 4985.01 
Σx2 16062.54  14955.02  
(Σx)2 47785.96  44521.00  
((Σx)2)/n 15928.65  14840.33  












σ σσ = +  41.43    



























Time: 10 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 62.50 3906.25 61.40 3769.96 
Replicate, x2 76.70 5882.89 68.30 4664.89 
Replicate, x3 72.20 5212.84 70.40 4956.16 
Average ( x ) 70.47 5000.66 66.70 4463.67 
Σx2 15001.98  13391.01  
(Σx)2 44689.96  40040.01  
((Σx)2)/n 14896.65  13346.67  












σ σσ = +  24.94    




−=  0.75 
 
 























Time: 20 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 62.20 3868.84 61.10 3733.21 
Replicate, x2 76.40 5836.96 65.40 4277.16 
Replicate, x3 70.20 4928.04 70.50 4970.25 
Average ( x ) 69.60 4877.95 65.67 4326.87 
Σx2 14633.84  12980.62  
(Σx)2 43597.44  38809.00  
((Σx)2)/n 14532.48  12936.33  












σ σσ = +  24.27    






























Time: 30 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 59.70 3564.09 59.90 3588.01 
Replicate, x2 73.30 5372.89 67.00 4489.00 
Replicate, x3 68.30 4664.89 66.80 4462.24 
Average ( x ) 67.10 4533.96 64.57 4179.75 
Σx2 13601.87  12539.25  
(Σx)2 40521.69  37519.69  
((Σx)2)/n 13507.23  12506.56  












σ σσ = +  21.22    




−=  0.55 
 
 























Time: 40 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 59.20 3504.64 53.00 2809.00 
Replicate, x2 72.20 5212.84 62.40 3893.76 
Replicate, x3 67.30 4529.29 66.90 4475.61 
Average ( x ) 66.23 4415.59 60.77 3726.12 
Σx2 13246.77  11178.37  
(Σx)2 39481.69  33233.29  
((Σx)2)/n 13160.56  11077.76  












σ σσ = +  31.14    


























Time: 50 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 55.50 3080.25 52.50 2756.25 
Replicate, x2 71.70 5140.89 62.70 3931.29 
Replicate, x3 66.00 4356.00 65.70 4316.49 
Average ( x ) 64.40 4192.38 60.30 3668.01 
Σx2 12577.14  11004.03  
(Σx)2 37326.24  32724.81  
((Σx)2)/n 12442.08  10908.27  












σ σσ = +  38.47    




−=  0.66 
 
 























Time: 60 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 57.90 3352.41 51.00 2601.00 
Replicate, x2 70.00 4900.00 62.30 3881.29 
Replicate, x3 63.60 4044.96 65.60 4303.36 
Average ( x ) 63.83 4099.12 59.63 3595.22 
Σx2 12297.37  10785.65  
(Σx)2 36672.25  32005.21  
((Σx)2)/n 12224.08  10668.40  












σ σσ = +  31.76    




−=  0.75 
 
 























Time: 70 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 54.30 2948.49 49.30 2430.49 
Replicate, x2 69.20 4788.64 61.10 3733.21 
Replicate, x3 62.40 3893.76 65.80 4329.64 
Average ( x ) 61.97 3876.96 58.73 3497.78 
Σx2 11630.89  10493.34  
(Σx)2 34558.81  31046.44  
((Σx)2)/n 11519.60  10348.81  












σ σσ = +  42.64    



























Time: 80 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 53.80 2894.44 47.40 2246.76 
Replicate, x2 68.80 4733.44 59.20 3504.64 
Replicate, x3 61.90 3831.61 63.80 4070.44 
Average ( x ) 61.50 3819.83 56.80 3273.95 
Σx2 11459.49  9821.84  
(Σx)2 34040.25  29036.16  
((Σx)2)/n 11346.75  9678.72  












σ σσ = +  42.64    






























Time: 90 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 52.30 2735.29 41.80 1747.24 
Replicate, x2 67.00 4489.00 58.30 3398.89 
Replicate, x3 61.50 3782.25 60.10 3612.01 
Average ( x ) 60.27 3668.85 53.40 2919.38 
Σx2 11006.54  8758.14  
(Σx)2 32688.64  25664.04  
((Σx)2)/n 10896.21  8554.68  












σ σσ = +  52.30    




−=  0.95 
 
 























Time: 100 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 50.10 2510.01 42.10 1772.41 
Replicate, x2 64.30 4134.49 58.50 3422.25 
Replicate, x3 58.30 3398.89 60.40 3648.16 
Average ( x ) 57.57 3347.80 53.67 2947.61 
Σx2 10043.39  8842.82  
(Σx)2 29825.29  25921.00  
((Σx)2)/n 9941.76  8640.33  












σ σσ = +  50.69    




−=  0.55 
 
 




















Time: 110 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 48.70 2371.69 38.90 1513.21 
Replicate, x2 63.50 4032.25 54.50 2970.25 
Replicate, x3 56.40 3180.96 58.70 3445.69 
Average ( x ) 56.20 3194.97 50.70 2643.05 
Σx2 9584.90  7929.15  
(Σx)2 28425.96  23134.41  
((Σx)2)/n 9475.32  7711.47  












σ σσ = +  54.54    




−=  0.74 
 
 























Time: 120 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 48.60 2361.96 34.10 1162.81 
Replicate, x2 62.20 3868.84 52.50 2756.25 
Replicate, x3 55.40 3069.16 55.70 3102.49 
Average ( x ) 55.40 3099.99 47.43 2340.52 
Σx2 9299.96  7021.55  
(Σx)2 27622.44  20249.29  
((Σx)2)/n 9207.48  6749.76  












σ σσ = +  60.71    




−=  1.02 
 
 























Time: 130 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 47.50 2256.25 29.40 864.36 
Replicate, x2 61.40 3769.96 51.30 2631.69 
Replicate, x3 52.90 2798.41 55.20 3047.04 
Average ( x ) 53.93 2941.54 45.30 2181.03 
Σx2 8824.62  6543.09  
(Σx)2 26179.24  18468.81  
((Σx)2)/n 8726.41  6156.27  












σ σσ = +  80.84    




−=  0.96 
 
 




















Time: 140 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 46.60 2171.56 21.90 479.61 
Replicate, x2 58.90 3469.21 50.00 2500.00 
Replicate, x3 51.10 2611.21 55.80 3113.64 
Average ( x ) 52.20 2750.66 42.57 2031.08 
Σx2 8251.98  6093.25  
(Σx)2 24523.56  16307.29  
((Σx)2)/n 8174.52  5435.76  












σ σσ = +  122.49    




−=  0.87 
 
 























Time: 150 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 44.50 1980.25 22.30 497.29 
Replicate, x2 56.20 3158.44 49.20 2420.64 
Replicate, x3 50.60 2560.36 50.90 2590.81 
Average ( x ) 50.43 2566.35 40.80 1836.25 
Σx2 7699.05  5508.74  
(Σx)2 22891.69  14981.76  
((Σx)2)/n 7630.56  4993.92  












σ σσ = +  97.22    




−=  0.98 
 















Time: 0 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 70.00 4900.00 64.30 4134.49 
Replicate, x2 74.10 5490.81 81.45 6634.10 
Replicate, x3 71.60 5126.56 73.30 5372.89 
Average ( x ) 71.90 5172.46 73.02 5380.49 
Σx2 15517.37  16141.48  
(Σx)2 46526.49  47982.90  
((Σx)2)/n 15508.83  15994.30  












σ σσ = +  25.95    




−=  0.22 
 























Time: 10 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 62.90 3956.41 57.20 3271.84 
Replicate, x2 71.20 5069.44 80.30 6448.09 
Replicate, x3 65.60 4303.36 70.10 4914.01 
Average ( x ) 66.57 4443.07 69.20 4877.98 
Σx2 13329.21  14633.94  
(Σx)2 39880.09  43097.76  
((Σx)2)/n 13293.36  14365.92  












σ σσ = +  50.64    




−=  0.37 
 
 






















Time: 20 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 61.10 3733.21 56.00 3136.00 
Replicate, x2 68.40 4678.56 79.15 6264.72 
Replicate, x3 65.20 4251.04 68.40 4678.56 
Average ( x ) 64.90 4220.94 67.85 4693.09 
Σx2 12662.81  14079.28  
(Σx)2 37908.09  41432.60  
((Σx)2)/n 12636.03  13810.87  












σ σσ = +  49.20    




−=  0.42 
 
 






















Time: 30 s 
 
Polished 0-0 x2 Unpolished 0-0 x2 
Replicate, x1 60.70 3684.49 55.30 3058.09 
Replicate, x2 67.90 4610.41 78.00 6084.00 
Replicate, x3 62.90 3956.41 67.00 4489.00 
Average ( x ) 63.83 4083.77 66.77 4543.70 
Σx2 12251.31  13631.09  
(Σx)2 36672.25  40120.09  
((Σx)2)/n 12224.08  13373.36  












σ σσ = +  47.49    




−=  0.43 
 
 






















Time: 40 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 58.20 3387.24 53.10 2819.61 
Replicate, x2 66.80 4462.24 76.85 5905.92 
Replicate, x3 61.00 3721.00 65.30 4264.09 
Average ( x ) 62.00 3856.83 65.08 4329.87 
Σx2 11570.48  12989.62  
(Σx)2 34596.00  38122.56  
((Σx)2)/n 11532.00  12707.52  












σ σσ = +  53.43    




−=  0.42 
 























Time: 50 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 57.50 3306.25 52.80 2787.84 
Replicate, x2 64.30 4134.49 75.70 5730.49 
Replicate, x3 58.90 3469.21 63.90 4083.21 
Average ( x ) 60.23 3636.65 64.13 4200.51 
Σx2 10909.95  12601.54  
(Σx)2 32652.49  37017.76  
((Σx)2)/n 10884.16  12339.25  












σ σσ = +  48.01    





























Time: 60 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 55.80 3113.64 48.30 2332.89 
Replicate, x2 62.80 3943.84 74.90 5610.01 
Replicate, x3 58.00 3364.00 62.10 3856.41 
Average ( x ) 58.87 3473.83 61.77 3933.10 
Σx2 10421.48  11799.31  
(Σx)2 31187.56  34336.09  
((Σx)2)/n 10395.85  11445.36  












σ σσ = +  63.26    





























Time: 70 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 54.60 2981.16 48.50 2352.25 
Replicate, x2 62.00 3844.00 72.70 5285.29 
Replicate, x3 57.00 3249.00 61.00 3721.00 
Average ( x ) 57.87 3358.05 60.73 3786.18 
Σx2 10074.16  11358.54  
(Σx)2 30136.96  33196.84  
((Σx)2)/n 10045.65  11065.61  












σ σσ = +  53.57    




−=  0.39 
 
 






















Time: 80 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 54.20 2937.64 47.80 2284.84 
Replicate, x2 60.30 3636.09 72.60 5270.76 
Replicate, x3 55.70 3102.49 60.10 3612.01 
Average ( x ) 56.73 3225.41 60.17 3722.54 
Σx2 9676.22  11167.61  
(Σx)2 28968.04  32580.25  
((Σx)2)/n 9656.01  10860.08  












σ σσ = +  54.62    




−=  0.46 
 
























Time: 90 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 52.70 2777.29 44.60 1989.16 
Replicate, x2 59.80 3576.04 71.80 5155.24 
Replicate, x3 52.00 2704.00 58.80 3457.44 
Average ( x ) 54.83 3019.11 58.40 3533.95 
Σx2 9057.33  10601.84  
(Σx)2 27060.25  30695.04  
((Σx)2)/n 9020.08  10231.68  












σ σσ = +  67.90    




−=  0.43 
 























Time: 100 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 49.30 2430.49 42.00 1764.00 
Replicate, x2 57.30 3283.29 70.10 4914.01 
Replicate, x3 49.70 2470.09 56.50 3192.25 
Average ( x ) 52.10 2727.96 56.20 3290.09 
Σx2 8183.87  9870.26  
(Σx)2 24429.69  28425.96  
((Σx)2)/n 8143.23  9475.32  












σ σσ = +  72.60    




−=  0.48 
 























Time: 110 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 47.00 2209.00 43.10 1857.61 
Replicate, x2 56.80 3226.24 69.90 4886.01 
Replicate, x3 48.90 2391.21 54.30 2948.49 
Average ( x ) 50.90 2608.82 55.77 3230.70 
Σx2 7826.45  9692.11  
(Σx)2 23317.29  27989.29  
((Σx)2)/n 7772.43  9329.76  












σ σσ = +  69.39    




−=  0.58 
 
 






















Time: 120 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 46.90 2199.61 37.80 1428.84 
Replicate, x2 55.20 3047.04 67.20 4515.84 
Replicate, x3 46.80 2190.24 53.10 2819.61 
Average ( x ) 49.63 2478.96 52.70 2921.43 
Σx2 7436.89  8764.29  
(Σx)2 22171.21  24995.61  
((Σx)2)/n 7390.40  8331.87  












σ σσ = +  79.82    




−=  0.34 
 
 






















Time: 130 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 45.10 2034.01 37.50 1406.25 
Replicate, x2 52.90 2798.41 65.90 4342.81 
Replicate, x3 46.30 2143.69 50.20 2520.04 
Average ( x ) 48.10 2325.37 51.20 2756.37 
Σx2 6976.11  8269.10  
(Σx)2 20822.49  23592.96  
((Σx)2)/n 6940.83  7864.32  












σ σσ = +  73.34    




−=  0.36 
 
 






















Time: 140 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 45.00 2025.00 34.80 1211.04 
Replicate, x2 52.20 2724.84 61.80 3819.24 
Replicate, x3 42.50 1806.25 46.20 2134.44 
Average ( x ) 46.57 2185.36 47.60 2388.24 
Σx2 6556.09  7164.72  
(Σx)2 19516.09  20391.84  
((Σx)2)/n 6505.36  6797.28  












σ σσ = +  69.69    




−=  0.12 
 
 






















Time: 150 s 
 
Polished 10-5 x2 Unpolished 10-5 x2 
Replicate, x1 40.20 1616.04 34.70 1204.09 
Replicate, x2 52.20 2724.84 60.60 3672.36 
Replicate, x3 41.00 1681.00 44.60 1989.16 
Average ( x ) 44.47 2007.29 46.63 2288.54 
Σx2 6021.88  6865.61  
(Σx)2 17795.56  19572.01  
((Σx)2)/n 5931.85  6524.00  












σ σσ = +  71.94    




−=  0.26 
 

















Time: 0 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 69.60 4844.16 40.80 1664.64 
Replicate, x2 59.40 3528.36 54.60 2981.16 
Replicate, x3 63.30 4006.89 58.80 3457.44 
Average ( x ) 64.10 4126.47 51.40 2701.08 
Σx2 12379.41  8103.24  
(Σx)2 36979.29  23777.64  
((Σx)2)/n 12326.43  7925.88  












σ σσ = +  38.39    




−=  2.05 
 























Time: 10 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 65.30 4264.09 38.70 1497.69 
Replicate, x2 56.30 3169.69 49.50 2450.25 
Replicate, x3 61.10 3733.21 56.70 3214.89 
Average ( x ) 60.90 3722.33 48.30 2387.61 
Σx2 11166.99  7162.83  
(Σx)2 33379.29  20996.01  
((Σx)2)/n 11126.43  6998.67  












σ σσ = +  34.12    




−=  2.16 
 
 






















Time: 20 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 63.80 4070.44 38.00 1444.00 
Replicate, x2 52.40 2745.76 48.10 2313.61 
Replicate, x3 59.50 3540.25 56.00 3136.00 
Average ( x ) 58.57 3452.15 47.37 2297.87 
Σx2 10356.45  6893.61  
(Σx)2 30870.49  20192.41  
((Σx)2)/n 10290.16  6730.80  












σ σσ = +  38.18    




−=  1.81 
 























Time: 30 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 62.60 3918.76 25.10 630.01 
Replicate, x2 48.50 2352.25 46.90 2199.61 
Replicate, x3 59.50 3540.25 43.10 1857.61 
Average ( x ) 56.87 3270.42 38.37 1562.41 
Σx2 9811.26  4687.23  
(Σx)2 29104.36  13248.01  
((Σx)2)/n 9701.45  4416.00  












σ σσ = +  63.51    




−=  2.32 
 
 






















Time: 40 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 61.20 3745.44 19.00 361.00 
Replicate, x2 46.50 2162.25 44.00 1936.00 
Replicate, x3 56.80 3226.24 37.00 1369.00 
Average ( x ) 54.83 3044.64 33.33 1222.00 
Σx2 9133.93  3666.00  
(Σx)2 27060.25  10000.00  
((Σx)2)/n 9020.08  3333.33  












σ σσ = +  74.42    




−=  2.49 
 























Time: 50 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 60.10 3612.01 16.00 256.00 
Replicate, x2 44.20 1953.64 43.20 1866.24 
Replicate, x3 56.40 3180.96 34.00 1156.00 
Average ( x ) 53.57 2915.54 31.07 1092.75 
Σx2 8746.61  3278.24  
(Σx)2 25824.49  8686.24  
((Σx)2)/n 8608.16  2895.41  












σ σσ = +  86.88    




−=  2.41 
 
 























Time: 60 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 59.40 3528.36 13.10 171.61 
Replicate, x2 43.90 1927.21 42.60 1814.76 
Replicate, x3 55.20 3047.04 31.10 967.21 
Average ( x ) 52.83 2834.20 28.93 984.53 
Σx2 8502.61  2953.58  
(Σx)2 25122.25  7534.24  
((Σx)2)/n 8374.08  2511.41  












σ σσ = +  95.12    




−=  2.45 
 
 























Time: 70 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 57.80 3340.84 12.80 163.84 
Replicate, x2 41.10 1689.21 40.20 1616.04 
Replicate, x3 53.10 2819.61 30.80 948.64 
Average ( x ) 50.67 2616.55 27.93 909.51 
Σx2 7849.66  2728.52  
(Σx)2 23104.00  7022.44  
((Σx)2)/n 7701.33  2340.81  












σ σσ = +  89.34    




−=  2.41 
 
 





















Time: 80 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 55.80 3113.64 11.40 129.96 
Replicate, x2 39.60 1568.16 38.50 1482.25 
Replicate, x3 53.60 2872.96 29.40 864.36 
Average ( x ) 49.67 2518.25 26.43 825.52 
Σx2 7554.76  2476.57  
(Σx)2 22201.00  6288.49  
((Σx)2)/n 7400.33  2096.16  












σ σσ = +  89.14    




−=  2.46 
 
 























Time: 90 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 53.30 2840.89 10.20 104.04 
Replicate, x2 36.20 1310.44 34.10 1162.81 
Replicate, x3 50.70 2570.49 28.20 795.24 
Average ( x ) 46.73 2240.61 24.17 687.36 
Σx2 6721.82  2062.09  
(Σx)2 19656.04  5256.25  
((Σx)2)/n 6552.01  1752.08  












σ σσ = +  79.97    




−=  2.52 
 
 























Time: 100 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 52.40 2745.76 9.80 96.04 
Replicate, x2 37.50 1406.25 30.80 948.64 
Replicate, x3 50.20 2520.04 27.80 772.84 
Average ( x ) 46.70 2224.02 22.80 605.84 
Σx2 6672.05  1817.52  
(Σx)2 19628.01  4678.56  
((Σx)2)/n 6542.67  1559.52  












σ σσ = +  64.56    




−=  2.97 
 
 























Time: 110 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 50.50 2550.25 7.30 53.29 
Replicate, x2 37.80 1428.84 27.20 739.84 
Replicate, x3 45.80 2097.64 25.30 640.09 
Average ( x ) 44.70 2025.58 19.93 477.74 
Σx2 6076.73  1433.22  
(Σx)2 17982.81  3576.04  
((Σx)2)/n 5994.27  1192.01  












σ σσ = +  53.94    




−=  3.37 
 
 























Time: 120 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 50.00 2500.00 6.70 44.89 
Replicate, x2 32.10 1030.41 25.40 645.16 
Replicate, x3 47.00 2209.00 24.70 610.09 
Average ( x ) 43.03 1913.14 18.93 433.38 
Σx2 5739.41  1300.14  
(Σx)2 16666.81  3226.24  
((Σx)2)/n 5555.60  1075.41  












σ σσ = +  68.09    




−=  2.92 
 
























Time: 130 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 48.70 2371.69 8.90 79.21 
Replicate, x2 32.60 1062.76 23.90 571.21 
Replicate, x3 47.50 2256.25 26.90 723.61 
Average ( x ) 42.93 1896.90 19.90 458.01 
Σx2 5690.70  1374.03  
(Σx)2 16589.44  3564.09  
((Σx)2)/n 5529.81  1188.03  












σ σσ = +  57.81    




−=  3.03 
 
























Time: 140 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 46.80 2190.24 6.40 40.96 
Replicate, x2 29.70 882.09 22.10 488.41 
Replicate, x3 41.50 1722.25 24.40 595.36 
Average ( x ) 39.33 1598.19 17.63 374.91 
Σx2 4794.58  1124.73  
(Σx)2 13924.00  2798.41  
((Σx)2)/n 4641.33  932.80  












σ σσ = +  57.53    




−=  2.86 
 
























Time: 150 s 
 
Polished 10-10 x2 Unpolished 10-10 x2 
Replicate, x1 44.70 1998.09 6.60 43.56 
Replicate, x2 29.40 864.36 20.30 412.09 
Replicate, x3 42.70 1823.29 24.60 605.16 
Average ( x ) 38.93 1561.91 17.17 353.60 
Σx2 4685.74  1060.81  
(Σx)2 13642.24  2652.25  
((Σx)2)/n 4547.41  884.08  












σ σσ = +  52.51    




−=  3.00 
 

















Time: 0 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 64.10 4108.81 70.00 4900.00 
Replicate, x2 80.30 6448.09 74.10 5490.81 
Replicate, x3 74.20 5505.64 71.60 5126.56 
Average ( x ) 72.87 5354.18 71.90 5172.46 
Σx2 16062.54  15517.37  
(Σx)2 47785.96  46526.49  
((Σx)2)/n 15928.65  15508.83  












σ σσ = +  23.74    




−=  0.20 
 
 























Time: 10 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 62.50 3906.25 62.90 3956.41 
Replicate, x2 76.70 5882.89 71.20 5069.44 
Replicate, x3 72.20 5212.84 65.60 4303.36 
Average ( x ) 70.47 5000.66 66.57 4443.07 
Σx2 15001.98  13329.21  
(Σx)2 44689.96  39880.09  
((Σx)2)/n 14896.65  13293.36  












σ σσ = +  23.53    




−=  0.80 
 
 























Time: 20 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 62.20 3868.84 61.10 3733.21 
Replicate, x2 76.40 5836.96 68.40 4678.56 
Replicate, x3 70.20 4928.04 65.20 4251.04 
Average ( x ) 69.60 4877.95 64.90 4220.94 
Σx2 14633.84  12662.81  
(Σx)2 43597.44  37908.09  
((Σx)2)/n 14532.48  12636.03  












σ σσ = +  21.36    




−=  1.02 
 
























Time: 30 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 59.70 3564.09 60.70 3684.49 
Replicate, x2 73.30 5372.89 67.90 4610.41 
Replicate, x3 68.30 4664.89 62.90 3956.41 
Average ( x ) 67.10 4533.96 63.83 4083.77 
Σx2 13601.87  12251.31  
(Σx)2 40521.69  36672.25  
((Σx)2)/n 13507.23  12224.08  












σ σσ = +  20.31    




−=  0.72 
 
 























Time: 40 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 59.20 3504.64 58.20 3387.24 
Replicate, x2 72.20 5212.84 66.80 4462.24 
Replicate, x3 67.30 4529.29 61.00 3721.00 
Average ( x ) 66.23 4415.59 62.00 3856.83 
Σx2 13246.77  11570.48  
(Σx)2 39481.69  34596.00  
((Σx)2)/n 13160.56  11532.00  












σ σσ = +  20.78    




−=  0.93 
 
























Time: 50 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 55.50 3080.25 57.50 3306.25 
Replicate, x2 71.70 5140.89 64.30 4134.49 
Replicate, x3 66.00 4356.00 58.90 3469.21 
Average ( x ) 64.40 4192.38 60.23 3636.65 
Σx2 12577.14  10909.95  
(Σx)2 37326.24  32652.49  
((Σx)2)/n 12442.08  10884.16  












σ σσ = +  26.81    




−=  0.80 
 
























Time: 60 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 57.90 3352.41 55.80 3113.64 
Replicate, x2 70.00 4900.00 62.80 3943.84 
Replicate, x3 63.60 4044.96 58.00 3364.00 
Average ( x ) 63.83 4099.12 58.87 3473.83 
Σx2 12297.37  10421.48  
(Σx)2 36672.25  31187.56  
((Σx)2)/n 12224.08  10395.85  












σ σσ = +  16.49    




−=  1.22 
 
 























Time: 70 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 54.30 2948.49 54.60 2981.16 
Replicate, x2 69.20 4788.64 62.00 3844.00 
Replicate, x3 62.40 3893.76 57.00 3249.00 
Average ( x ) 61.97 3876.96 57.87 3358.05 
Σx2 11630.89  10074.16  
(Σx)2 34558.81  30136.96  
((Σx)2)/n 11519.60  10045.65  












σ σσ = +  23.30    




−=  0.85 
 
 























Time: 80 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 53.80 2894.44 54.20 2937.64 
Replicate, x2 68.80 4733.44 60.30 3636.09 
Replicate, x3 61.90 3831.61 55.70 3102.49 
Average ( x ) 61.50 3819.83 56.73 3225.41 
Σx2 11459.49  9676.22  
(Σx)2 34040.25  28968.04  
((Σx)2)/n 11346.75  9656.01  












σ σσ = +  22.16    




−=  1.01 
 
 























Time: 90 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 52.30 2735.29 52.70 2777.29 
Replicate, x2 67.00 4489.00 59.80 3576.04 
Replicate, x3 61.50 3782.25 52.00 2704.00 
Average ( x ) 60.27 3668.85 54.83 3019.11 
Σx2 11006.54  9057.33  
(Σx)2 32688.64  27060.25  
((Σx)2)/n 10896.21  9020.08  












σ σσ = +  24.60    




−=  1.10 
 
 























Time: 100 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 50.10 2510.01 49.30 2430.49 
Replicate, x2 64.30 4134.49 57.30 3283.29 
Replicate, x3 58.30 3398.89 49.70 2470.09 
Average ( x ) 57.57 3347.80 52.10 2727.96 
Σx2 10043.39  8183.87  
(Σx)2 29825.29  24429.69  
((Σx)2)/n 9941.76  8143.23  












σ σσ = +  23.71    




−=  1.12 
 
 























Time: 110 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 48.70 2371.69 47.00 2209.00 
Replicate, x2 63.50 4032.25 56.80 3226.24 
Replicate, x3 56.40 3180.96 48.90 2391.21 
Average ( x ) 56.20 3194.97 50.90 2608.82 
Σx2 9584.90  7826.45  
(Σx)2 28425.96  23317.29  
((Σx)2)/n 9475.32  7772.43  












σ σσ = +  27.27    




−=  1.01 
 
 























Time: 120 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 48.60 2361.96 46.90 2199.61 
Replicate, x2 62.20 3868.84 55.20 3047.04 
Replicate, x3 55.40 3069.16 46.80 2190.24 
Average ( x ) 55.40 3099.99 49.63 2478.96 
Σx2 9299.96  7436.89  
(Σx)2 27622.44  22171.21  
((Σx)2)/n 9207.48  7390.40  












σ σσ = +  23.16    




−=  1.20 
 
 























Time: 130 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 47.50 2256.25 45.10 2034.01 
Replicate, x2 61.40 3769.96 52.90 2798.41 
Replicate, x3 52.90 2798.41 46.30 2143.69 
Average ( x ) 53.93 2941.54 48.10 2325.37 
Σx2 8824.62  6976.11  
(Σx)2 26179.24  20822.49  
((Σx)2)/n 8726.41  6940.83  












σ σσ = +  22.25    




−=  1.24 
 
 























Time: 140 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 46.60 2171.56 45.00 2025.00 
Replicate, x2 58.90 3469.21 52.20 2724.84 
Replicate, x3 51.10 2611.21 42.50 1806.25 
Average ( x ) 52.20 2750.66 46.57 2185.36 
Σx2 8251.98  6556.09  
(Σx)2 24523.56  19516.09  
((Σx)2)/n 8174.52  6505.36  












σ σσ = +  21.36    






























Time: 150 s 
 
Polished 0-0 x2 Polished 10-5 x2 
Replicate, x1 44.50 1980.25 40.20 1616.04 
Replicate, x2 56.20 3158.44 52.20 2724.84 
Replicate, x3 50.60 2560.36 41.00 1681.00 
Average ( x ) 50.43 2566.35 44.47 2007.29 
Σx2 7699.05  6021.88  
(Σx)2 22891.69  17795.56  
((Σx)2)/n 7630.56  5931.85  












σ σσ = +  26.42    




−=  1.16 
 


















Time: 0 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 64.10 4108.81 69.60 4844.16 
Replicate, x2 80.30 6448.09 59.40 3528.36 
Replicate, x3 74.20 5505.64 63.30 4006.89 
Average ( x ) 72.87 5354.18 64.10 4126.47 
Σx2 16062.54  12379.41  
(Σx)2 47785.96  36979.29  
((Σx)2)/n 15928.65  12326.43  












σ σσ = +  31.14    




−=  1.57 
 
 























Time: 10 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 62.50 3906.25 65.30 4264.09 
Replicate, x2 76.70 5882.89 56.30 3169.69 
Replicate, x3 72.20 5212.84 61.10 3733.21 
Average ( x ) 70.47 5000.66 60.90 3722.33 
Σx2 15001.98  11166.99  
(Σx)2 44689.96  33379.29  
((Σx)2)/n 14896.65  11126.43  












σ σσ = +  24.31    




−=  1.94 
 
 























Time: 20 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 62.20 3868.84 63.80 4070.44 
Replicate, x2 76.40 5836.96 52.40 2745.76 
Replicate, x3 70.20 4928.04 59.50 3540.25 
Average ( x ) 69.60 4877.95 58.57 3452.15 
Σx2 14633.84  10356.45  
(Σx)2 43597.44  30870.49  
((Σx)2)/n 14532.48  10290.16  












σ σσ = +  27.94    




−=  2.09 
 
 























Time: 30 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 59.70 3564.09 62.60 3918.76 
Replicate, x2 73.30 5372.89 48.50 2352.25 
Replicate, x3 68.30 4664.89 59.50 3540.25 
Average ( x ) 67.10 4533.96 56.87 3270.42 
Σx2 13601.87  9811.26  
(Σx)2 40521.69  29104.36  
((Σx)2)/n 13507.23  9701.45  












σ σσ = +  34.07    




−=  1.75 
 
























Time: 40 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 59.20 3504.64 61.20 3745.44 
Replicate, x2 72.20 5212.84 46.50 2162.25 
Replicate, x3 67.30 4529.29 56.80 3226.24 
Average ( x ) 66.23 4415.59 54.83 3044.64 
Σx2 13246.77  9133.93  
(Σx)2 39481.69  27060.25  
((Σx)2)/n 13160.56  9020.08  












σ σσ = +  33.34    




−=  1.97 
 
 























Time: 50 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 55.50 3080.25 60.10 3612.01 
Replicate, x2 71.70 5140.89 44.20 1953.64 
Replicate, x3 66.00 4356.00 56.40 3180.96 
Average ( x ) 64.40 4192.38 53.57 2915.54 
Σx2 12577.14  8746.61  
(Σx)2 37326.24  25824.49  
((Σx)2)/n 12442.08  8608.16  












σ σσ = +  45.58    




−=  1.60 
 
 























Time: 60 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 57.90 3352.41 59.40 3528.36 
Replicate, x2 70.00 4900.00 43.90 1927.21 
Replicate, x3 63.60 4044.96 55.20 3047.04 
Average ( x ) 63.83 4099.12 52.83 2834.20 
Σx2 12297.37  8502.61  
(Σx)2 36672.25  25122.25  
((Σx)2)/n 12224.08  8374.08  












σ σσ = +  33.64    




−=  1.90 
 
























Time: 70 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 54.30 2948.49 57.80 3340.84 
Replicate, x2 69.20 4788.64 41.10 1689.21 
Replicate, x3 62.40 3893.76 53.10 2819.61 
Average ( x ) 61.97 3876.96 50.67 2616.55 
Σx2 11630.89  7849.66  
(Σx)2 34558.81  23104.00  
((Σx)2)/n 11519.60  7701.33  












σ σσ = +  43.27    




−=  1.72 
 
 























Time: 80 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 53.80 2894.44 55.80 3113.64 
Replicate, x2 68.80 4733.44 39.60 1568.16 
Replicate, x3 61.90 3831.61 53.60 2872.96 
Average ( x ) 61.50 3819.83 49.67 2518.25 
Σx2 11459.49  7554.76  
(Σx)2 34040.25  22201.00  
((Σx)2)/n 11346.75  7400.33  












σ σσ = +  44.53    




−=  1.77 
 
























Time: 90 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 52.30 2735.29 53.30 2840.89 
Replicate, x2 67.00 4489.00 36.20 1310.44 
Replicate, x3 61.50 3782.25 50.70 2570.49 
Average ( x ) 60.27 3668.85 46.73 2240.61 
Σx2 11006.54  6721.82  
(Σx)2 32688.64  19656.04  
((Σx)2)/n 10896.21  6552.01  












σ σσ = +  46.69    




−=  1.98 
 
 























Time: 100 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 50.10 2510.01 52.40 2745.76 
Replicate, x2 64.30 4134.49 37.50 1406.25 
Replicate, x3 58.30 3398.89 50.20 2520.04 
Average ( x ) 57.57 3347.80 46.70 2224.02 
Σx2 10043.39  6672.05  
(Σx)2 29825.29  19628.01  
((Σx)2)/n 9941.76  6542.67  












σ σσ = +  38.50    




−=  1.75 
 
 























Time: 110 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 48.70 2371.69 50.50 2550.25 
Replicate, x2 63.50 4032.25 37.80 1428.84 
Replicate, x3 56.40 3180.96 45.80 2097.64 
Average ( x ) 56.20 3194.97 44.70 2025.58 
Σx2 9584.90  6076.73  
(Σx)2 28425.96  17982.81  
((Σx)2)/n 9475.32  5994.27  












σ σσ = +  32.01    




−=  2.03 
 
 























Time: 120 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 48.60 2361.96 50.00 2500.00 
Replicate, x2 62.20 3868.84 32.10 1030.41 
Replicate, x3 55.40 3069.16 47.00 2209.00 
Average ( x ) 55.40 3099.99 43.03 1913.14 
Σx2 9299.96  5739.41  
(Σx)2 27622.44  16666.81  
((Σx)2)/n 9207.48  5555.60  












σ σσ = +  46.05    




−=  1.82 
 
























Time: 130 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 47.50 2256.25 48.70 2371.69 
Replicate, x2 61.40 3769.96 32.60 1062.76 
Replicate, x3 52.90 2798.41 47.50 2256.25 
Average ( x ) 53.93 2941.54 42.93 1896.90 
Σx2 8824.62  5690.70  
(Σx)2 26179.24  16589.44  
((Σx)2)/n 8726.41  5529.81  












σ σσ = +  43.18    




−=  1.67 
 
 























Time: 140 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 46.60 2171.56 46.80 2190.24 
Replicate, x2 58.90 3469.21 29.70 882.09 
Replicate, x3 51.10 2611.21 41.50 1722.25 
Average ( x ) 52.20 2750.66 39.33 1598.19 
Σx2 8251.98  4794.58  
(Σx)2 24523.56  13924.00  
((Σx)2)/n 8174.52  4641.33  












σ σσ = +  38.45    




−=  2.07 
 
 























Time: 150 s 
 
Polished 0-0 x2 Polished 10-10 x2 
Replicate, x1 44.50 1980.25 44.70 1998.09 
Replicate, x2 56.20 3158.44 29.40 864.36 
Replicate, x3 50.60 2560.36 42.70 1823.29 
Average ( x ) 50.43 2566.35 38.93 1561.91 
Σx2 7699.05  4685.74  
(Σx)2 22891.69  13642.24  
((Σx)2)/n 7630.56  4547.41  












σ σσ = +  34.47    




−=  1.96 
 
















Time: 0 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 62.10 3856.41 64.30 4134.49 
Replicate, x2 71.90 5169.61 81.45 6634.10 
Replicate, x3 77.00 5929.00 73.30 5372.89 
Average ( x ) 70.33 4985.01 73.02 5380.49 
Σx2 14955.02  16141.48  
(Σx)2 44521.00  47982.90  
((Σx)2)/n 14840.33  15994.30  












σ σσ = +  43.64    




−=  0.41 
 
 























Time: 10 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 61.40 3769.96 57.20 3271.84 
Replicate, x2 68.30 4664.89 80.30 6448.09 
Replicate, x3 70.40 4956.16 70.10 4914.01 
Average ( x ) 66.70 4463.67 69.20 4877.98 
Σx2 13391.01  14633.94  
(Σx)2 40040.01  43097.76  
((Σx)2)/n 13346.67  14365.92  












σ σσ = +  52.06    




−=  0.35 
 
 























Time: 20 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 61.10 3733.21 56.00 3136.00 
Replicate, x2 65.40 4277.16 79.15 6264.72 
Replicate, x3 70.50 4970.25 68.40 4678.56 
Average ( x ) 65.67 4326.87 67.85 4693.09 
Σx2 12980.62  14079.28  
(Σx)2 38809.00  41432.60  
((Σx)2)/n 12936.33  13810.87  












σ σσ = +  52.12    






























Time: 30 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 59.90 3588.01 55.30 3058.09 
Replicate, x2 67.00 4489.00 78.00 6084.00 
Replicate, x3 66.80 4462.24 67.00 4489.00 
Average ( x ) 64.57 4179.75 66.77 4543.70 
Σx2 12539.25  13631.09  
(Σx)2 37519.69  40120.09  
((Σx)2)/n 12506.56  13373.36  












σ σσ = +  48.40    




−=  0.32 
 
 























Time: 40 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 53.00 2809.00 53.10 2819.61 
Replicate, x2 62.40 3893.76 76.85 5905.92 
Replicate, x3 66.90 4475.61 65.30 4264.09 
Average ( x ) 60.77 3726.12 65.08 4329.87 
Σx2 11178.37  12989.62  
(Σx)2 33233.29  38122.56  
((Σx)2)/n 11077.76  12707.52  












σ σσ = +  63.78    




−=  0.54 
 
 























Time: 50 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 52.50 2756.25 52.80 2787.84 
Replicate, x2 62.70 3931.29 75.70 5730.49 
Replicate, x3 65.70 4316.49 63.90 4083.21 
Average ( x ) 60.30 3668.01 64.13 4200.51 
Σx2 11004.03  12601.54  
(Σx)2 32724.81  37017.76  
((Σx)2)/n 10908.27  12339.25  












σ σσ = +  59.67    




−=  0.50 
 
 























Time: 60 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 51.00 2601.00 48.30 2332.89 
Replicate, x2 62.30 3881.29 74.90 5610.01 
Replicate, x3 65.60 4303.36 62.10 3856.41 
Average ( x ) 59.63 3595.22 61.77 3933.10 
Σx2 10785.65  11799.31  
(Σx)2 32005.21  34336.09  
((Σx)2)/n 10668.40  11445.36  












σ σσ = +  78.53    






























Time: 70 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 49.30 2430.49 48.50 2352.25 
Replicate, x2 61.10 3733.21 72.70 5285.29 
Replicate, x3 65.80 4329.64 61.00 3721.00 
Average ( x ) 58.73 3497.78 60.73 3786.18 
Σx2 10493.34  11358.54  
(Σx)2 31046.44  33196.84  
((Σx)2)/n 10348.81  11065.61  












σ σσ = +  72.91    




−=  0.23 
 
 























Time: 80 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 47.40 2246.76 47.80 2284.84 
Replicate, x2 59.20 3504.64 72.60 5270.76 
Replicate, x3 63.80 4070.44 60.10 3612.01 
Average ( x ) 56.80 3273.95 60.17 3722.54 
Σx2 9821.84  11167.61  
(Σx)2 29036.16  32580.25  
((Σx)2)/n 9678.72  10860.08  












σ σσ = +  75.11    




−=  0.39 
 
 























Time: 90 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 41.80 1747.24 44.60 1989.16 
Replicate, x2 58.30 3398.89 71.80 5155.24 
Replicate, x3 60.10 3612.01 58.80 3457.44 
Average ( x ) 53.40 2919.38 58.40 3533.95 
Σx2 8758.14  10601.84  
(Σx)2 25664.04  30695.04  
((Σx)2)/n 8554.68  10231.68  












σ σσ = +  95.60    




−=  0.51 
 
 























Time: 100 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 42.10 1772.41 42.00 1764.00 
Replicate, x2 58.50 3422.25 70.10 4914.01 
Replicate, x3 60.40 3648.16 56.50 3192.25 
Average ( x ) 53.67 2947.61 56.20 3290.09 
Σx2 8842.82  9870.26  
(Σx)2 25921.00  28425.96  
((Σx)2)/n 8640.33  9475.32  












σ σσ = +  99.57    




−=  0.25 
 
 























Time: 110 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 38.90 1513.21 43.10 1857.61 
Replicate, x2 54.50 2970.25 69.90 4886.01 
Replicate, x3 58.70 3445.69 54.30 2948.49 
Average ( x ) 50.70 2643.05 55.77 3230.70 
Σx2 7929.15  9692.11  
(Σx)2 23134.41  27989.29  
((Σx)2)/n 7711.47  9329.76  












σ σσ = +  96.67    




−=  0.52 
 
 























Time: 120 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 34.10 1162.81 37.80 1428.84 
Replicate, x2 52.50 2756.25 67.20 4515.84 
Replicate, x3 55.70 3102.49 53.10 2819.61 
Average ( x ) 47.43 2340.52 52.70 2921.43 
Σx2 7021.55  8764.29  
(Σx)2 20249.29  24995.61  
((Σx)2)/n 6749.76  8331.87  












σ σσ = +  117.37    




−=  0.49 
 
 























Time: 130 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 29.40 864.36 37.50 1406.25 
Replicate, x2 51.30 2631.69 65.90 4342.81 
Replicate, x3 55.20 3047.04 50.20 2520.04 
Average ( x ) 45.30 2181.03 51.20 2756.37 
Σx2 6543.09  8269.10  
(Σx)2 18468.81  23592.96  
((Σx)2)/n 6156.27  7864.32  












σ σσ = +  131.93    




−=  0.51 
 
 























Time: 140 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 21.90 479.61 34.80 1211.04 
Replicate, x2 50.00 2500.00 61.80 3819.24 
Replicate, x3 55.80 3113.64 46.20 2134.44 
Average ( x ) 42.57 2031.08 47.60 2388.24 
Σx2 6093.25  7164.72  
(Σx)2 16307.29  20391.84  
((Σx)2)/n 5435.76  6797.28  












σ σσ = +  170.82    




−=  0.39 
 
























Time: 150 s 
 
Unpolished 0-0 x2 Unpolished 10-5 x2 
Replicate, x1 22.30 497.29 34.70 1204.09 
Replicate, x2 49.20 2420.64 60.60 3672.36 
Replicate, x3 50.90 2590.81 44.60 1989.16 
Average ( x ) 40.80 1836.25 46.63 2288.54 
Σx2 5508.74  6865.61  
(Σx)2 14981.76  19572.01  
((Σx)2)/n 4993.92  6524.00  












σ σσ = +  142.74    




−=  0.49 
 

















Time: 0 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 62.10 3856.41 40.80 1664.64 
Replicate, x2 71.90 5169.61 54.60 2981.16 
Replicate, x3 77.00 5929.00 58.80 3457.44 
Average ( x ) 70.33 4985.01 51.40 2701.08 
Σx2 14955.02  8103.24  
(Σx)2 44521.00  23777.64  
((Σx)2)/n 14840.33  7925.88  












σ σσ = +  48.67    




−=  2.71 
 
 























Time: 10 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 61.40 3769.96 38.70 1497.69 
Replicate, x2 68.30 4664.89 49.50 2450.25 
Replicate, x3 70.40 4956.16 56.70 3214.89 
Average ( x ) 66.70 4463.67 48.30 2387.61 
Σx2 13391.01  7162.83  
(Σx)2 40040.01  20996.01  
((Σx)2)/n 13346.67  6998.67  












σ σσ = +  34.75    




−=  3.12 
 
























Time: 20 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 61.10 3733.21 38.00 1444.00 
Replicate, x2 65.40 4277.16 48.10 2313.61 
Replicate, x3 70.50 4970.25 56.00 3136.00 
Average ( x ) 65.67 4326.87 47.37 2297.87 
Σx2 12980.62  6893.61  
(Σx)2 38809.00  20192.41  
((Σx)2)/n 12936.33  6730.80  












σ σσ = +  34.52    




−=  3.11 
 
























Time: 30 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 59.90 3588.01 25.10 630.01 
Replicate, x2 67.00 4489.00 46.90 2199.61 
Replicate, x3 66.80 4462.24 43.10 1857.61 
Average ( x ) 64.57 4179.75 38.37 1562.41 
Σx2 12539.25  4687.23  
(Σx)2 37519.69  13248.01  
((Σx)2)/n 12506.56  4416.00  












σ σσ = +  50.65    




−=  3.68 
 
 























Time: 40 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 53.00 2809.00 19.00 361.00 
Replicate, x2 62.40 3893.76 44.00 1936.00 
Replicate, x3 66.90 4475.61 37.00 1369.00 
Average ( x ) 60.77 3726.12 33.33 1222.00 
Σx2 11178.37  3666.00  
(Σx)2 33233.29  10000.00  
((Σx)2)/n 11077.76  3333.33  












σ σσ = +  72.21    




−=  3.23 
 
























Time: 50 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 52.50 2756.25 16.00 256.00 
Replicate, x2 62.70 3931.29 43.20 1866.24 
Replicate, x3 65.70 4316.49 34.00 1156.00 
Average ( x ) 60.30 3668.01 31.07 1092.75 
Σx2 11004.03  3278.24  
(Σx)2 32724.81  8686.24  
((Σx)2)/n 10908.27  2895.41  












σ σσ = +  79.76    




−=  3.27 
 
 























Time: 60 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 51.00 2601.00 13.10 171.61 
Replicate, x2 62.30 3881.29 42.60 1814.76 
Replicate, x3 65.60 4303.36 31.10 967.21 
Average ( x ) 59.63 3595.22 28.93 984.53 
Σx2 10785.65  2953.58  
(Σx)2 32005.21  7534.24  
((Σx)2)/n 10668.40  2511.41  












σ σσ = +  93.24    




−=  3.18 
 
 























Time: 70 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 49.30 2430.49 12.80 163.84 
Replicate, x2 61.10 3733.21 40.20 1616.04 
Replicate, x3 65.80 4329.64 30.80 948.64 
Average ( x ) 58.73 3497.78 27.93 909.51 
Σx2 10493.34  2728.52  
(Σx)2 31046.44  7022.44  
((Σx)2)/n 10348.81  2340.81  












σ σσ = +  88.71    




−=  3.27 
 
 























Time: 80 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 47.40 2246.76 11.40 129.96 
Replicate, x2 59.20 3504.64 38.50 1482.25 
Replicate, x3 63.80 4070.44 29.40 864.36 
Average ( x ) 56.80 3273.95 26.43 825.52 
Σx2 9821.84  2476.57  
(Σx)2 29036.16  6288.49  
((Σx)2)/n 9678.72  2096.16  












σ σσ = +  87.25    




−=  3.25 
 
 























Time: 90 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 41.80 1747.24 10.20 104.04 
Replicate, x2 58.30 3398.89 34.10 1162.81 
Replicate, x3 60.10 3612.01 28.20 795.24 
Average ( x ) 53.40 2919.38 24.17 687.36 
Σx2 8758.14  2062.09  
(Σx)2 25664.04  5256.25  
((Σx)2)/n 8554.68  1752.08  












σ σσ = +  85.58    




−=  3.16 
 
 























Time: 100 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 42.10 1772.41 9.80 96.04 
Replicate, x2 58.50 3422.25 30.80 948.64 
Replicate, x3 60.40 3648.16 27.80 772.84 
Average ( x ) 53.67 2947.61 22.80 605.84 
Σx2 8842.82  1817.52  
(Σx)2 25921.00  4678.56  
((Σx)2)/n 8640.33  1559.52  












σ σσ = +  76.75    




−=  3.52 
 
 























Time: 110 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 38.90 1513.21 7.30 53.29 
Replicate, x2 54.50 2970.25 27.20 739.84 
Replicate, x3 58.70 3445.69 25.30 640.09 
Average ( x ) 50.70 2643.05 19.93 477.74 
Σx2 7929.15  1433.22  
(Σx)2 23134.41  3576.04  
((Σx)2)/n 7711.47  1192.01  












σ σσ = +  76.48    




−=  3.52 
 
 























Time: 120 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 34.10 1162.81 6.70 44.89 
Replicate, x2 52.50 2756.25 25.40 645.16 
Replicate, x3 55.70 3102.49 24.70 610.09 
Average ( x ) 47.43 2340.52 18.93 433.38 
Σx2 7021.55  1300.14  
(Σx)2 20249.29  3226.24  
((Σx)2)/n 6749.76  1075.41  












σ σσ = +  82.75    




−=  3.13 
 
 























Time: 130 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 29.40 864.36 8.90 79.21 
Replicate, x2 51.30 2631.69 23.90 571.21 
Replicate, x3 55.20 3047.04 26.90 723.61 
Average ( x ) 45.30 2181.03 19.90 458.01 
Σx2 6543.09  1374.03  
(Σx)2 18468.81  3564.09  
((Σx)2)/n 6156.27  1188.03  












σ σσ = +  95.47    




−=  2.60 
 
 























Time: 140 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 21.90 479.61 6.40 40.96 
Replicate, x2 50.00 2500.00 22.10 488.41 
Replicate, x3 55.80 3113.64 24.40 595.36 
Average ( x ) 42.57 2031.08 17.63 374.91 
Σx2 6093.25  1124.73  
(Σx)2 16307.29  2798.41  
((Σx)2)/n 5435.76  932.80  












σ σσ = +  141.57    




−=  2.10 
 
 























Time: 150 s 
 
Unpolished 0-0 x2 Unpolished 10-10 x2 
Replicate, x1 22.30 497.29 6.60 43.56 
Replicate, x2 49.20 2420.64 20.30 412.09 
Replicate, x3 50.90 2590.81 24.60 605.16 
Average ( x ) 40.80 1836.25 17.17 353.60 
Σx2 5508.74  1060.81  
(Σx)2 14981.76  2652.25  
((Σx)2)/n 4993.92  884.08  












σ σσ = +  115.26    




−=  2.20 
 











Calculations for the Students T-Test on the Cell Proliferation 
Assay Involving Sintered Compacts 
 
 
3T3 Cells Specimen 
 
Time: 3 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 0.97 0.93 0.94 0.89 
Replicate, x2 0.97 0.94 0.96 0.93 
Replicate, x3 0.96 0.92 0.93 0.87 
Replicate, x4 0.96 0.92 0.95 0.90 
Replicate, x5 0.97 0.94 0.93 0.86 
Average ( x ) 0.97 0.93 0.94 0.89 
Σx2 4.66  4.46  
(Σx)2 23.29  22.31  
((Σx)2)/n 4.66  4.46  












σ σσ = +  4.09E-05    




−=  3.22 
 
























3T3 Cells Specimen 
 
Time: 24 hrs 
 
0-0 x2 10-5 x2 
Replicate, x1 1.00 1.00 0.87 0.76 
Replicate, x2 1.05 1.09 0.89 0.78 
Replicate, x3 0.95 0.90 0.85 0.73 
Replicate, x4 0.99 0.98 0.87 0.76 
Replicate, x5 1.01 1.02 0.88 0.77 
Average ( x ) 1.00 1.00 0.87 0.76 
Σx2 5.00  3.81  
(Σx)2 24.98  19.04  
((Σx)2)/n 5.00  3.81  












σ σσ = +  2.74E-04    




−=  7.67 
 














3T3 Cells Specimen 
 







Replicate, x1 0.98 0.95 0.88 0.77 
Replicate, x2 1.04 1.07 0.91 0.83 
Replicate, x3 0.92 0.85 0.84 0.71 
Replicate, x4 0.97 0.94 0.88 0.77 
Replicate, x5 0.98 0.96 0.87 0.76 
Average ( x ) 0.98 0.96 0.88 0.77 
Σx2 4.78  3.84  
(Σx)2 23.87  19.19  
((Σx)2)/n 4.77  3.84  












σ σσ = +  4.37E-04    




−=  4.83 
 














3T3 Cells Specimen 
 







Replicate, x1 1.08 1.17 0.99 0.98 
Replicate, x2 1.10 1.22 1.06 1.13 
Replicate, x3 1.04 1.08 0.97 0.94 
Replicate, x4 1.09 1.19 1.02 1.04 
Replicate, x5 1.10 1.21 1.01 1.02 
Average ( x ) 1.08 1.17 1.01 1.02 
Σx2 5.86  5.11  
(Σx)2 29.29  25.53  
((Σx)2)/n 5.86  5.11  












σ σσ = +  3.89E-04    




−=  3.64 
 














3T3 Cells Specimen 
 







Replicate, x1 1.15 1.32 1.05 1.10 
Replicate, x2 1.24 1.54 1.12 1.26 
Replicate, x3 1.05 1.11 0.98 0.97 
Replicate, x4 1.12 1.25 1.08 1.17 
Replicate, x5 1.20 1.44 1.02 1.04 
Average ( x ) 1.15 1.33 1.05 1.11 
Σx2 6.67  5.54  
(Σx)2 33.22  27.64  
((Σx)2)/n 6.64  5.53  












σ σσ = +  1.61E-03    




−=  2.53 
 















3T3 Cells Specimen 
 







Replicate, x1 0.97 0.93 0.92 0.85 
Replicate, x2 0.97 0.94 0.92 0.85 
Replicate, x3 0.96 0.92 0.92 0.84 
Replicate, x4 0.96 0.92 0.92 0.85 
Replicate, x5 0.97 0.94 0.92 0.85 
Average ( x ) 0.97 0.93 0.92 0.85 
Σx2 4.66  4.24  
(Σx)2 23.29  21.19  
((Σx)2)/n 4.66  4.24  












σ σσ = +  6.32E-06    




−=  17.74 
 














3T3 Cells Specimen 
 







Replicate, x1 1.00 1.00 0.89 0.79 
Replicate, x2 1.05 1.09 0.90 0.80 
Replicate, x3 0.95 0.90 0.88 0.77 
Replicate, x4 0.99 0.98 0.88 0.77 
Replicate, x5 1.01 1.02 0.90 0.81 
Average ( x ) 1.00 1.00 0.89 0.79 
Σx2 5.00  3.95  
(Σx)2 24.98  19.75  
((Σx)2)/n 5.00  3.95  












σ σσ = +  2.65E-04    




−=  6.81 
 














3T3 Cells Specimen 
 







Replicate, x1 0.98 0.95 0.90 0.81 
Replicate, x2 1.04 1.07 0.91 0.82 
Replicate, x3 0.92 0.85 0.89 0.80 
Replicate, x4 0.97 0.94 0.89 0.79 
Replicate, x5 0.98 0.96 0.91 0.83 
Average ( x ) 0.98 0.96 0.90 0.81 
Σx2 4.78  4.05  
(Σx)2 23.87  20.23  
((Σx)2)/n 4.77  4.05  












σ σσ = +  3.41E-04    




−=  4.20 
 














3T3 Cells Specimen 
 







Replicate, x1 1.08 1.17 0.95 0.90 
Replicate, x2 1.10 1.22 0.98 0.95 
Replicate, x3 1.04 1.08 0.92 0.85 
Replicate, x4 1.09 1.19 0.96 0.92 
Replicate, x5 1.10 1.21 0.94 0.88 
Average ( x ) 1.08 1.17 0.95 0.90 
Σx2 5.86  4.52  
(Σx)2 29.29  22.57  
((Σx)2)/n 5.86  4.51  












σ σσ = +  2.17E-04    




−=  8.99 
 














3T3 Cells Specimen 
 







Replicate, x1 1.15 1.32 1.01 1.02 
Replicate, x2 1.24 1.54 1.05 1.10 
Replicate, x3 1.05 1.11 0.92 0.85 
Replicate, x4 1.12 1.25 1.01 1.02 
Replicate, x5 1.20 1.44 1.02 1.04 
Average ( x ) 1.15 1.33 1.00 1.01 
Σx2 6.67  5.03  
(Σx)2 33.22  25.10  
((Σx)2)/n 6.64  5.02  












σ σσ = +  1.48E-03    




−=  3.93 
 












Rat Osteoblast Specimen 
 







Replicate, x1 0.90 0.81 0.86 0.74 
Replicate, x2 0.91 0.82 0.88 0.78 
Replicate, x3 0.90 0.80 0.85 0.73 
Replicate, x4 0.90 0.81 0.87 0.76 
Replicate, x5 0.90 0.81 0.85 0.72 
Average ( x ) 0.90 0.81 0.86 0.74 
Σx2 4.06  3.72  
(Σx)2 20.28  18.60  
((Σx)2)/n 4.06  3.72  












σ σσ = +  3.65E-05    




−=  6.33 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.92 0.85 0.88 0.77 
Replicate, x2 0.97 0.93 0.89 0.80 
Replicate, x3 0.87 0.76 0.86 0.74 
Replicate, x4 0.94 0.87 0.87 0.76 
Replicate, x5 0.91 0.83 0.88 0.77 
Average ( x ) 0.92 0.85 0.88 0.77 
Σx2 4.24  3.85  
(Σx)2 21.17  19.23  
((Σx)2)/n 4.23  3.85  












σ σσ = +  2.80E-04    




−=  2.59 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.96 0.92 0.93 0.86 
Replicate, x2 0.99 0.97 0.94 0.88 
Replicate, x3 0.93 0.86 0.92 0.84 
Replicate, x4 0.97 0.94 0.94 0.88 
Replicate, x5 0.95 0.90 0.93 0.86 
Average ( x ) 0.96 0.92 0.93 0.87 
Σx2 4.60  4.33  
(Σx)2 22.97  21.66  
((Σx)2)/n 4.59  4.33  












σ σσ = +  1.13E-04    




−=  2.60 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.97 0.94 0.95 0.90 
Replicate, x2 1.03 1.07 0.99 0.98 
Replicate, x3 0.93 0.86 0.93 0.86 
Replicate, x4 0.97 0.94 0.97 0.94 
Replicate, x5 0.94 0.88 0.94 0.88 
Average ( x ) 0.97 0.94 0.95 0.91 
Σx2 4.69  4.56  
(Σx)2 23.40  22.79  
((Σx)2)/n 4.68  4.56  












σ σσ = +  4.50E-04    




−=  0.60 
 














Rat Osteoblast Specimen 
 







Replicate, x1 1.01 1.02 0.97 0.94 
Replicate, x2 1.04 1.09 1.01 1.03 
Replicate, x3 0.97 0.94 0.92 0.84 
Replicate, x4 0.99 0.98 1.00 1.00 
Replicate, x5 1.02 1.04 0.96 0.92 
Average ( x ) 1.01 1.01 0.97 0.95 
Σx2 5.07  4.73  
(Σx)2 25.32  23.64  
((Σx)2)/n 5.06  4.73  












σ σσ = +  4.47E-04    




−=  1.61 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.90 0.81 0.88 0.77 
Replicate, x2 0.91 0.82 0.88 0.78 
Replicate, x3 0.90 0.80 0.88 0.77 
Replicate, x4 0.90 0.81 0.88 0.77 
Replicate, x5 0.90 0.81 0.88 0.77 
Average ( x ) 0.90 0.81 0.88 0.78 
Σx2 4.06  3.88  
(Σx)2 20.28  19.38  
((Σx)2)/n 4.06  3.88  












σ σσ = +  3.88E-06    




−=  10.35 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.92 0.85 0.91 0.83 
Replicate, x2 0.97 0.93 0.92 0.84 
Replicate, x3 0.87 0.76 0.90 0.81 
Replicate, x4 0.94 0.87 0.90 0.81 
Replicate, x5 0.91 0.83 0.92 0.85 
Average ( x ) 0.92 0.85 0.91 0.83 
Σx2 4.24  4.13  
(Σx)2 21.17  20.65  
((Σx)2)/n 4.23  4.13  












σ σσ = +  2.71E-04    




−=  0.69 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.96 0.92 0.94 0.88 
Replicate, x2 0.99 0.97 0.97 0.94 
Replicate, x3 0.93 0.86 0.92 0.85 
Replicate, x4 0.97 0.94 0.95 0.90 
Replicate, x5 0.95 0.90 0.93 0.86 
Average ( x ) 0.96 0.92 0.94 0.89 
Σx2 4.60  4.44  
(Σx)2 22.97  22.19  
((Σx)2)/n 4.59  4.44  












σ σσ = +  1.72E-04    




−=  1.24 
 














Rat Osteoblast Specimen 
 







Replicate, x1 0.97 0.94 0.98 0.96 
Replicate, x2 1.03 1.07 1.01 1.02 
Replicate, x3 0.93 0.86 0.94 0.88 
Replicate, x4 0.97 0.94 1.00 1.00 
Replicate, x5 0.94 0.88 0.97 0.94 
Average ( x ) 0.97 0.94 0.98 0.96 
Σx2 4.69  4.80  
(Σx)2 23.40  23.97  
((Σx)2)/n 4.68  4.79  












σ σσ = +  4.98E-04    




−=  0.52 
 














Rat Osteoblast Specimen 
 







Replicate, x1 1.01 1.02 0.99 0.98 
Replicate, x2 1.04 1.09 1.01 1.02 
Replicate, x3 0.97 0.94 0.97 0.94 
Replicate, x4 0.99 0.98 0.98 0.96 
Replicate, x5 1.02 1.04 1.00 1.00 
Average ( x ) 1.01 1.01 0.99 0.98 
Σx2 5.07  4.90  
(Σx)2 25.32  24.48  
((Σx)2)/n 5.06  4.90  












σ σσ = +  2.05E-04    




−=  1.17 
 
p > 0.1 
 
